WO2013077343A1 - Polymerizable compound - Google Patents

Polymerizable compound Download PDF

Info

Publication number
WO2013077343A1
WO2013077343A1 PCT/JP2012/080130 JP2012080130W WO2013077343A1 WO 2013077343 A1 WO2013077343 A1 WO 2013077343A1 JP 2012080130 W JP2012080130 W JP 2012080130W WO 2013077343 A1 WO2013077343 A1 WO 2013077343A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
hydrogen
formula
replaced
alkylene
Prior art date
Application number
PCT/JP2012/080130
Other languages
French (fr)
Japanese (ja)
Inventor
泰行 後藤
真依子 松隈
Original Assignee
Jnc株式会社
Jnc石油化学株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jnc株式会社, Jnc石油化学株式会社 filed Critical Jnc株式会社
Priority to JP2013545941A priority Critical patent/JP6136932B2/en
Publication of WO2013077343A1 publication Critical patent/WO2013077343A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533Monocarboxylic acid esters having only one carbon-to-carbon double bond
    • C07C69/54Acrylic acid esters; Methacrylic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62Halogen-containing esters
    • C07C69/65Halogen-containing esters of unsaturated acids
    • C07C69/653Acrylic acid esters; Methacrylic acid esters; Haloacrylic acid esters; Halomethacrylic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96Esters of carbonic or haloformic acids
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0448Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • C09K2019/121Compounds containing phenylene-1,4-diyl (-Ph-)
    • C09K2019/122Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • C09K2019/121Compounds containing phenylene-1,4-diyl (-Ph-)
    • C09K2019/123Ph-Ph-Ph
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/137Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells characterised by the electro-optical or magneto-optical effect, e.g. field-induced phase transition, orientation effect, guest-host interaction or dynamic scattering
    • G02F1/13775Polymer-stabilized liquid crystal layers

Definitions

  • the present invention includes a polymerizable compound having two polymerizable groups, one directly bonded to a ring and the other having a spacer (bonding group) between the ring and the polymerizable group,
  • the present invention relates to a composition having a polymerizable compound, a polymer obtained from the composition, and uses thereof.
  • a liquid crystal display element typified by a liquid crystal display panel, a liquid crystal display module, etc. utilizes the optical anisotropy, dielectric anisotropy, etc. of the liquid crystal compound. , PC (phase changed) mode, TN (twisted nematic) mode, STN (super twisted nematic) mode, BTN (bistably twisted nematic) mode, ECB (electrically controlled birefringed birefringent) -Plane switching) mode, FFS (ringe field switching) mode, A (vertical alignment) mode, and the like.
  • PC phase changed
  • TN twisted nematic
  • STN super twisted nematic
  • BTN birefringed birefringent
  • FFS ringe field switching
  • A vertical alignment
  • a liquid crystal display element in which a polymerizable compound is added to a liquid crystal composition is known.
  • a PSA (Polymer Sustained Alignment) mode liquid crystal display element a small amount (for example, about 0.3 wt% to about 1 wt%) of a polymerizable compound is added to the liquid crystal composition, introduced into the liquid crystal display cell, and then between the electrodes.
  • the polymerizable compound is polymerized usually under UV irradiation to form a polymer structure in the cell.
  • This method is applied to various liquid crystal display elements, and modes such as PS-TN, PS-IPS, PS-FFS, PSA-VA, and PSA-OCB are known.
  • the polymerizable compound added to the liquid crystal composition used in these mode elements has a rigid skeleton. This compound is generally considered to have a high ability to align liquid crystal molecules. On the other hand, the solubility in the liquid crystal composition is poor, and a large amount of the polymerizable compound cannot be added (Patent Document 1 to Patent Document 5).
  • One object of the present invention is to provide a polymerizable compound having high solubility in a liquid crystal composition without reducing polymerization reactivity. Another object is a liquid crystal composition containing this compound and a liquid crystal display device containing such a composition. Another object is to provide a polymer obtained from a composition containing the compound, an optical element produced from the polymer, and the like.
  • the present inventor has studied the skeletal structure of a polymerizable compound used in a liquid crystal display device such as a PSA mode, and found that the compound (1) increases the solubility in the liquid crystal composition without decreasing the polymerization reactivity. It was.
  • Compound (1) has two polymerizable groups, one is directly bonded to the ring, and the other has a bonding group between the ring and the polymerizable group.
  • the compound (1) showed sufficient polymerization reactivity by having a polymerizable group directly bonded to the ring.
  • Compound (1) exhibited high solubility in the liquid crystal composition by having a linking group such as ester or alkylene between the ring and the polymerizable group.
  • a 1 is independently a single bond, 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1 , 3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in which at least one hydrogen is halogen, alkyl having 1 to 12 carbons, or At least one hydrogen may be replaced by alkyl having 1 to 12 carbons replaced by halogen;
  • a 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is halogen, alkyl having 1 to 12 carbons, or carbon in which at least one hydrogen is replaced by halogen.
  • Z 1 is alkylene having 1 to 12 carbons, in which at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH ⁇ CH—, or — May be replaced by C ⁇ C-;
  • Z 2 is independently a single bond or alkylene having 1 to 12 carbon atoms, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, — May be replaced by CH ⁇ CH—, or —C ⁇ C—;
  • X 1 is hydrogen, fluorine, methyl, or trifluoromethyl;
  • P 1 is a polymerizable group;
  • a is an integer of 0 to 3.
  • Compound (1) satisfies many advantages such as high solubility in the liquid crystal composition without lowering the polymerization reactivity.
  • a liquid crystal composition containing compound (1) as a raw material, a liquid crystal display device having a short response time and an improved degree of image sticking can be produced.
  • Liquid crystal compound is a general term for a compound having a liquid crystal phase and a compound having no liquid crystal phase but useful as a component of a liquid crystal composition.
  • the “non-polymerizable liquid crystal composition” is a liquid crystal composition composed of a liquid crystal compound having no polymerizable group.
  • a liquid crystal compound, a liquid crystal composition, and a liquid crystal display element may be referred to as a compound, a composition, and an element, respectively.
  • the compound represented by formula (1) may be referred to as compound (1) or compound of formula (1). Other formulas may be abbreviated as well.
  • Compound (1) means one compound or two or more compounds represented by formula (1). The same applies to compounds represented by other formulas.
  • the group represented by the formula (P-1) may be abbreviated as “group (P-1)”.
  • group (P-1) The same applies to groups represented by other formulas.
  • symbols such as B 11 and C 11 surrounded by hexagons correspond to the rings B 11 and C 11 , respectively.
  • Multiple R 11 were described in the same or different formula.
  • two groups represented by any two R 11 may be the same or different. This rule also applies to symbols such as rings A 1 and Z 2 .
  • the ratio of the additive mixed with the composition means a weight percentage (% by weight) based on the total weight of the liquid crystal composition.
  • —CH 2 — When at least one —CH 2 — may be replaced with —O—, the adjacent —CH 2 — may be replaced with —O— and —CH 2 — next to —O— may be replaced with —O—. It is not included to be replaced with-.
  • “Monofunctional” means that there is one polymerizable group, and “polyfunctional” means that there are two or more polymerizable groups.
  • 2-Fluoro-1,4-phenylene means the following two divalent groups.
  • fluorine may be leftward or rightward. This rule also applies to asymmetric divalent groups such as tetrahydropyran-2,5-diyl.
  • a compound represented by formula (1) is independently a single bond, 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1 , 3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in which at least one hydrogen is halogen, alkyl having 1 to 12 carbons, or At least one hydrogen may be replaced by alkyl having 1 to 12 carbons replaced by halogen;
  • a 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is halogen, alkyl having 1 to 12 carbons, or carbon in which at least one hydrogen is replaced by halogen.
  • Z 1 is alkylene having 1 to 12 carbons, in which at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH ⁇ CH—, or — May be replaced by C ⁇ C-;
  • Z 2 is independently a single bond or alkylene having 1 to 12 carbon atoms, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, — May be replaced by CH ⁇ CH—, or —C ⁇ C—;
  • X 1 is hydrogen, fluorine, methyl, or trifluoromethyl;
  • P 1 is a polymerizable group;
  • a is an integer of 0 to 3.
  • a 1 is 1,4-cyclohexylene, 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl having 1 to 4 carbons, or At least one hydrogen may be replaced by alkyl of 1 to 4 carbons replaced by halogen;
  • a 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl of 1 to 4 carbons, or at least one hydrogen is replaced by halogen Optionally substituted with 1 to 4 carbon alkyls;
  • Z 1 is alkylene having 1 to 12 carbons, in which at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH ⁇ CH—, or — May be replaced by C ⁇ C-;
  • Z 2 is a single bond or alkylene having 1 to 12 carbon atoms, and in this alkylene
  • a 1 is 1,4-cyclohexylene, 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl having 1 to 4 carbons, or At least one hydrogen may be replaced by alkyl of 1 to 4 carbons replaced by fluorine;
  • a 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl of 1 to 4 carbons, or at least one hydrogen is replaced by fluorine Optionally substituted with 1 to 4 carbon alkyls;
  • Z 1 is alkylene having 1 to 7 carbons, in which at least one —CH 2 — may be replaced by —O— or —CH ⁇ CH—;
  • Z 2 is a single bond or alkylene having 1 to 7 carbon atoms, in which at least one —CH 2 — may be replaced by —O— or —CH ⁇ CH—;
  • Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH ⁇ CH— or —C May be replaced by ⁇ C-;
  • Y 1 to Y 8 are independently hydrogen, fluorine, methyl, or trifluoromethyl;
  • Z 3 is replaced by at least one —CH 2 — with —COO—, —OCO—, —OCOO—, —CH ⁇ CH—, or —C ⁇ C—. 1 to 7 carbon atoms produced;
  • X 1 is hydrogen, fluorine, methyl, or trifluoromethyl;
  • P 1 is a polymerizable group.
  • Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — is —COO—, —OCO—, —OCOO— , —CH ⁇ CH—, or —C ⁇ C—, and at least one —CH 2 — may be replaced with —O—;
  • Y 1 to Y 8 are independently hydrogen Item 5.
  • Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — may be replaced by —O—; Y Item 5.
  • 1 to Y 8 is independently hydrogen, fluorine, methyl, or trifluoromethyl; and at least one of Y 1 to Y 8 is fluorine, methyl, or trifluoromethyl.
  • Item 6 The compound according to Item 5, wherein in Formula (1-1) according to Item 4, X 1 is hydrogen or methyl; Y 1 to Y 8 are all hydrogen.
  • Item 6 The compound according to Item 5, wherein in Formula (1-1) according to Item 4, P 1 is a group represented by Formula (P-3) according to Item 3.
  • Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH ⁇ CH— or —C May be replaced by ⁇ C-;
  • L 1 to L 12 are independently hydrogen, fluorine, methyl, or trifluoromethyl;
  • L 1 to L 12 are all hydrogen, Z 3 is replaced by at least one —CH 2 — with —COO—, —OCO—, —OCOO—, —CH ⁇ CH—, or —C ⁇ C—.
  • X 1 is hydrogen, fluorine, methyl, or trifluoromethyl;
  • P 1 is a polymerizable group.
  • Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — is —COO—, —OCO—, —OCOO— , —CH ⁇ CH—, or —C ⁇ C—, and at least one —CH 2 — may be replaced with —O—;
  • L 1 to L 12 are independently hydrogen Item 11.
  • Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — may be replaced by —O—;
  • L Item 11 The compound according to Item 10, wherein 1 to L 12 are independently hydrogen, fluorine, methyl, or trifluoromethyl; and at least one of L 1 to L 12 is fluorine, methyl, or trifluoromethyl.
  • Item 12 The compound according to Item 11, wherein in Formula (1-2) according to Item 10, X 1 is hydrogen or methyl; and L 1 to L 12 are all hydrogen.
  • Item 12 The compound according to Item 11, wherein in Formula (1-2) according to Item 10, P 1 is a group represented by Formula (P-3) according to Item 3.
  • composition comprising the compound according to any one of items 1 to 15.
  • Item 16 The composition according to item 16, wherein the compound according to any one of items 1 to 15 is added to a non-polymerizable liquid crystal composition.
  • Item 18 The composition according to item 16 or 17, further comprising at least one compound selected from the group of compounds represented by formula (2) to formula (4).
  • R 11 is independently alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, in which at least one hydrogen may be replaced by fluorine, and at least one —CH 2 - May be replaced by -O-;
  • Ring B 11 , Ring B 12 , and Ring B 13 are independently 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, tetrahydropyran-2,5-diyl, or at least one hydrogen Is 1,4-phenylene which may be replaced by fluorine;
  • Z 11 and Z 12 are independently — (CH 2 ) 2 —, — (CH 2 ) 4 —, —COO—, —CF 2 O—, —OCF 2 —, —CH ⁇ CH—, —C ⁇ .
  • Y 11 is independently fluorine, chlorine, —OCF 3 , —OCHF 2 , —CF 3 , —CHF 2 , —CH 2 F, —OCF 2 CHF 2 , or —OCF 2 CHFCF 3 ;
  • Y 12 and Y 13 are independently hydrogen or fluorine.
  • Item 19 The composition according to item 16, 17 or 18, further comprising at least one compound selected from the group of compounds represented by formula (5) to formula (7).
  • R 12 and R 13 are independently alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, in which at least one hydrogen may be replaced by fluorine, and at least one —CH 2 — may be replaced by —O—;
  • Ring C 11 , Ring C 12 , and Ring C 13 are independently 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, or 2,5-difluoro-1,4 -Phenylene;
  • Z 13 and Z 14 are independently — (CH 2 ) 2 —, —COO—, —CH ⁇ CH—, —C ⁇ C—, or a single bond.
  • Item 20 A polymer obtained by polymerizing the composition according to any one of items 16 to 19.
  • Item 20 The compound according to any one of items 1 to 15, the composition according to any one of items 16 to 19, and at least one liquid crystal display selected from the group of the polymers according to item 20 or 21. Use in devices.
  • the present invention includes the following items. 1) The above-described composition further containing an optically active compound, 2) the above-mentioned composition further containing additives such as an antioxidant, an ultraviolet absorber, and an antifoaming agent. 3) an AM device containing the above composition, 4) a device containing the above composition and having a TN, ECB, OCB, IPS, FFS, VA, or PSA mode, 5) the above composition A transmissive element containing 6) Use of the above composition as a composition having a nematic phase, 7) Use of the composition as an optically active composition by adding an optically active compound to the above composition.
  • the compound of the present invention will be described.
  • the compound of the present invention is represented by the formula (1).
  • a 1 is independently a single bond, 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2 , 5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in which at least one hydrogen is halogen, carbon number 1 May be substituted with 1 to 12 alkyls or alkyls of 1 to 12 carbons in which at least one hydrogen is replaced with a halogen.
  • a is 2 or 3
  • the two groups represented by any two A 1 may be the same or different.
  • Preferred A 1 is 1,4-cyclohexylene, 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, C 1-4 Alkyl, or alkyl having 1 to 4 carbon atoms in which at least one hydrogen is replaced by fluorine, may be substituted. More preferable A 1 is 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,3-difluoro-1,4-phenylene, 2-methyl-1,4-phenylene, 2-trifluoromethyl-1 , 4-phenylene, 2,3-bis (trifluoromethyl) -1,4-phenylene or naphthalene-2,6-diyl. Further preferred A 1 is 1,4-phenylene or 2-fluoro-1,4-phenylene, and particularly preferred A 1 is 1,4-phenylene.
  • a 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is halogen, alkyl having 1 to 12 carbons, or carbon in which at least one hydrogen is replaced by halogen. It may be substituted with an alkyl of the formula 1 to 12.
  • Preferred A 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl of 1 to 4 carbons, or at least one hydrogen is halogen. It may be replaced with substituted alkyl having 1 to 4 carbon atoms. More preferable A 2 is 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,3-difluoro-1,4-phenylene, 2-methyl-1,4-phenylene, 2-trifluoromethyl- 1,4-phenylene, 2,3-bis (trifluoromethyl) -1,4-phenylene or naphthalene-2,6-diyl. Further preferred A 2 is 1,4-phenylene or 2-fluoro-1,4-phenylene, and particularly preferred A 2 is 1,4-phenylene.
  • Z 1 is alkylene having 1 to 12 carbons, in which at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH ⁇ CH—, or — C ⁇ C— may be substituted.
  • Preferred Z 1 is alkylene having 1 to 7 carbon atoms, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH ⁇ CH—, Or it may be replaced by -C ⁇ C-. More preferred Z 1 is —COO—, —OCO—, —OCOO—, —CH ⁇ CH—, —CH ⁇ CH—O— or —C ⁇ C—. Further preferred Z 1 is —OCOO—, —CH ⁇ CH—, or —CH ⁇ CH—O—, and particularly preferred Z 1 is —CH ⁇ CH—O—.
  • Z 2 is independently a single bond or alkylene having 1 to 12 carbon atoms, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, It may be replaced by —CH ⁇ CH— or —C ⁇ C—.
  • all A 1 and A 2 are groups in which one hydrogen is not replaced, at least one of Z 1 and Z 2 has an unsaturated bond.
  • An unsaturated bond means a group containing —CH ⁇ CH—, —C ⁇ C—, or> C ⁇ O.
  • a is 2 or 3
  • two groups represented by any two Z 2 may be the same or different.
  • Preferred Z 2 is a single bond, —COO—, —OCO—, —CH ⁇ CH—, or —C ⁇ C—. More preferred Z 2 is a single bond, —COO— or —CH ⁇ CH—, and particularly preferred Z 2 is a single bond.
  • the steric configuration may be a cis form or a trans form.
  • X 1 is hydrogen, fluorine, methyl, or trifluoromethyl. Preferred X 1 is hydrogen or methyl.
  • P 1 is a polymerizable group.
  • Preferred P 1 is acryloxy group, methacryloxy group, acrylamide group, methacrylamide group, vinyl group, vinyloxy group, vinylcarbonyl group, epoxy group, oxetane group, 3,4-epoxycyclohexyl group, maleimide group, and the like. More preferred P 1 is the group (P-1) to the group (P-3). Particularly preferred P 1 is the group (P-1) or the group (P-2).
  • A is an integer from 0 to 3.
  • Preferred a is 0 to 2, and more preferred a is 1 or 2.
  • Particularly preferred a is 1.
  • Preferred examples of the compound (1) include the following compound (1-1) and compound (1-2).
  • Y 1 to Y 8 are independently hydrogen, fluorine, methyl, or trifluoromethyl.
  • Preferred Y 1 to Y 8 are hydrogen, fluorine, or trifluoromethyl. More preferred Y 1 to Y 8 are hydrogen or fluorine, and particularly preferred Y 1 to Y 8 are hydrogen.
  • L 1 to L 12 are independently hydrogen, fluorine, methyl, or trifluoromethyl.
  • Preferred L 1 to L 12 are hydrogen, fluorine, or trifluoromethyl. More preferred L 1 to L 12 are hydrogen or fluorine, and particularly preferred L 1 to L 12 are hydrogen.
  • Z 3 is alkylene having 1 to 7 carbons.
  • at least one —CH 2 — may be replaced by —O—, —COO—, —OCO—, —OCOO—, —CH ⁇ CH—, or —C ⁇ C—
  • Y 1 To Y 8 are all hydrogen, or when L 1 to L 12 are all hydrogen, Z 3 is at least one —CH 2 — is —COO—, —OCO—, —OCOO—, —CH ⁇ CH -, Or alkylene having 1 to 7 carbon atoms replaced by -C ⁇ C-.
  • Preferred Z 3 is —COO—, —OCO—, —OCOO—, —CH ⁇ CH—, —CH ⁇ CH—O— or —C ⁇ C—. More preferred Z 3 is —OCOO—, —CH ⁇ CH—, or —CH ⁇ CH—O—, and particularly preferred Z 3 is —CH ⁇ CH—O—.
  • Z 3 is a group having a double bond such as —CH ⁇ CH—, the configuration thereof may be a cis isomer or a trans isomer.
  • X 1 is hydrogen, fluorine, methyl, or trifluoromethyl. More preferred X 1 is hydrogen or fluorine.
  • P 1 is a polymerizable group.
  • Preferred P 1 is acryloxy group, methacryloxy group, acrylamide group, methacrylamide group, vinyl group, vinyloxy group, vinylcarbonyl group, epoxy group, oxetane group, 3,4-epoxycyclohexyl group, maleimide group, and the like. More preferred P 1 is the group (P-1) to the group (P-3). Particularly preferred P 1 is the group (P-1) or the group (P-2).
  • More preferred examples of the compound (1) include the following compound (1-1-1) and compound (1-2-1).
  • Y 1 to Y 8 are hydrogen. One of Y 1 to Y 8 may be fluorine, methyl or trifluoromethyl.
  • L 1 to L 12 are hydrogen. One of L 1 to L 12 may be fluorine, methyl or trifluoromethyl.
  • X 1 and X 2 are independently hydrogen or methyl.
  • compound (1) More preferred examples include the following compound (1-1-2) and compound (1-2-2).
  • X 1 and X 2 are independently hydrogen or methyl.
  • composition of the present invention contains at least one compound (1), but may contain two or more compounds (1).
  • the composition may further contain other polymerizable compound.
  • Preferred examples of other polymerizable compounds are acrylate, methacrylate, vinyl compound, vinyloxy compound, propenyl ether, epoxy compound (oxirane, oxetane), and vinyl ketone.
  • Further preferred examples are compounds having at least one acryloyloxy and compounds having at least one methacryloyloxy.
  • Further preferred examples include compounds having acryloyloxy and methacryloyloxy.
  • R 20 is hydrogen or methyl; s is 0 or 1; t and u are independently integers from 1 to 10.
  • the symbol F in parentheses means hydrogen or fluorine.
  • Compound (1) may be added to the non-polymerizable liquid crystal composition.
  • a preferable composition is a liquid crystal composition which can be used for a liquid crystal display element.
  • the composition of the present invention needs to contain compound (1) as component A.
  • the composition may be composed of only the component A, or the composition of the component A and other components not specifically indicated in the present specification, but the component A is selected from the following components B and C.
  • Component B consisting of at least one compound selected from the group consisting of Compound (2), Compound (3), and Compound (4) is preferable. Further, by mixing Component C consisting of at least one compound selected from the group consisting of Compound (5), Compound (6), and Compound (7), the threshold voltage, the temperature range of the liquid crystal phase, and the optical difference are mixed. The directionality, dielectric anisotropy, viscosity and the like can be adjusted.
  • the compound (1) may contain an isotope such as 2 H (deuterium) and 13 C in an amount larger than the natural abundance. The same applies to the component compounds added to the liquid crystal composition.
  • compounds (2-1) to (2-13) are preferred examples of compound (2), and compounds (3-1) to (3-109) are preferred examples of compound (3).
  • preferred examples of compound (4) include compounds (4-1) to (4-55).
  • R 11 and Y 11 are the same as described above.
  • a liquid crystal composition for TFT is prepared.
  • the content of component B in the liquid crystal composition is suitably in the range of about 1% to about 99% by weight, preferably in the range of about 10% to about 97% by weight, based on the total weight of the liquid crystal composition. Preferably it is in the range of about 40% to about 95% by weight.
  • a viscosity can be adjusted by further including a compound (5) to a compound (7) (component C).
  • Preferred examples of compound (5), compound (6), and compound (7) include compound (5-1) to compound (5-10) and compound (6-1) to compound (6-14). ), And compound (7-1) to compound (7-6).
  • R 12 and R 13 are the same as described above.
  • Compound (5) to Compound (7) are compounds having a small absolute value of dielectric anisotropy and close to neutrality.
  • the compound (5) mainly has the effect of adjusting the viscosity or the optical anisotropy
  • the compound (6) and the compound (7) have the effect of expanding the temperature range of the nematic phase by increasing the clearing point, or the like.
  • the content of component C decreases the viscosity of the liquid crystal composition, but increases the threshold voltage. Therefore, as long as the required value of the threshold voltage of the liquid crystal composition is satisfied, the content is preferably large.
  • the content of component C is preferably about 30% by weight or more, more preferably about 50% by weight or more based on the total amount of the composition.
  • composition of the present invention preferably contains at least one compound (1) in a proportion of about 0.05 wt% to about 20 wt%. Further, it is more preferable that at least one of the compounds (1) is contained at a ratio of about 0.1 wt% to about 10 wt%.
  • the composition of the present invention is generally prepared by a known method, for example, a method of dissolving necessary components at a high temperature.
  • an additive well known to those skilled in the art may be added depending on the application, for example, to prepare a composition containing an optically active compound as described below, or a composition for GH type to which a dye is added. it can.
  • Such additives are well known to those skilled in the art and are described in the literature.
  • the composition of the present invention may further contain one or more optically active compounds.
  • an optically active compound a known chiral dopant can be added. This chiral dopant has the effect of inducing the helical structure of the liquid crystal to adjust the necessary twist angle and preventing reverse twist.
  • the chiral dopant include the following compounds (Op-1) to (Op-18).
  • ring E is 1,4-cyclohexylene or 1,4-phenylene
  • R 24 is alkyl having 1 to 10 carbons.
  • composition of the present invention can be used as a liquid crystal composition for GH type by adding dichroic dyes such as merocyanine, styryl, azo, azomethine, azoxy, quinophthalone, anthraquinone, and tetrazine. You can also
  • the composition of the present invention includes NCAP produced by encapsulating nematic liquid crystal, polymer dispersed liquid crystal display device (PDLCD) produced by forming a three-dimensional network polymer in liquid crystal, for example, polymer network liquid crystal display device ( It can be used as a liquid crystal composition for birefringence control (ECB) type and DS type as well as for PNLCD.
  • NCAP produced by encapsulating nematic liquid crystal
  • PLCD polymer dispersed liquid crystal display device
  • It can be used as a liquid crystal composition for birefringence control (ECB) type and DS type as well as for PNLCD.
  • additives such as a polymerization initiator, an antioxidant, an ultraviolet absorber, a light stabilizer, a heat stabilizer, and an antifoaming agent to the composition of the present invention.
  • An antioxidant is effective for maintaining a large voltage holding ratio.
  • Preferred examples of the antioxidant include the following compounds (AO-1) and (AO-2); and IRGANOX 415, IRGANOX 565, IRGANOX 1010, IRGANOX 1035, IRGANOX 3114, and IRGANOX 1098 (trade name: BASF) Can be mentioned.
  • the ultraviolet absorber is effective for preventing a decrease in the maximum temperature.
  • Preferred examples of the ultraviolet absorber include benzophenone derivatives, benzoate derivatives, triazole derivatives and the like.
  • TINUVIN 329 As specific examples, the following compounds (AO-3) and (AO-4): TINUVIN 329, TINUVIN P, TINUVIN 326, TINUVIN 234, TINUVIN 213, TINUVIN 400, TINUVIN 328, and TINUVIN 99-2 (trade name: BASF Corporation) And 1,4-diazabicyclo [2.2.2] octane (DABCO).
  • a light stabilizer such as an amine having steric hindrance is preferable in order to maintain a large voltage holding ratio.
  • Preferred examples of the light stabilizer include the following compounds (AO-5) and (AO-6); TINUVIN 144, TINUVIN 765, and TINUVIN 770DF (trade name: BASF).
  • a thermal stabilizer is also effective for maintaining a large voltage holding ratio, and a preferred example is IRGAFOS 168 (trade name: BASF).
  • Antifoaming agents are effective for preventing foaming.
  • Preferred examples of the antifoaming agent include dimethyl silicone oil and methylphenyl silicone oil.
  • R 25 represents alkyl having 1 to 20 carbons, alkoxy having 1 to 20 carbons, —COOR 26 , or —CH 2 CH 2 COOR 26 ; R 26 represents 1 to 20 carbons. Of alkyl.
  • R 27 is alkyl having 1 to 20 carbons.
  • ring F and ring G is 1,4-cyclohexylene or 1,4-phenylene, v is 0, 1 or 2,, R 28 is hydrogen, methyl or O ⁇ It is.
  • the compound of the present invention is suitable for radical polymerization. Polymerization can be carried out more rapidly by adding a polymerization initiator or optimizing the reaction temperature, but a polymerization initiator may or may not be added.
  • photo radical polymerization initiator examples include specific trade names, such as TPO, 1173 and 4265 from Darocur series of Ciba Specialty Chemicals Co., Ltd., 184, 369, 500, 651, 784, 819 from Irgacure series. 907, 1300, 1700, 1800, 1850, 2959, any known radical photopolymerization initiator can be used.
  • radical photopolymerization initiators include 4-methoxyphenyl-2,4-bis (trichloromethyl) triazine, 2- (4-butoxystyryl) -5-trichloromethyl-1,3,4-oxadiazole 9-phenylacridine, 9,10-benzphenazine, benzophenone / Michler's ketone mixture, hexaarylbiimidazole / mercaptobenzimidazole mixture, 1- (4-isopropylphenyl) -2-hydroxy-2-methylpropan-1-one, Benzyldimethyl ketal, 2-methyl-1- [4- (methylthio) phenyl] -2-morpholinopropan-1-one, 2,4-diethylxanthone / methyl p-dimethylaminobenzoate, benzophenone / methyltriethanolamine A mixture but known Photoradical polymerization initiator les may also be used.
  • the polymer of the present invention can be produced by polymerizing the compound (1) or a composition containing them. When only one of the compounds (1) is polymerized, a homopolymer is obtained. When a composition containing a plurality of polymerizable compounds is polymerized, a copolymer is obtained. When a composition obtained by adding the compound (1) to a non-polymerizable liquid crystal composition is polymerized, a homopolymer of the compound (1) is contained in the non-polymerizable liquid crystal composition. This composition is also called a polymer.
  • Polymerization can be carried out by irradiating energy (electromagnetic waves).
  • electromagnetic waves are ultraviolet rays, infrared rays, visible rays, X-rays, ⁇ rays, and the like.
  • high energy particles such as ions and electrons may be irradiated.
  • the orientation of compound (1) or this composition can be fixed by irradiation with electromagnetic waves.
  • the wavelength range of the electromagnetic wave is preferably 150 nm to 500 nm.
  • a more preferable range is 250 nm to 450 nm, and a particularly preferable range is 300 nm to 400 nm.
  • the temperature at the time of irradiation is a temperature at which the compound (1) or this composition is in a liquid crystal state, but is preferably 100 ° C. or lower in order to prevent thermal polymerization.
  • Compound (1) is polymerized or crosslinked by polymerizing in the liquid crystal composition between the substrates of the liquid crystal display element. Polymerization may be performed in a state where a voltage or a magnetic field is applied. A preferred polymerization method is, for example, heat or photopolymerization, preferably photopolymerization. If necessary, a polymerization initiator can be added here. Polymerization conditions and suitable types of polymerization initiators are known to those skilled in the art and are described in the literature.
  • Compound (1) is excellent in that it reacts quickly without using a polymerization initiator. As a result, it is possible to reduce display defects due to unreacted radical photopolymerization initiator or its decomposition products and to prolong the product life.
  • the polymerizable compound of the present invention may be used alone or in combination with other polymerizable compounds. Examples of the polymerizable compound that can be used in combination include commercially available or known monomers, for example, existing monofunctional or polyfunctional liquid crystalline monomers suitable for liquid crystal display elements described in JP-A No. 2004-123829.
  • the liquid crystal display element of the present invention has, for example, two substrates provided with a transparent electrode and an alignment control film for aligning liquid crystal molecules.
  • a liquid crystal composition containing a polymerizable compound is disposed between these substrates.
  • a device is manufactured by polymerizing the polymerizable compound in these substrates. The polymerization may be performed while applying a voltage.
  • MSG 1 (or MSG 2 ) is a monovalent organic group having at least one ring.
  • the monovalent organic groups represented by a plurality of MSG 1 (or MSG 2 ) may be the same or different. From compound (1A) to compound (1L) corresponds to compound (1).
  • Compound (1A) is synthesized by reacting arylboric acid (Q1) with compound (Q2) synthesized by a known method in an aqueous carbonate solution in the presence of a catalyst such as tetrakis (triphenylphosphine) palladium. .
  • This compound (1A) is obtained by reacting compound (Q3) synthesized by a known method with n-butyllithium and then with zinc chloride, and in the presence of a catalyst such as dichlorobis (triphenylphosphine) palladium. ) Is also reacted.
  • Compound (1B) is synthesized by reacting a phosphonium salt (Q5) synthesized by a known method with a base such as potassium t-butoxide and a phosphorus ylide generated with aldehyde (Q4).
  • Compound (1C) is synthesized by hydrogenating compound (1B) in the presence of a catalyst such as palladium carbon.
  • Compound (Q4) is reduced with a reducing agent such as sodium borohydride to obtain compound (Q8). This is brominated with hydrobromic acid or the like to obtain compound (Q9).
  • Compound (1F) is synthesized by reacting compound (Q9) with compound (Q10) in the presence of potassium carbonate or the like. A compound having —CH 2 O— can also be synthesized by this method.
  • Compound (Q3) is reacted with n-butyllithium and subsequently with carbon dioxide to obtain carboxylic acid (Q11).
  • Compound (1G) having —COO— is synthesized by dehydrating compound (Q11) and phenol (Q16) in the presence of DCC (1,3-dicyclohexylcarbodiimide) and DMAP (4-dimethylaminopyridine). To do.
  • a compound having —OCO— can also be synthesized by this method.
  • Compound (1J) is synthesized by reacting compound (Q13) with compound (Q2) in the presence of a catalyst of dichloropalladium and copper halide.
  • carboxylic acid (Q14) is obtained by the action of carbon dioxide.
  • Carboxylic acid (Q14) and phenol (Q16) are dehydrated in the presence of DCC and DMAP to synthesize compound (1K) having —C ⁇ C—COO—.
  • a compound having —OCO—C ⁇ C— can also be synthesized by this method.
  • Compound (1L) having —C ⁇ C—CH ⁇ CH— can be synthesized by cross-coupling reaction of compound (Q13) and vinyl bromide (Q15). When the cis-form compound (Q15) is used, a cis-form (1L) is produced.
  • the polymerizable group (P-1) or group (P-2) can be introduced by allowing an acid chloride (or acid anhydride) of acrylic acid or methacrylic acid to act on an organic group having a hydroxyl group.
  • the polymerizable group (P-3) can be introduced by a Grignard reaction between a halogen-containing organic group and vinyl bromide.
  • the composition is prepared from the compound thus obtained by known methods. For example, the component compounds are mixed and dissolved in each other by heating.
  • the compound (a-292) is synthesized from the compound (a-1) by the above method.
  • % means “% by weight”.
  • Example of Compound The synthesized compound was identified by proton nuclear magnetic resonance spectroscopy ( 1 H-NMR) and the like. The melting point of the compound was determined by differential scanning calorimetry (DSC). First, each analysis method will be described.
  • HPLC analysis Prominence (LC-20AD; SPD-20A) manufactured by Shimadzu Corporation was used as the measurement apparatus.
  • YMC-Pack ODS-A length 150 mm, inner diameter 4.6 mm, particle diameter 5 ⁇ m
  • acetonitrile and pure water were appropriately mixed and used.
  • a detector a UV detector, an RI detector, a CORONA detector, or the like was appropriately used. When a UV detector was used, the detection wavelength was 254 nm.
  • the sample was dissolved in acetonitrile to prepare a 0.1 wt% solution, and 1 ⁇ L of this solution was introduced into the sample chamber.
  • a recorder a C-R7Aplus manufactured by Shimadzu Corporation was used.
  • the obtained chromatogram shows the peak retention time and peak area values corresponding to the component compounds.
  • the peak area ratio in the chromatogram obtained from HPLC corresponds to the ratio of the component compounds.
  • the weight% of the component compound of the analysis sample is not completely the same as the area% of each peak of the analysis sample.
  • the correction factor is substantially 1. Therefore, the weight% of the component compound in the analysis sample substantially corresponds to the area% of each peak in the analysis sample. This is because there is no significant difference in the correction coefficients of the component liquid crystal compounds.
  • DSC measurement Using a scanning calorimeter DSC-7 system manufactured by PerkinElmer or a Diamond DSC system, the temperature is raised and lowered at a rate of 3 ° C / min. The melting point was determined by insertion.
  • Phase structure A sample (compound) is placed on a hot plate (Mettler FP-52 type hot stage) of a melting point measurement apparatus equipped with a polarizing microscope, and the phase state and its change are heated while heating at a rate of 3 ° C / min. Observation with a polarizing microscope identified the type of phase.
  • the crystal was represented as C. When the types of crystals can be distinguished, they are expressed as C 1 or C 2 , respectively.
  • the smectic phase is represented as S and the nematic phase is represented as N.
  • the smectic phase when a smectic A phase, a smectic B phase, a smectic C phase, or a smectic F phase can be distinguished, they are represented as S A , S B , S C , or S F , respectively.
  • the liquid (isotropic) was designated as I.
  • the transition temperature is expressed as “C 50.0 N 100.0 I”, for example. This indicates that the transition temperature (CN) from the crystal to the nematic phase is 50.0 ° C., and the transition temperature (clearing point) from the nematic phase to the liquid is 100.0 ° C.
  • T C Minimum Temperature of a Nematic Phase
  • a sample having a nematic phase was stored in a freezer at 0 ° C., ⁇ 10 ° C., ⁇ 20 ° C., ⁇ 30 ° C., and ⁇ 40 ° C. for 10 days, and then the liquid crystal phase was observed.
  • TC was described as ⁇ ⁇ 20 ° C.
  • the lower limit temperature of the nematic phase may be abbreviated as “lower limit temperature”.
  • Viscosity (bulk viscosity; ⁇ ; measured at 20 ° C .; mPa ⁇ s) It measured using the E-type rotational viscometer.
  • Viscosity (Rotational viscosity; ⁇ 1; measured at 25 ° C .; mPa ⁇ s) The measurement followed the method described in M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, 37 (1995). A sample was put in a TN device having a twist angle of 0 ° and a distance (cell gap) between two glass substrates of 5 ⁇ m. A voltage was applied to this device in steps of 0.5 V in the range of 16 V to 19.5 V. After no application for 0.2 seconds, the application was repeated under the condition of only one rectangular wave (rectangular pulse; 0.2 seconds) and no application (2 seconds). The peak current and peak time of the transient current generated by this application were measured.
  • Threshold voltage (Vth; measured at 25 ° C .; V) An LCD5100 luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement.
  • the light source is a halogen lamp.
  • a sample was put in a normally white mode TN device in which the distance between two glass substrates (cell gap) was about 0.45 / ⁇ n ( ⁇ m) and the twist angle was 80 degrees.
  • the voltage (32 Hz, rectangular wave) applied to this element was increased stepwise from 0V to 10V by 0.02V.
  • the device was irradiated with light from the vertical direction, and the amount of light transmitted through the device was measured.
  • a voltage-transmittance curve was created in which the transmittance was 100% when the light amount reached the maximum and the transmittance was 0% when the light amount was the minimum.
  • the threshold voltage is a voltage when the transmittance reaches 90%.
  • Second Step Synthesis of Compound (a-4)
  • compound (S-3) (16.0 g, 0.0629 mol), triethylamine (3.82 g, 0.0377 mol), BHT (5.000 mg, 0 0.020 mmol) and dichloromethane (200 mL) were added dropwise a solution of compound (S-4) (4.17 g, 0.0346 mol) in dichloromethane (10 mL) under ice cooling, and then the temperature was gradually raised to room temperature. After stirring at room temperature for 16 hours, the reaction solution was poured into water, and the organic layer was washed successively with 1M hydrochloric acid, saturated brine, and 1M aqueous sodium hydroxide.
  • MTBE methyl tert-butyl ether
  • hexane 1: 1 (volume ratio)
  • Washed with 0.6M aqueous sodium hydroxide Washed with 0.6M aqueous sodium hydroxide.
  • the organic solvent was distilled off under reduced pressure to obtain compound (S-10) as a yellow liquid (47.1 g).
  • Example of Composition The liquid crystal composition of the present invention will be described in detail by way of examples. The present invention is not limited by the following examples.
  • the compounds in Examples were represented by symbols based on the definitions in Table 1 below.
  • Table 1 the configuration regarding 1,4-cyclohexylene is trans.
  • the ratio (percentage) of the liquid crystal compound is a weight percentage (% by weight) based on the total weight of the liquid crystal composition.
  • Example 13 (Use Example 1) 2-HH-3 15% 3-HH-4 5% 3-HB-O2 5% 3-HHB-1 8% 3-HHB-3 2% 3-HBB-F 20% 2-HHB (F, F) -F 14% 3-HHB (F, F) -F 4% 3-HBB (F, F) -F 2% 5-HBB (F, F) -F 6% 2-HHBB (F, F) -F 8% 3-HHBB (F, F) -F 5% 4-HHBB (F, F) -F 6% 0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
  • Example 14 (Use Example 2) 5-HB-CL 16% 3-HH-4 12% 3-HH-5 4% 3-HHB-F 4% 3-HHB-CL 3% 4-HHB-CL 4% 3-HHB (F) -F 10% 4-HHB (F) -F 9% 5-HHB (F) -F 9% 7-HHB (F) -F 8% 5-HBB (F) -F 4% 1O1-HBBH-5 3% 3-HHBB (F, F) -F 2% 4-HHBB (F, F) -F 3% 5-HHBB (F, F) -F 3% 3-HH2BB (F, F) -F 3% 4-HH2BB (F, F) -F 3% 0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
  • Example 15 (Use Example 3) 3-HHB (F, F) -F 9% 3-H2HB (F, F) -F 8% 4-H2HB (F, F) -F 8% 5-H2HB (F, F) -F 8% 3-HBB (F, F) -F 21% 5-HBB (F, F) -F 20% 3-H2BB (F, F) -F 10% 5-HHBB (F, F) -F 3% 5-HHEBB-F 2% 3-HH2BB (F, F) -F 3% 1O1-HBBH-4 4% 1O1-HBBH-5 4% 0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
  • Example 16 (Use Example 4) 5-HB-F 12% 6-HB-F 9% 7-HB-F 7% 2-HHB-OCF3 7% 3-HHB-OCF3 7% 4-HHB-OCF3 7% 5-HHB-OCF3 5% 3-HH2B-OCF3 4% 5-HH2B-OCF3 4% 3-HHB (F, F) -OCF2H 4% 3-HHB (F, F) -OCF3 5% 3-HH2B (F) -F 3% 3-HBB (F) -F 10% 5-HBB (F) -F 10% 5-HBBH-3 3% 3-HB (F) BH-3 3% 0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
  • Example 17 (Use Example 5) 5-HB-CL 11% 3-HH-4 8% 3-HHB-1 5% 3-HHB (F, F) -F 8% 3-HBB (F, F) -F 20% 5-HBB (F, F) -F 15% 3-HHEB (F, F) -F 10% 4-HHEB (F, F) -F 3% 5-HHEB (F, F) -F 3% 2-HBEB (F, F) -F 3% 3-HBEB (F, F) -F 5% 5-HBEB (F, F) -F 3% 3-HHBB (F, F) -F 6% 0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
  • Example 18 (Use Example 6) 3-HB-CL 6% 5-HB-CL 4% 3-HHB-OCF3 5% 3-H2HB-OCF3 5% 5-H4HB-OCF3 15% V-HHB (F) -F 5% 3-HHB (F) -F 5% 5-HHB (F) -F 5% 3-H4HB (F, F) -CF3 8% 5-H4HB (F, F) -CF3 10% 5-H2HB (F, F) -F 5% 5-H4HB (F, F) -F 7% 2-H2BB (F) -F 5% 3-H2BB (F) -F 10% 3-HBEB (F, F) -F 5% 0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
  • Example 19 (Use Example 7) 5-HB-CL 17% 7-HB (F, F) -F 3% 3-HH-4 10% 3-HH-5 5% 3-HB-O2 15% 3-HHB-1 8% 3-HHB-O1 5% 2-HHB (F) -F 7% 3-HHB (F) -F 7% 5-HHB (F) -F 7% 3-HHB (F, F) -F 6% 3-H2HB (F, F) -F 5% 4-H2HB (F, F) -F 5% 0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
  • Example 20 (Use Example 8) 5-HB-CL 3% 7-HB (F) -F 7% 3-HH-4 9% 3-HH-EMe 23% 3-HHEB-F 8% 5-HHEB-F 8% 3-HHEB (F, F) -F 10% 4-HHEB (F, F) -F 5% 4-HGB (F, F) -F 5% 5-HGB (F, F) -F 6% 2-H2GB (F, F) -F 4% 3-H2GB (F, F) -F 5% 5-GHB (F, F) -F 7% 0.15 parts by weight of the following compound is added to 100 parts by weight of the composition, Further, 0.15 parts by weight of the following compound was added.
  • Step 1 Synthesis was performed in the same manner as in Step 3 of [Example 2] except that the compound (S-8) was changed to the compound (S-1), and colorless crystals of the compound (R-1) were obtained. .

Abstract

Provided is a compound having two polymerizable groups, one bonding directly to a ring, the other having a spacer between a ring and the polymerizable group, as a compound having high solubility in a liquid crystal composition without lowering the polymerization reactivity. A compound represented by formula (1). In formula (1), for example, A1 and A2 are 1,4-phenylene in which at least one hydrogen has been substituted by fluorine; Z1 is an alkylene having from 1 to 12 carbon atoms; Z2 is an alkylene having from 1 to 12 carbon atoms; X1 is hydrogen, fluorine, methyl, or trifluoromethyl; P1 is a polymerizable group; and a is an integer of from 0 to 3.

Description

重合性化合物Polymerizable compound
 本発明は、重合可能な基を2つ有し、1つは環に直接結合しており、もう一方は環と重合可能な基との間にスペーサー(結合基)を有する重合性化合物、この重合性化合物を有する組成物、この組成物から得られる重合体、およびこれらの用途に関する。 The present invention includes a polymerizable compound having two polymerizable groups, one directly bonded to a ring and the other having a spacer (bonding group) between the ring and the polymerizable group, The present invention relates to a composition having a polymerizable compound, a polymer obtained from the composition, and uses thereof.
 液晶表示パネル、液晶表示モジュール等に代表される液晶表示素子は、液晶性化合物が有する光学異方性、誘電率異方性などを利用したものであるが、この液晶表示素子の動作モードとしては、PC(phase change)モード、TN(twisted nematic)モード、STN(super twisted nematic)モード、BTN(bistable twisted nematic)モード、ECB(electrically controlled birefringence)モード、OCB(optically compensated bend)モード、IPS(in-plane switching)モード、FFS(fringe field switching)モード、VA(vertical alignment)モードなどである。 A liquid crystal display element typified by a liquid crystal display panel, a liquid crystal display module, etc. utilizes the optical anisotropy, dielectric anisotropy, etc. of the liquid crystal compound. , PC (phase changed) mode, TN (twisted nematic) mode, STN (super twisted nematic) mode, BTN (bistably twisted nematic) mode, ECB (electrically controlled birefringed birefringent) -Plane switching) mode, FFS (ringe field switching) mode, A (vertical alignment) mode, and the like.
 加えて、液晶組成物に重合性化合物を添加した液晶表示素子が知られている。例えばPSA(Polymer Sustained Alignment)モードの液晶表示素子では、少量(例えば約0.3重量%から約1重量%)の重合性化合物が液晶組成物に添加され、液晶表示セルに導入後、電極間に電圧を印加した状態で通常UV照射下に重合性化合物を重合させ、セル内でポリマー構造を形成する。この方法により、焼き付きの程度を改善し、さらに応答時間の短い液晶表示素子が得られる。 In addition, a liquid crystal display element in which a polymerizable compound is added to a liquid crystal composition is known. For example, in a PSA (Polymer Sustained Alignment) mode liquid crystal display element, a small amount (for example, about 0.3 wt% to about 1 wt%) of a polymerizable compound is added to the liquid crystal composition, introduced into the liquid crystal display cell, and then between the electrodes. In the state where a voltage is applied to the polymerizable compound, the polymerizable compound is polymerized usually under UV irradiation to form a polymer structure in the cell. By this method, the degree of image sticking is improved, and a liquid crystal display element with a shorter response time is obtained.
 この方法は、様々な液晶表示素子に適用され、PS-TN、PS-IPS、PS-FFS、PSA-VA、PSA-OCBなどのモードが知られている。これらのモードの素子で使用される液晶組成物に添加する重合性化合物は、剛直な骨格を有する。この化合物は一般に、液晶分子を配向させる能力が高いとされている。その反面、液晶組成物への溶解性が悪く、多くの量の重合性化合物を添加することができない(特許文献1から特許文献5)。 This method is applied to various liquid crystal display elements, and modes such as PS-TN, PS-IPS, PS-FFS, PSA-VA, and PSA-OCB are known. The polymerizable compound added to the liquid crystal composition used in these mode elements has a rigid skeleton. This compound is generally considered to have a high ability to align liquid crystal molecules. On the other hand, the solubility in the liquid crystal composition is poor, and a large amount of the polymerizable compound cannot be added (Patent Document 1 to Patent Document 5).
特開2003-307720号公報JP 2003-307720 A 特開2004-131704号公報JP 2004-131704 A 特開2006-133619号公報JP 2006-133619 A 欧州特許出願公開1889894号明細書European Patent Application Publication No. 1898894 特表2010-537256号公報Special table 2010-537256
 本発明の1つの目的は、重合反応性を低下させずに液晶組成物への高い溶解性を有する重合性化合物を提供することである。他の目的はこの化合物を含有する液晶組成物、およびこのような組成物を含有する液晶表示素子である。別の目的はこの化合物を含む組成物から得られる重合体、およびこの重合体から製造した光学素子などを提供することである。 One object of the present invention is to provide a polymerizable compound having high solubility in a liquid crystal composition without reducing polymerization reactivity. Another object is a liquid crystal composition containing this compound and a liquid crystal display device containing such a composition. Another object is to provide a polymer obtained from a composition containing the compound, an optical element produced from the polymer, and the like.
 本発明者はPSAモードなどの液晶表示素子に用いる重合性化合物の骨格構造を検討し、化合物(1)が、重合反応性を低下させずに、液晶組成物への溶解性を高めることを見出した。化合物(1)は重合可能な基を2つ有し、1つは環に直接結合しており、もう一方は環と重合可能な基との間に結合基を有する。化合物(1)は、環に直接結合している重合可能な基を有することにより、十分な重合反応性を示した。化合物(1)は、環と重合可能な基との間にエステルやアルキレンなどの結合基を有することにより、液晶組成物への高い溶解性を示した。 The present inventor has studied the skeletal structure of a polymerizable compound used in a liquid crystal display device such as a PSA mode, and found that the compound (1) increases the solubility in the liquid crystal composition without decreasing the polymerization reactivity. It was. Compound (1) has two polymerizable groups, one is directly bonded to the ring, and the other has a bonding group between the ring and the polymerizable group. The compound (1) showed sufficient polymerization reactivity by having a polymerizable group directly bonded to the ring. Compound (1) exhibited high solubility in the liquid crystal composition by having a linking group such as ester or alkylene between the ring and the polymerizable group.
 式(1)で表わされる化合物。
Figure JPOXMLDOC01-appb-I000008
A compound represented by formula (1).
Figure JPOXMLDOC01-appb-I000008
式(1)において、
 Aは独立して、単結合、1,4-シクロへキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、またはピリジン-2,5-ジイルであり、これらにおいて、少なくとも1つの水素は、ハロゲン、炭素数1から12のアルキル、または少なくとも1つの水素がハロゲンで置き換えられた炭素数1から12のアルキルで、置き換えられてもよく;
 Aは1,4-フェニレンまたはナフタレン-2,6-ジイルであり、これらにおいて、少なくとも1つの水素は、ハロゲン、炭素数1から12のアルキル、または少なくとも1つの水素がハロゲンで置き換えられた炭素数1から12のアルキルで、置き換えられてもよく;
 Zは炭素数1から12のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよく;
 Zは独立して、単結合または炭素数1から12のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよく;
 すべてのAおよびAが、1つの水素も置き換えられていない基の場合、ZおよびZの少なくとも1つが不飽和結合を有しており;
 Xは、水素、フッ素、メチル、またはトリフルオロメチルであり;
 Pは重合可能な基であり;
 aは0から3の整数である。
In equation (1),
A 1 is independently a single bond, 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1 , 3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in which at least one hydrogen is halogen, alkyl having 1 to 12 carbons, or At least one hydrogen may be replaced by alkyl having 1 to 12 carbons replaced by halogen;
A 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is halogen, alkyl having 1 to 12 carbons, or carbon in which at least one hydrogen is replaced by halogen. May be substituted with an alkyl of the number 1 to 12;
Z 1 is alkylene having 1 to 12 carbons, in which at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH═CH—, or — May be replaced by C≡C-;
Z 2 is independently a single bond or alkylene having 1 to 12 carbon atoms, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, — May be replaced by CH═CH—, or —C≡C—;
When all A 1 and A 2 are groups in which no hydrogen is replaced, at least one of Z 1 and Z 2 has an unsaturated bond;
X 1 is hydrogen, fluorine, methyl, or trifluoromethyl;
P 1 is a polymerizable group;
a is an integer of 0 to 3.
 化合物(1)は重合反応性を低下させずに液晶組成物への高い溶解性を有するなどの利点を多く充足する。化合物(1)を含有する液晶組成物を原料にすることによって、短い応答時間を有し、焼き付きの程度が改善された液晶表示素子を製造することができる。 Compound (1) satisfies many advantages such as high solubility in the liquid crystal composition without lowering the polymerization reactivity. By using a liquid crystal composition containing compound (1) as a raw material, a liquid crystal display device having a short response time and an improved degree of image sticking can be produced.
 この明細書における用語の使い方は次のとおりである。「液晶性化合物」は、液晶相を有する化合物および液晶相を有しないが液晶組成物の成分として有用な化合物の総称である。「非重合性の液晶組成物」とは、重合可能な基を有しない液晶化合物からなる液晶組成物である。液晶性化合物、液晶組成物、液晶表示素子をそれぞれ化合物、組成物、素子と表記することがある。式(1)で表わされる化合物を化合物(1)または式(1)の化合物と表記することがある。他の式についても同様に略記することがある。「化合物(1)」は、式(1)で表される1つの化合物または2つ以上の化合物を意味する。他の式で表される化合物についても同様である。式(P-1)で表される基を「基(P-1)」と略すことがある。他の式で表される基についても同様である。式(2)から(7)において、六角形で囲んだB11、C11などの記号は、それぞれ環B11、環C11などに対応する。複数のR11を同一の式または異なった式に記載した。これらの化合物において、任意の2つのR11が表わす2つの基は、同一であってもよいし、または異なってもよい。このルールは、環A、Zなどの記号にも適用される。組成物に混合される添加物の割合は、液晶組成物の全重量に基づいた重量百分率(重量%)を意味する。少なくとも1つの-CH-が-O-で置き換えられてもよいとするとき、隣り合った-CH-が-O-で置き換えられることおよび-O-の隣の-CH-が-O-で置き換えられることは含まれない。「単官能」とは、重合性基が1つであることで、「多官能」とは、重合性基が2つ以上あることを示す。 Terms used in this specification are as follows. “Liquid crystal compound” is a general term for a compound having a liquid crystal phase and a compound having no liquid crystal phase but useful as a component of a liquid crystal composition. The “non-polymerizable liquid crystal composition” is a liquid crystal composition composed of a liquid crystal compound having no polymerizable group. A liquid crystal compound, a liquid crystal composition, and a liquid crystal display element may be referred to as a compound, a composition, and an element, respectively. The compound represented by formula (1) may be referred to as compound (1) or compound of formula (1). Other formulas may be abbreviated as well. “Compound (1)” means one compound or two or more compounds represented by formula (1). The same applies to compounds represented by other formulas. The group represented by the formula (P-1) may be abbreviated as “group (P-1)”. The same applies to groups represented by other formulas. In the formulas (2) to (7), symbols such as B 11 and C 11 surrounded by hexagons correspond to the rings B 11 and C 11 , respectively. Multiple R 11 were described in the same or different formula. In these compounds, two groups represented by any two R 11 may be the same or different. This rule also applies to symbols such as rings A 1 and Z 2 . The ratio of the additive mixed with the composition means a weight percentage (% by weight) based on the total weight of the liquid crystal composition. When at least one —CH 2 — may be replaced with —O—, the adjacent —CH 2 — may be replaced with —O— and —CH 2 — next to —O— may be replaced with —O—. It is not included to be replaced with-. “Monofunctional” means that there is one polymerizable group, and “polyfunctional” means that there are two or more polymerizable groups.
 2-フルオロ-1,4-フェニレンは、下記の2つの二価基を意味する。式(1)などにおいて、フッ素は左向きであってもよいし、右向きであってもよい。このルールは、テトラヒドロピラン-2,5-ジイルのような、非対称の二価基にも適用される。
Figure JPOXMLDOC01-appb-I000009
2-Fluoro-1,4-phenylene means the following two divalent groups. In the formula (1) and the like, fluorine may be leftward or rightward. This rule also applies to asymmetric divalent groups such as tetrahydropyran-2,5-diyl.
Figure JPOXMLDOC01-appb-I000009
 本発明は、下記の項などである。
1. 式(1)で表わされる化合物。
Figure JPOXMLDOC01-appb-I000010

式(1)において、
 Aは独立して、単結合、1,4-シクロへキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、またはピリジン-2,5-ジイルであり、これらにおいて、少なくとも1つの水素は、ハロゲン、炭素数1から12のアルキル、または少なくとも1つの水素がハロゲンで置き換えられた炭素数1から12のアルキルで、置き換えられてもよく;
 Aは1,4-フェニレンまたはナフタレン-2,6-ジイルであり、これらにおいて、少なくとも1つの水素は、ハロゲン、炭素数1から12のアルキル、または少なくとも1つの水素がハロゲンで置き換えられた炭素数1から12のアルキルで、置き換えられてもよく;
 Zは炭素数1から12のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよく;
 Zは独立して、単結合または炭素数1から12のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよく;
 すべてのAおよびAが、1つの水素も置き換えられていない基の場合、ZおよびZの少なくとも1つが不飽和結合を有しており;
 Xは、水素、フッ素、メチル、またはトリフルオロメチルであり;
 Pは重合可能な基であり;
 aは0から3の整数である。
The present invention includes the following items.
1. A compound represented by formula (1).
Figure JPOXMLDOC01-appb-I000010

In equation (1),
A 1 is independently a single bond, 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1 , 3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in which at least one hydrogen is halogen, alkyl having 1 to 12 carbons, or At least one hydrogen may be replaced by alkyl having 1 to 12 carbons replaced by halogen;
A 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is halogen, alkyl having 1 to 12 carbons, or carbon in which at least one hydrogen is replaced by halogen. May be substituted with an alkyl of the number 1 to 12;
Z 1 is alkylene having 1 to 12 carbons, in which at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH═CH—, or — May be replaced by C≡C-;
Z 2 is independently a single bond or alkylene having 1 to 12 carbon atoms, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, — May be replaced by CH═CH—, or —C≡C—;
When all A 1 and A 2 are groups in which no hydrogen is replaced, at least one of Z 1 and Z 2 has an unsaturated bond;
X 1 is hydrogen, fluorine, methyl, or trifluoromethyl;
P 1 is a polymerizable group;
a is an integer of 0 to 3.
2. 項1に記載の式(1)において、
 Aが、1,4-シクロへキシレン、1,4-フェニレンまたはナフタレン-2,6-ジイルであり、これらにおいて、少なくとも1つの水素は、フッ素、塩素、炭素数1から4のアルキル、または少なくとも1つの水素がハロゲンで置き換えられた炭素数1から4のアルキルで、置き換えられてもよく;
 Aが1,4-フェニレンまたはナフタレン-2,6-ジイルであり、これらにおいて、少なくとも1つの水素は、フッ素、塩素、炭素数1から4のアルキル、または少なくとも1つの水素がハロゲンで置き換えられた炭素数1から4のアルキルで、置き換えられてもよく;
 Zが炭素数1から12のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよく;
 Zが、単結合または炭素数1から12のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよく;
 ZおよびZの少なくとも1つは、少なくとも1つの-CH-が、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられた炭素数1から12のアルキレンであり;
 Xが水素またはメチルであり;
 Pが式(P-1)から式(P-3)で表わされる基から選択された基であり;
Figure JPOXMLDOC01-appb-I000011

 aが1である、項1に記載の化合物。
2. In the formula (1) described in item 1,
A 1 is 1,4-cyclohexylene, 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl having 1 to 4 carbons, or At least one hydrogen may be replaced by alkyl of 1 to 4 carbons replaced by halogen;
A 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl of 1 to 4 carbons, or at least one hydrogen is replaced by halogen Optionally substituted with 1 to 4 carbon alkyls;
Z 1 is alkylene having 1 to 12 carbons, in which at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH═CH—, or — May be replaced by C≡C-;
Z 2 is a single bond or alkylene having 1 to 12 carbon atoms, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH═CH May be replaced by-, or -C≡C-;
At least one of Z 1 and Z 2 is a carbon number in which at least one —CH 2 — is replaced by —COO—, —OCO—, —OCOO—, —CH═CH—, or —C≡C—. 1 to 12 alkylene;
X 1 is hydrogen or methyl;
P 1 is a group selected from the groups represented by formula (P-1) to formula (P-3);
Figure JPOXMLDOC01-appb-I000011

Item 2. The compound according to Item 1, wherein a is 1.
3. 項1に記載の式(1)において、
 Aが、1,4-シクロへキシレン、1,4-フェニレンまたはナフタレン-2,6-ジイルであり、これらにおいて、少なくとも1つの水素は、フッ素、塩素、炭素数1から4のアルキル、または少なくとも1つの水素がフッ素で置き換えられた炭素数1から4のアルキルで、置き換えられてもよく;
 Aが1,4-フェニレンまたはナフタレン-2,6-ジイルであり、これらにおいて、少なくとも1つの水素は、フッ素、塩素、炭素数1から4のアルキル、または少なくとも1つの水素がフッ素で置き換えられた炭素数1から4のアルキルで、置き換えられてもよく;
 Zが炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-または-CH=CH-で置き換えられてもよく;
 Zが単結合または炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-または-CH=CH-で置き換えられてもよく;
 ZおよびZの少なくとも1つは、少なくとも1つの-CH-が-CH=CH-で置き換えられた炭素数1から7のアルキレンであり;
 Xが水素またはメチルであり;
 Pが式(P-1)から式(P-3)で表わされる基から選択された基であり;
Figure JPOXMLDOC01-appb-I000012

 aが1である、項1に記載の化合物。
3. In the formula (1) described in item 1,
A 1 is 1,4-cyclohexylene, 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl having 1 to 4 carbons, or At least one hydrogen may be replaced by alkyl of 1 to 4 carbons replaced by fluorine;
A 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl of 1 to 4 carbons, or at least one hydrogen is replaced by fluorine Optionally substituted with 1 to 4 carbon alkyls;
Z 1 is alkylene having 1 to 7 carbons, in which at least one —CH 2 — may be replaced by —O— or —CH═CH—;
Z 2 is a single bond or alkylene having 1 to 7 carbon atoms, in which at least one —CH 2 — may be replaced by —O— or —CH═CH—;
At least one of Z 1 and Z 2 is an alkylene of 1 to 7 carbons in which at least one —CH 2 — is replaced by —CH═CH—;
X 1 is hydrogen or methyl;
P 1 is a group selected from the groups represented by formula (P-1) to formula (P-3);
Figure JPOXMLDOC01-appb-I000012

Item 2. The compound according to Item 1, wherein a is 1.
4. 式(1-1)で表わされる項1に記載の化合物。
Figure JPOXMLDOC01-appb-I000013

式(1-1)において、
 Zは炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-または-C≡C-で置き換えられてもよく;
 YからYは独立して、水素、フッ素、メチル、またはトリフルオロメチルであり;
 YからYがすべて水素の場合、Zは、少なくとも1つの-CH-が、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられた炭素数1から7のアルキレンであり;
 Xは、水素、フッ素、メチル、またはトリフルオロメチルであり;
 Pは重合可能な基である。
4). Item 2. The compound according to item 1, represented by formula (1-1):
Figure JPOXMLDOC01-appb-I000013

In formula (1-1),
Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH═CH— or —C May be replaced by ≡C-;
Y 1 to Y 8 are independently hydrogen, fluorine, methyl, or trifluoromethyl;
When Y 1 to Y 8 are all hydrogen, Z 3 is replaced by at least one —CH 2 — with —COO—, —OCO—, —OCOO—, —CH═CH—, or —C≡C—. 1 to 7 carbon atoms produced;
X 1 is hydrogen, fluorine, methyl, or trifluoromethyl;
P 1 is a polymerizable group.
5. 項4に記載の式(1-1)において、Zが炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-が、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられており、そして少なくとも1つの-CH-が、-O-で置き換えられてもよく;YからYが独立して、水素、フッ素、メチル、またはトリフルオロメチルである項4に記載の化合物。 5. In Formula (1-1) according to Item 4, Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — is —COO—, —OCO—, —OCOO— , —CH═CH—, or —C≡C—, and at least one —CH 2 — may be replaced with —O—; Y 1 to Y 8 are independently hydrogen Item 5. The compound according to Item 4, which is fluorine, methyl, or trifluoromethyl.
6. 項4に記載の式(1-1)において、Zが炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-で置き換えられてもよく;YからYが独立して、水素、フッ素、メチルまたはトリフルオロメチルであり;YからYのうち少なくとも1つが、フッ素、メチル、またはトリフルオロメチルである項4に記載の化合物。 6). In formula (1-1) according to item 4, Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — may be replaced by —O—; Y Item 5. The compound according to Item 4, wherein 1 to Y 8 is independently hydrogen, fluorine, methyl, or trifluoromethyl; and at least one of Y 1 to Y 8 is fluorine, methyl, or trifluoromethyl.
7. 項4に記載の式(1-1)において、Xが水素またはメチルであり;YからYがすべて水素である項5に記載の化合物。 7). Item 6. The compound according to Item 5, wherein in Formula (1-1) according to Item 4, X 1 is hydrogen or methyl; Y 1 to Y 8 are all hydrogen.
8. 項4に記載の式(1-1)において、Pが項3に記載の式(P-1)および式(P-2)で表わされる基から選択された基である項5に記載の化合物。 8). Item 4. The formula (1-1) according to item 4, wherein P 1 is a group selected from the groups represented by formula (P-1) and formula (P-2) according to item 3. Compound.
9. 項4に記載の式(1-1)において、Pが項3に記載の式(P-3)で表わされる基である項5に記載の化合物。 9. Item 6. The compound according to Item 5, wherein in Formula (1-1) according to Item 4, P 1 is a group represented by Formula (P-3) according to Item 3.
10.式(1-2)で表される項1に記載の化合物。
Figure JPOXMLDOC01-appb-I000014

式(1-2)において、
 Zは炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-または-C≡C-で置き換えられてもよく;
 LからL12は独立して、水素、フッ素、メチル、またはトリフルオロメチルであり;
 LからL12がすべて水素の場合、Zは、少なくとも1つの-CH-が、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられた炭素数1から7のアルキレンであり;
 Xは、水素、フッ素、メチル、またはトリフルオロメチルであり;
 Pは重合可能な基である。
10. Item 2. The compound according to item 1, represented by formula (1-2):
Figure JPOXMLDOC01-appb-I000014

In formula (1-2),
Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH═CH— or —C May be replaced by ≡C-;
L 1 to L 12 are independently hydrogen, fluorine, methyl, or trifluoromethyl;
When L 1 to L 12 are all hydrogen, Z 3 is replaced by at least one —CH 2 — with —COO—, —OCO—, —OCOO—, —CH═CH—, or —C≡C—. 1 to 7 carbon atoms produced;
X 1 is hydrogen, fluorine, methyl, or trifluoromethyl;
P 1 is a polymerizable group.
11.項10に記載の式(1-2)において、Zが炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-が、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられており、そして少なくとも1つの-CH-が、-O-で置き換えられてもよく;LからL12が独立して、水素、フッ素、メチル、またはトリフルオロメチルである項10に記載の化合物。 11. In Formula (1-2) according to Item 10, Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — is —COO—, —OCO—, —OCOO— , —CH═CH—, or —C≡C—, and at least one —CH 2 — may be replaced with —O—; L 1 to L 12 are independently hydrogen Item 11. The compound according to Item 10, which is fluorine, methyl, or trifluoromethyl.
12.項10に記載の式(1-2)において、Zが炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-で置き換えられてもよく;LからL12が独立して、水素、フッ素、メチル、またはトリフルオロメチルであり;LからL12のうち少なくとも1つが、フッ素、メチル、またはトリフルオロメチルである項10に記載の化合物。 12 In formula (1-2) according to item 10, Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — may be replaced by —O—; L Item 11. The compound according to Item 10, wherein 1 to L 12 are independently hydrogen, fluorine, methyl, or trifluoromethyl; and at least one of L 1 to L 12 is fluorine, methyl, or trifluoromethyl.
13.項10に記載の式(1-2)において、Xが水素またはメチルであり;LからL12がすべて水素である項11に記載の化合物。 13. Item 12. The compound according to Item 11, wherein in Formula (1-2) according to Item 10, X 1 is hydrogen or methyl; and L 1 to L 12 are all hydrogen.
14.項10に記載の式(1-2)において、Pが請求項3に記載の式(P-1)および式(P-2)で表わされる基から選択された基である、項11に記載の化合物。 14 In Formula (1-2) according to Item 10, in which P 1 is a group selected from the groups represented by Formula (P-1) and Formula (P-2) according to Claim 3, The described compound.
15.項10に記載の式(1-2)において、Pが項3に記載の式(P-3)で表わされる基である項11に記載の化合物。 15. Item 12. The compound according to Item 11, wherein in Formula (1-2) according to Item 10, P 1 is a group represented by Formula (P-3) according to Item 3.
16. 項1から15のいずれか1項に記載の化合物を含む組成物。 16. A composition comprising the compound according to any one of items 1 to 15.
17. 項1から15のいずれか1項に記載の化合物を非重合性の液晶組成物に添加してなる項16に記載の組成物。 17. Item 16. The composition according to item 16, wherein the compound according to any one of items 1 to 15 is added to a non-polymerizable liquid crystal composition.
18. 式(2)から式(4)で表わされる化合物の群から選択される少なくとも1つの化合物をさらに含有する項16または17に記載の組成物。
Figure JPOXMLDOC01-appb-I000015

式(2)から式(4)において、
 R11は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの水素はフッ素で置き換えられてもよく、少なくとも1つの-CH-は-O-で置き換えられてもよく;
 環B11、環B12、および環B13は独立して、1,4-シクロヘキシレン、1,3-ジオキサン-2,5-ジイル、テトラヒドロピラン-2,5-ジイル、または少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレンであり;
 Z11およびZ12は独立して、-(CH-、-(CH-、-COO-、-CFO-、-OCF-、-CH=CH-、-C≡C-、-CHO-、または単結合であり;
 Y11は独立して、フッ素、塩素、-OCF、-OCHF、-CF、-CHF、-CHF、-OCFCHF、または-OCFCHFCFであり;
 Y12およびY13は独立して水素またはフッ素である。
18. Item 18. The composition according to item 16 or 17, further comprising at least one compound selected from the group of compounds represented by formula (2) to formula (4).
Figure JPOXMLDOC01-appb-I000015

In Formula (2) to Formula (4),
R 11 is independently alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, in which at least one hydrogen may be replaced by fluorine, and at least one —CH 2 -May be replaced by -O-;
Ring B 11 , Ring B 12 , and Ring B 13 are independently 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, tetrahydropyran-2,5-diyl, or at least one hydrogen Is 1,4-phenylene which may be replaced by fluorine;
Z 11 and Z 12 are independently — (CH 2 ) 2 —, — (CH 2 ) 4 —, —COO—, —CF 2 O—, —OCF 2 —, —CH═CH—, —C≡. C—, —CH 2 O—, or a single bond;
Y 11 is independently fluorine, chlorine, —OCF 3 , —OCHF 2 , —CF 3 , —CHF 2 , —CH 2 F, —OCF 2 CHF 2 , or —OCF 2 CHFCF 3 ;
Y 12 and Y 13 are independently hydrogen or fluorine.
19. 式(5)から式(7)で表わされる化合物の群から選択される少なくとも1つの化合物をさらに含有する項16、17または18に記載の組成物。
Figure JPOXMLDOC01-appb-I000016

式(5)から式(7)において、
 R12およびR13は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの水素はフッ素で置き換えられてもよく、少なくとも1つの-CH-は-O-で置き換えられてもよく;
 環C11、環C12、および環C13は独立して、1,4-シクロヘキシレン、1,4-フェニレン、2-フルオロ-1,4-フェニレン、または2,5-ジフルオロ-1,4-フェニレンであり;
 Z13およびZ14は独立して、-(CH-、-COO-、-CH=CH-、-C≡C-、または単結合である。
19. Item 19. The composition according to item 16, 17 or 18, further comprising at least one compound selected from the group of compounds represented by formula (5) to formula (7).
Figure JPOXMLDOC01-appb-I000016

In the equations (5) to (7),
R 12 and R 13 are independently alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, in which at least one hydrogen may be replaced by fluorine, and at least one —CH 2 — may be replaced by —O—;
Ring C 11 , Ring C 12 , and Ring C 13 are independently 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, or 2,5-difluoro-1,4 -Phenylene;
Z 13 and Z 14 are independently — (CH 2 ) 2 —, —COO—, —CH═CH—, —C≡C—, or a single bond.
20. 項1から15のいずれか1項に記載の化合物を重合させて得られる重合体。 20. A polymer obtained by polymerizing the compound according to any one of items 1 to 15.
21. 項16から19のいずれか1項に記載の組成物を重合させて得られる重合体。 21. Item 20. A polymer obtained by polymerizing the composition according to any one of items 16 to 19.
22. 項1から15のいずれか1項に記載の化合物、項16から19のいずれか1項に記載の組成物、および項20または21に記載の重合体の群から選択される少なくとも1つを含む液晶表示素子。 22. Item 20. The compound according to any one of items 1 to 15, the composition according to any one of items 16 to 19, and at least one selected from the group of polymers according to item 20 or 21. Liquid crystal display element.
23. 項1から15のいずれか1項に記載の化合物、項16から19のいずれか1項に記載の組成物、および項20または21に記載の重合体の群から選択される少なくとも1つの液晶表示素子における使用。 23. Item 20. The compound according to any one of items 1 to 15, the composition according to any one of items 16 to 19, and at least one liquid crystal display selected from the group of the polymers according to item 20 or 21. Use in devices.
 本発明は、次の項も含む。1)光学活性な化合物をさらに含有する上記の組成物、2)酸化防止剤、紫外線吸収剤、消泡剤などの添加物をさらに含有する上記の組成物。3)上記の組成物を含有するAM素子、4)上記の組成物を含有し、そしてTN、ECB、OCB、IPS、FFS、VA、またはPSAのモードを有する素子、5)上記の組成物を含有する透過型の素子、6)上記の組成物を、ネマチック相を有する組成物としての使用、7)上記の組成物に光学活性な化合物を添加することによって光学活性な組成物としての使用。 The present invention includes the following items. 1) The above-described composition further containing an optically active compound, 2) the above-mentioned composition further containing additives such as an antioxidant, an ultraviolet absorber, and an antifoaming agent. 3) an AM device containing the above composition, 4) a device containing the above composition and having a TN, ECB, OCB, IPS, FFS, VA, or PSA mode, 5) the above composition A transmissive element containing 6) Use of the above composition as a composition having a nematic phase, 7) Use of the composition as an optically active composition by adding an optically active compound to the above composition.
 本発明の化合物について説明する。本発明の化合物は式(1)で表わされる。
Figure JPOXMLDOC01-appb-I000017
The compound of the present invention will be described. The compound of the present invention is represented by the formula (1).
Figure JPOXMLDOC01-appb-I000017
 式(1)において、Aは、独立して単結合、1,4-シクロへキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、またはピリジン-2,5-ジイルであり、これらにおいて、少なくとも1つの水素は、ハロゲン、炭素数1から12のアルキル、または少なくとも1つの水素がハロゲンで置き換えられた炭素数1から12のアルキルで、置き換えられてもよい。aが2または3のとき、任意の2つのAが表わす2つの基は、同じであっても異なってもよい。 In formula (1), A 1 is independently a single bond, 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2 , 5-diyl, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in which at least one hydrogen is halogen, carbon number 1 May be substituted with 1 to 12 alkyls or alkyls of 1 to 12 carbons in which at least one hydrogen is replaced with a halogen. When a is 2 or 3, the two groups represented by any two A 1 may be the same or different.
 好ましいAは、1,4-シクロへキシレン、1,4-フェニレンまたはナフタレン-2,6-ジイルであり、これらの基において、少なくとも1つの水素は、フッ素、塩素、炭素数1から4のアルキル、または少なくとも1つの水素がフッ素で置き換えられた炭素数1から4のアルキルで、置き換えられてもよい。より好ましいAは1,4-フェニレン、2-フルオロ-1,4-フェニレン、2,3-ジフルオロ-1,4-フェニレン、2-メチル-1,4-フェニレン、2-トリフルオロメチル-1,4-フェニレン、2,3-ビス(トリフルオロメチル)-1,4-フェニレンまたはナフタレン-2,6-ジイルである。さらに好ましいAは、1,4-フェニレンまたは2-フルオロ-1,4-フェニレンであり、特に好ましいAは1,4-フェニレンである。 Preferred A 1 is 1,4-cyclohexylene, 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, C 1-4 Alkyl, or alkyl having 1 to 4 carbon atoms in which at least one hydrogen is replaced by fluorine, may be substituted. More preferable A 1 is 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,3-difluoro-1,4-phenylene, 2-methyl-1,4-phenylene, 2-trifluoromethyl-1 , 4-phenylene, 2,3-bis (trifluoromethyl) -1,4-phenylene or naphthalene-2,6-diyl. Further preferred A 1 is 1,4-phenylene or 2-fluoro-1,4-phenylene, and particularly preferred A 1 is 1,4-phenylene.
 Aは1,4-フェニレンまたはナフタレン-2,6-ジイルであり、これらにおいて、少なくとも1つの水素は、ハロゲン、炭素数1から12のアルキル、または少なくとも1つの水素がハロゲンで置き換えられた炭素数1から12のアルキルで、置き換えられてもよい。 A 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is halogen, alkyl having 1 to 12 carbons, or carbon in which at least one hydrogen is replaced by halogen. It may be substituted with an alkyl of the formula 1 to 12.
 好ましいAは1,4-フェニレンまたはナフタレン-2,6-ジイルであり、これらの基において、少なくとも1つの水素はフッ素、塩素、炭素数1から4のアルキル、または少なくとも1つの水素がハロゲンで置き換えられた炭素数1から4のアルキルで、置き換えられてもよい。より好ましいAは、1,4-フェニレン、2-フルオロ-1,4-フェニレン、2,3-ジフルオロ-1,4-フェニレン、2-メチル-1,4-フェニレン、2-トリフルオロメチル-1,4-フェニレン、2,3-ビス(トリフルオロメチル)-1,4-フェニレンまたはナフタレン-2,6-ジイルである。さらに好ましいAは、1,4-フェニレンまたは2-フルオロ-1,4-フェニレンであり、特に好ましいAは1,4-フェニレンである。 Preferred A 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl of 1 to 4 carbons, or at least one hydrogen is halogen. It may be replaced with substituted alkyl having 1 to 4 carbon atoms. More preferable A 2 is 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,3-difluoro-1,4-phenylene, 2-methyl-1,4-phenylene, 2-trifluoromethyl- 1,4-phenylene, 2,3-bis (trifluoromethyl) -1,4-phenylene or naphthalene-2,6-diyl. Further preferred A 2 is 1,4-phenylene or 2-fluoro-1,4-phenylene, and particularly preferred A 2 is 1,4-phenylene.
 Zは炭素数1から12のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよい。 Z 1 is alkylene having 1 to 12 carbons, in which at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH═CH—, or — C≡C— may be substituted.
 好ましいZは、炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよい。より好ましいZは、-COO-、-OCO-、-OCOO-、-CH=CH-、-CH=CH-O-または-C≡C-である。さらに好ましいZは、-OCOO-、-CH=CH-、または-CH=CH-O-であり、特に好ましいZは、-CH=CH-O-である。 Preferred Z 1 is alkylene having 1 to 7 carbon atoms, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH═CH—, Or it may be replaced by -C≡C-. More preferred Z 1 is —COO—, —OCO—, —OCOO—, —CH═CH—, —CH═CH—O— or —C≡C—. Further preferred Z 1 is —OCOO—, —CH═CH—, or —CH═CH—O—, and particularly preferred Z 1 is —CH═CH—O—.
 Zは、独立して、単結合または炭素数1から12のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよい。すべてのAおよびAが1つの水素も置き換えられていない基の場合、ZおよびZの少なくとも1つが不飽和結合を有している。不飽和結合は、-CH=CH-、-C≡C-、または>C=Oを含む基を意味する。aが2または3のときの、任意の2つのZが表わす2つの基は、同じであっても異なってもよい。 Z 2 is independently a single bond or alkylene having 1 to 12 carbon atoms, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, It may be replaced by —CH═CH— or —C≡C—. When all A 1 and A 2 are groups in which one hydrogen is not replaced, at least one of Z 1 and Z 2 has an unsaturated bond. An unsaturated bond means a group containing —CH═CH—, —C≡C—, or> C═O. When a is 2 or 3, two groups represented by any two Z 2 may be the same or different.
 好ましいZ、は単結合、-COO-、-OCO-、-CH=CH-、または-C≡C-である。より好ましいZ2、は単結合、-COO-または-CH=CH-であり、特に好ましいZ2は単結合である。 Preferred Z 2 is a single bond, —COO—, —OCO—, —CH═CH—, or —C≡C—. More preferred Z 2 is a single bond, —COO— or —CH═CH—, and particularly preferred Z 2 is a single bond.
 結合基ZまたはZが、-CH=CH-などの二重結合を有する基であるとき、その立体配置はシス体であっても、トランス体であってもよい。 When the linking group Z 1 or Z 2 is a group having a double bond such as —CH═CH—, the steric configuration may be a cis form or a trans form.
 Xは、水素、フッ素、メチル、またはトリフルオロメチルである。好ましいXは水素またはメチルである。 X 1 is hydrogen, fluorine, methyl, or trifluoromethyl. Preferred X 1 is hydrogen or methyl.
 Pは重合可能な基である。好ましいPは、アクリロキシ基、メタクリロキシ基、アクリルアミド基、メタクリルアミド基、ビニル基、ビニルオキシ基、ビニルカルボニル基、エポキシ基、オキセタン基、3,4-エポキシシクロヘキシル基、マレイミド基、などである。より好ましいPは、基(P-1)から基(P-3)である。特に好ましいPは基(P-1)または基(P-2)である。
Figure JPOXMLDOC01-appb-I000018
P 1 is a polymerizable group. Preferred P 1 is acryloxy group, methacryloxy group, acrylamide group, methacrylamide group, vinyl group, vinyloxy group, vinylcarbonyl group, epoxy group, oxetane group, 3,4-epoxycyclohexyl group, maleimide group, and the like. More preferred P 1 is the group (P-1) to the group (P-3). Particularly preferred P 1 is the group (P-1) or the group (P-2).
Figure JPOXMLDOC01-appb-I000018
 aは0から3の整数である。好ましいaは0から2であり、より好ましいaは1または2である。特に好ましいaは1である。 A is an integer from 0 to 3. Preferred a is 0 to 2, and more preferred a is 1 or 2. Particularly preferred a is 1.
 化合物(1)の好ましい例として、以下の化合物(1-1)および化合物(1-2)が挙げられる。
Figure JPOXMLDOC01-appb-I000019

Figure JPOXMLDOC01-appb-I000020
Preferred examples of the compound (1) include the following compound (1-1) and compound (1-2).
Figure JPOXMLDOC01-appb-I000019

Figure JPOXMLDOC01-appb-I000020
 式(1-1)において、YからYは独立して、水素、フッ素、メチル、またはトリフルオロメチルである。好ましいYからYは、水素、フッ素、またはトリフルオロメチルである。より好ましいYからYは、水素またはフッ素であり、特に好ましいYからYは、水素である。 In formula (1-1), Y 1 to Y 8 are independently hydrogen, fluorine, methyl, or trifluoromethyl. Preferred Y 1 to Y 8 are hydrogen, fluorine, or trifluoromethyl. More preferred Y 1 to Y 8 are hydrogen or fluorine, and particularly preferred Y 1 to Y 8 are hydrogen.
 式(1-2)において、LからL12は独立して、水素、フッ素、メチル、またはトリフルオロメチルである。好ましいLからL12は、水素、フッ素、またはトリフルオロメチルである。より好ましいLからL12は、水素またはフッ素であり、特に好ましいLからL12は、水素である。 In formula (1-2), L 1 to L 12 are independently hydrogen, fluorine, methyl, or trifluoromethyl. Preferred L 1 to L 12 are hydrogen, fluorine, or trifluoromethyl. More preferred L 1 to L 12 are hydrogen or fluorine, and particularly preferred L 1 to L 12 are hydrogen.
 式(1-1)または式(1-2)において、Zは炭素数1から7のアルキレンである。このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよく、YからYがすべて水素の場合、またはLからL12がすべて水素の場合、Zは、少なくとも1つの-CH-が、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられた炭素数1から7のアルキレンである。 In Formula (1-1) or Formula (1-2), Z 3 is alkylene having 1 to 7 carbons. In this alkylene, at least one —CH 2 — may be replaced by —O—, —COO—, —OCO—, —OCOO—, —CH═CH—, or —C≡C—, and Y 1 To Y 8 are all hydrogen, or when L 1 to L 12 are all hydrogen, Z 3 is at least one —CH 2 — is —COO—, —OCO—, —OCOO—, —CH═CH -, Or alkylene having 1 to 7 carbon atoms replaced by -C≡C-.
 好ましいZは、-COO-、-OCO-、-OCOO-、-CH=CH-、-CH=CH-O-または-C≡C-である。より好ましいZは、-OCOO-、-CH=CH-、または-CH=CH-O-であり、特に好ましいZは、-CH=CH-O-である。Zが、-CH=CH-などの二重結合を有する基であるとき、その立体配置はシス体であっても、トランス体であってもよい。 Preferred Z 3 is —COO—, —OCO—, —OCOO—, —CH═CH—, —CH═CH—O— or —C≡C—. More preferred Z 3 is —OCOO—, —CH═CH—, or —CH═CH—O—, and particularly preferred Z 3 is —CH═CH—O—. When Z 3 is a group having a double bond such as —CH═CH—, the configuration thereof may be a cis isomer or a trans isomer.
 Xは、水素、フッ素、メチル、またはトリフルオロメチルである。より好ましいXは、水素またはフッ素である。 X 1 is hydrogen, fluorine, methyl, or trifluoromethyl. More preferred X 1 is hydrogen or fluorine.
 Pは重合可能な基である。好ましいPは、アクリロキシ基、メタクリロキシ基、アクリルアミド基、メタクリルアミド基、ビニル基、ビニルオキシ基、ビニルカルボニル基、エポキシ基、オキセタン基、3,4-エポキシシクロヘキシル基、マレイミド基、などである。より好ましいPは、基(P-1)から基(P-3)である。特に好ましいPは基(P-1)または基(P-2)である。
Figure JPOXMLDOC01-appb-I000021
P 1 is a polymerizable group. Preferred P 1 is acryloxy group, methacryloxy group, acrylamide group, methacrylamide group, vinyl group, vinyloxy group, vinylcarbonyl group, epoxy group, oxetane group, 3,4-epoxycyclohexyl group, maleimide group, and the like. More preferred P 1 is the group (P-1) to the group (P-3). Particularly preferred P 1 is the group (P-1) or the group (P-2).
Figure JPOXMLDOC01-appb-I000021
 化合物(1)のより好ましい例として、以下の化合物(1-1-1)および化合物(1-2-1)が挙げられる。

Figure JPOXMLDOC01-appb-I000022

Figure JPOXMLDOC01-appb-I000023
More preferred examples of the compound (1) include the following compound (1-1-1) and compound (1-2-1).

Figure JPOXMLDOC01-appb-I000022

Figure JPOXMLDOC01-appb-I000023
 式(1-1-1)において、YからYは水素である。YからYの1つは、フッ素、メチルまたはトリフルオロメチルであってもよい。式(1-2-1)において、LからL12は水素である。LからL12の1つはフッ素、メチルまたはトリフルオロメチルであってもよい。XおよびXは独立して、水素またはメチルである。 In the formula (1-1-1), Y 1 to Y 8 are hydrogen. One of Y 1 to Y 8 may be fluorine, methyl or trifluoromethyl. In the formula (1-2-1), L 1 to L 12 are hydrogen. One of L 1 to L 12 may be fluorine, methyl or trifluoromethyl. X 1 and X 2 are independently hydrogen or methyl.
 化合物(1)のさらに好ましい例として、以下の化合物(1-1-2)および化合物(1-2-2)が挙げられる。式(1-1-2)および式(1-2-2)において、XおよびXは独立して、水素またはメチルである。

Figure JPOXMLDOC01-appb-I000024


Figure JPOXMLDOC01-appb-I000025
More preferred examples of compound (1) include the following compound (1-1-2) and compound (1-2-2). In formulas (1-1-2) and (1-2-2), X 1 and X 2 are independently hydrogen or methyl.

Figure JPOXMLDOC01-appb-I000024


Figure JPOXMLDOC01-appb-I000025
 本発明の組成物について説明する。この組成物は、少なくとも1つの化合物(1)を含むが、化合物(1)を2つ以上含んでいてもよい。この組成物は、その他の重合性化合物をさらに含んでもよい。その他の重合性化合物の好ましい例は、アクリレート、メタクリレート、ビニル化合物、ビニルオキシ化合物、プロペニルエーテル、エポキシ化合物(オキシラン、オキセタン)、およびビニルケトンである。さらに好ましい例は、少なくとも1つのアクリロイルオキシを有する化合物および少なくとも1つのメタクリロイルオキシを有する化合物である。さらに好ましい例には、アクリロイルオキシとメタクリロイルオキシとを有する化合物も含まれる。 The composition of the present invention will be described. This composition contains at least one compound (1), but may contain two or more compounds (1). The composition may further contain other polymerizable compound. Preferred examples of other polymerizable compounds are acrylate, methacrylate, vinyl compound, vinyloxy compound, propenyl ether, epoxy compound (oxirane, oxetane), and vinyl ketone. Further preferred examples are compounds having at least one acryloyloxy and compounds having at least one methacryloyloxy. Further preferred examples include compounds having acryloyloxy and methacryloyloxy.
 その他の重合性化合物の追加例は、化合物(M-1)~(M-12)である。これらの化合物において、R20は水素またはメチルであり;sは0または1であり;tおよびuは独立して、1~10の整数である。かっこに入れた記号Fは、水素またはフッ素を意味する。 Additional examples of other polymerizable compounds are compounds (M-1) to (M-12). In these compounds, R 20 is hydrogen or methyl; s is 0 or 1; t and u are independently integers from 1 to 10. The symbol F in parentheses means hydrogen or fluorine.

Figure JPOXMLDOC01-appb-I000026

Figure JPOXMLDOC01-appb-I000026
 化合物(1)は非重合性の液晶組成物に添加してもよい。好ましい組成物は、液晶表示素子に用いることのできる液晶組成物である。本発明の組成物は、化合物(1)を成分Aとして含む必要がある。この成分Aのみの組成物、または成分Aと本明細書中で特に成分名を示していないその他の成分との組成物でもよいが、この成分Aに以下に示す成分B、および成分Cから選ばれた成分を加えることにより種々の特性を有する液晶組成物が提供できる。 Compound (1) may be added to the non-polymerizable liquid crystal composition. A preferable composition is a liquid crystal composition which can be used for a liquid crystal display element. The composition of the present invention needs to contain compound (1) as component A. The composition may be composed of only the component A, or the composition of the component A and other components not specifically indicated in the present specification, but the component A is selected from the following components B and C. By adding the prepared components, liquid crystal compositions having various characteristics can be provided.
 成分Aに加える成分として、化合物(2)、化合物(3)、および化合物(4)の群から選ばれた少なくとも1つの化合物からなる成分Bが好ましい。さらに、化合物(5)、化合物(6)、および化合物(7)の群から選ばれた少なくとも1つの化合物からなる成分Cを混合することにより、しきい値電圧、液晶相の温度範囲、光学異方性、誘電率異方性、粘度等を調整することができる。 As the component added to Component A, Component B consisting of at least one compound selected from the group consisting of Compound (2), Compound (3), and Compound (4) is preferable. Further, by mixing Component C consisting of at least one compound selected from the group consisting of Compound (5), Compound (6), and Compound (7), the threshold voltage, the temperature range of the liquid crystal phase, and the optical difference are mixed. The directionality, dielectric anisotropy, viscosity and the like can be adjusted.
 化合物の物性に大きな差異がないので、化合物(1)は、H(重水素)、13Cなどの同位体を天然存在比の量より多く含んでもよい。液晶組成物に添加される成分化合物についても同様である。 Since there is no great difference in the physical properties of the compound, the compound (1) may contain an isotope such as 2 H (deuterium) and 13 C in an amount larger than the natural abundance. The same applies to the component compounds added to the liquid crystal composition.
 上記成分Bのうち、化合物(2)の好適例として化合物(2-1)から化合物(2-13)、化合物(3)の好適例として化合物(3-1)から化合物(3-109)、および化合物(4)の好適例として化合物(4-1)から化合物(4-55)を挙げることができる。 Among the components B, compounds (2-1) to (2-13) are preferred examples of compound (2), and compounds (3-1) to (3-109) are preferred examples of compound (3). Also, preferred examples of compound (4) include compounds (4-1) to (4-55).
Figure JPOXMLDOC01-appb-I000027
Figure JPOXMLDOC01-appb-I000027
Figure JPOXMLDOC01-appb-I000028
Figure JPOXMLDOC01-appb-I000028
Figure JPOXMLDOC01-appb-I000029
Figure JPOXMLDOC01-appb-I000029
Figure JPOXMLDOC01-appb-I000030
Figure JPOXMLDOC01-appb-I000030
Figure JPOXMLDOC01-appb-I000031
Figure JPOXMLDOC01-appb-I000031
Figure JPOXMLDOC01-appb-I000032
Figure JPOXMLDOC01-appb-I000032
Figure JPOXMLDOC01-appb-I000033
Figure JPOXMLDOC01-appb-I000033
Figure JPOXMLDOC01-appb-I000034
Figure JPOXMLDOC01-appb-I000034
Figure JPOXMLDOC01-appb-I000035
Figure JPOXMLDOC01-appb-I000035
Figure JPOXMLDOC01-appb-I000036

 これらの化合物において、R11およびY11の定義は、前記と同じである。
Figure JPOXMLDOC01-appb-I000036

In these compounds, the definitions of R 11 and Y 11 are the same as described above.
 これらの化合物(2)から化合物(4)すなわち成分Bは、誘電率異方性が正であり、熱安定性や化学的安定性が非常に優れているので、TFT用の液晶組成物を調製する場合に用いられる。液晶組成物における成分Bの含有量は、液晶組成物の全重量に対して約1重量%から約99重量%の範囲が適するが、好ましくは約10重量%から約97重量%の範囲、より好ましくは約40重量%から約95重量%の範囲である。また化合物(5)から化合物(7)(成分C)をさらに含有させることにより粘度を調整することができる。 Since these compounds (2) to (4), that is, component B, have positive dielectric anisotropy and are very excellent in thermal stability and chemical stability, a liquid crystal composition for TFT is prepared. Used when The content of component B in the liquid crystal composition is suitably in the range of about 1% to about 99% by weight, preferably in the range of about 10% to about 97% by weight, based on the total weight of the liquid crystal composition. Preferably it is in the range of about 40% to about 95% by weight. Moreover, a viscosity can be adjusted by further including a compound (5) to a compound (7) (component C).
 化合物(5)、化合物(6)、および化合物(7)(成分C)の好適例として、化合物(5-1)から化合物(5-10)、化合物(6-1)から化合物(6-14)、および化合物(7-1)から化合物(7-6)を挙げることができる。 Preferred examples of compound (5), compound (6), and compound (7) (component C) include compound (5-1) to compound (5-10) and compound (6-1) to compound (6-14). ), And compound (7-1) to compound (7-6).
Figure JPOXMLDOC01-appb-I000037
Figure JPOXMLDOC01-appb-I000037
Figure JPOXMLDOC01-appb-I000038
Figure JPOXMLDOC01-appb-I000038
Figure JPOXMLDOC01-appb-I000039

 これらの化合物において、R12およびR13の定義は、前記と同じである。
Figure JPOXMLDOC01-appb-I000039

In these compounds, the definitions of R 12 and R 13 are the same as described above.
 化合物(5)から化合物(7)(成分C)は、誘電率異方性の絶対値が小さく、中性に近い化合物である。化合物(5)は主として、粘度の調整または光学異方性の調整の効果があり、また化合物(6)および化合物(7)は透明点を高くするなどによってネマチック相の温度範囲を広げる効果、または光学異方性の調整の効果がある。 Compound (5) to Compound (7) (Component C) are compounds having a small absolute value of dielectric anisotropy and close to neutrality. The compound (5) mainly has the effect of adjusting the viscosity or the optical anisotropy, and the compound (6) and the compound (7) have the effect of expanding the temperature range of the nematic phase by increasing the clearing point, or the like. There is an effect of adjusting optical anisotropy.
 成分Cの含有量を増加させると液晶組成物の粘度が小さくなるが、しきい値電圧が高くなる。そこで、液晶組成物のしきい値電圧の要求値を満たす限り、含有量は多いほうが望ましい。TFT用の液晶組成物を調製する場合に、成分Cの含有量は、組成物全量に対して好ましくは約30重量%以上、より好ましくは約50重量%以上である。 Increasing the content of component C decreases the viscosity of the liquid crystal composition, but increases the threshold voltage. Therefore, as long as the required value of the threshold voltage of the liquid crystal composition is satisfied, the content is preferably large. When preparing a liquid crystal composition for TFT, the content of component C is preferably about 30% by weight or more, more preferably about 50% by weight or more based on the total amount of the composition.
 本発明の組成物は、化合物(1)の少なくとも1つを約0.05重量%から約20重量%の割合で含有することが好ましい。また、化合物(1)の少なくとも1つを約0.1重量%から約10重量%の割合で含有することが、より好ましい。 The composition of the present invention preferably contains at least one compound (1) in a proportion of about 0.05 wt% to about 20 wt%. Further, it is more preferable that at least one of the compounds (1) is contained at a ratio of about 0.1 wt% to about 10 wt%.
 本発明の組成物の調製は、公知の方法、例えば必要な成分を高温度下で溶解させる方法などにより一般に調製される。また、用途に応じて当業者によく知られている添加物を添加して、例えばつぎに述べるような光学活性化合物を含む組成物、染料を添加したGH型用の組成物を調製することができる。このような添加物は当該業者によく知られており、文献に記載されている。 The composition of the present invention is generally prepared by a known method, for example, a method of dissolving necessary components at a high temperature. In addition, an additive well known to those skilled in the art may be added depending on the application, for example, to prepare a composition containing an optically active compound as described below, or a composition for GH type to which a dye is added. it can. Such additives are well known to those skilled in the art and are described in the literature.
 本発明の組成物は、さらに1つ以上の光学活性化合物を含有してもよい。光学活性化合物として、公知のキラルド-プ剤を添加できる。このキラルド-プ剤は液晶のらせん構造を誘起して必要なねじれ角を調整し、逆ねじれを防ぐといった効果を有する。キラルド-プ剤の例として、下記の化合物(Op-1)~(Op-18)を挙げることができる。化合物(Op-18)において、環Eは1,4-シクロへキシレンまたは1,4-フェニレンであり、R24は炭素数1から10のアルキルである。 The composition of the present invention may further contain one or more optically active compounds. As an optically active compound, a known chiral dopant can be added. This chiral dopant has the effect of inducing the helical structure of the liquid crystal to adjust the necessary twist angle and preventing reverse twist. Examples of the chiral dopant include the following compounds (Op-1) to (Op-18). In the compound (Op-18), ring E is 1,4-cyclohexylene or 1,4-phenylene, and R 24 is alkyl having 1 to 10 carbons.
Figure JPOXMLDOC01-appb-I000040
Figure JPOXMLDOC01-appb-I000040
 本発明の組成物は、メロシアニン系、スチリル系、アゾ系、アゾメチン系、アゾキシ系、キノフタロン系、アントラキノン系、テトラジン系などの二色性色素を添加すれば、GH型用の液晶組成物として使用することもできる。 The composition of the present invention can be used as a liquid crystal composition for GH type by adding dichroic dyes such as merocyanine, styryl, azo, azomethine, azoxy, quinophthalone, anthraquinone, and tetrazine. You can also
 本発明の組成物は、ネマチック液晶をマイクロカプセル化して作製したNCAPや、液晶中に三次元網目状高分子を形成して作製したポリマー分散型液晶表示素子(PDLCD)例えばポリマーネットワーク液晶表示素子(PNLCD)用をはじめ、複屈折制御(ECB)型やDS型用の液晶組成物としても使用できる。 The composition of the present invention includes NCAP produced by encapsulating nematic liquid crystal, polymer dispersed liquid crystal display device (PDLCD) produced by forming a three-dimensional network polymer in liquid crystal, for example, polymer network liquid crystal display device ( It can be used as a liquid crystal composition for birefringence control (ECB) type and DS type as well as for PNLCD.
 本発明の組成物に、重合開始剤、酸化防止剤、紫外線吸収剤、光安定剤、熱安定剤、消泡剤などの添加物を添加しても何ら差し支えない。 It is possible to add additives such as a polymerization initiator, an antioxidant, an ultraviolet absorber, a light stabilizer, a heat stabilizer, and an antifoaming agent to the composition of the present invention.
 酸化防止剤は、大きな電圧保持率を維持するために有効である。酸化防止剤の好ましい例として、下記の化合物(AO-1)および(AO-2);およびIRGANOX 415、IRGANOX 565、IRGANOX 1010、IRGANOX 1035、IRGANOX 3114、およびIRGANOX 1098(商品名:BASF社)を挙げることができる。紫外線吸収剤は、上限温度の低下を防ぐために有効である。紫外線吸収剤の好ましい例は、ベンゾフェノン誘導体、ベンゾエート誘導体、トリアゾール誘導体などである。具体例として下記の化合物(AO-3)および(AO-4);TINUVIN 329、TINUVIN P、TINUVIN 326、TINUVIN 234、TINUVIN 213、TINUVIN 400、TINUVIN 328、およびTINUVIN 99-2(商品名:BASF社);および1,4-ジアザビシクロ[2.2.2]オクタン(DABCO)を挙げることができる。 An antioxidant is effective for maintaining a large voltage holding ratio. Preferred examples of the antioxidant include the following compounds (AO-1) and (AO-2); and IRGANOX 415, IRGANOX 565, IRGANOX 1010, IRGANOX 1035, IRGANOX 3114, and IRGANOX 1098 (trade name: BASF) Can be mentioned. The ultraviolet absorber is effective for preventing a decrease in the maximum temperature. Preferred examples of the ultraviolet absorber include benzophenone derivatives, benzoate derivatives, triazole derivatives and the like. As specific examples, the following compounds (AO-3) and (AO-4): TINUVIN 329, TINUVIN P, TINUVIN 326, TINUVIN 234, TINUVIN 213, TINUVIN 400, TINUVIN 328, and TINUVIN 99-2 (trade name: BASF Corporation) And 1,4-diazabicyclo [2.2.2] octane (DABCO).
 立体障害のあるアミンのような光安定剤は、大きな電圧保持率を維持するために好ましい。光安定剤の好ましい例として、下記の化合物(AO-5)および(AO-6);TINUVIN 144、TINUVIN 765、およびTINUVIN 770DF(商品名:BASF社)を挙げることができる。熱安定剤も大きな電圧保持率を維持するために有効であり、好ましい例としてIRGAFOS 168(商品名:BASF社)を挙げることができる。消泡剤は、泡立ちを防ぐために有効である。消泡剤の好ましい例は、ジメチルシリコーンオイル、メチルフェニルシリコーンオイルなどである。 A light stabilizer such as an amine having steric hindrance is preferable in order to maintain a large voltage holding ratio. Preferred examples of the light stabilizer include the following compounds (AO-5) and (AO-6); TINUVIN 144, TINUVIN 765, and TINUVIN 770DF (trade name: BASF). A thermal stabilizer is also effective for maintaining a large voltage holding ratio, and a preferred example is IRGAFOS 168 (trade name: BASF). Antifoaming agents are effective for preventing foaming. Preferred examples of the antifoaming agent include dimethyl silicone oil and methylphenyl silicone oil.

Figure JPOXMLDOC01-appb-I000041

Figure JPOXMLDOC01-appb-I000041
 化合物(AO-1)において、R25は炭素数1~20のアルキル、炭素数1~20のアルコキシ、-COOR26、または-CHCHCOOR26であり;R26は炭素数1~20のアルキルである。化合物(AO-2)および(AO-5)において、R27は炭素数1~20のアルキルである。化合物(AO-5)において、環Fおよび環Gは1,4-シクロへキシレンまたは1,4-フェニレンであり、vは0、1、または2であり、R28は水素、メチルまたはOである。 In the compound (AO-1), R 25 represents alkyl having 1 to 20 carbons, alkoxy having 1 to 20 carbons, —COOR 26 , or —CH 2 CH 2 COOR 26 ; R 26 represents 1 to 20 carbons. Of alkyl. In the compounds (AO-2) and (AO-5), R 27 is alkyl having 1 to 20 carbons. In the compound (AO-5), ring F and ring G is 1,4-cyclohexylene or 1,4-phenylene, v is 0, 1 or 2,, R 28 is hydrogen, methyl or O · It is.
 本発明の化合物はラジカル重合に適している。重合開始剤の添加または反応温度を最適化することにより、より敏速に重合させることができるが、重合開始剤は添加してもしなくてもよい。 The compound of the present invention is suitable for radical polymerization. Polymerization can be carried out more rapidly by adding a polymerization initiator or optimizing the reaction temperature, but a polymerization initiator may or may not be added.
 光ラジカル重合開始剤の例は、具体的な商品名で、チバ・スペシャルティ・ケミカルズ(株)のダロキュアシリーズからTPO、1173および4265、イルガキュアシリーズから184、369、500、651、784、819、907、1300、1700、1800、1850、2959の商品であるが、公知のいずれの光ラジカル重合開始剤も使用できる。 Examples of the photo radical polymerization initiator are specific trade names, such as TPO, 1173 and 4265 from Darocur series of Ciba Specialty Chemicals Co., Ltd., 184, 369, 500, 651, 784, 819 from Irgacure series. 907, 1300, 1700, 1800, 1850, 2959, any known radical photopolymerization initiator can be used.
 光ラジカル重合開始剤のその他の例は、4-メトキシフェニル-2,4-ビス(トリクロロメチル)トリアジン、2-(4-ブトキシスチリル)-5-トリクロロメチル-1,3,4-オキサジアゾール、9-フェニルアクリジン、9,10-ベンズフェナジン、ベンゾフェノン/ミヒラーズケトン混合物、ヘキサアリールビイミダゾール/メルカプトベンズイミダゾール混合物、1-(4-イソプロピルフェニル)-2-ヒドロキシ-2-メチルプロパン-1-オン、ベンジルジメチルケタール、2-メチル-1-[4-(メチルチオ)フェニル]-2-モルホリノプロパン-1-オン、2,4-ジエチルキサントン/p-ジメチルアミノ安息香酸メチル混合物、ベンゾフェノン/メチルトリエタノールアミン混合物であるが、公知のいずれの光ラジカル重合開始剤も使用できる。 Other examples of radical photopolymerization initiators include 4-methoxyphenyl-2,4-bis (trichloromethyl) triazine, 2- (4-butoxystyryl) -5-trichloromethyl-1,3,4-oxadiazole 9-phenylacridine, 9,10-benzphenazine, benzophenone / Michler's ketone mixture, hexaarylbiimidazole / mercaptobenzimidazole mixture, 1- (4-isopropylphenyl) -2-hydroxy-2-methylpropan-1-one, Benzyldimethyl ketal, 2-methyl-1- [4- (methylthio) phenyl] -2-morpholinopropan-1-one, 2,4-diethylxanthone / methyl p-dimethylaminobenzoate, benzophenone / methyltriethanolamine A mixture but known Photoradical polymerization initiator les may also be used.
 本発明の重合体は、化合物(1)またはそれらを含有する組成物を重合することで製造できる。化合物(1)の1つのみを重合させると、単独重合体が得られる。複数の重合性化合物を含有する組成物を重合させると、共重合体が得られる。化合物(1)を、非重合性の液晶組成物に添加してなる組成物を重合させた場合、非重合性の液晶組成物中に化合物(1)の単独重合体が含まれることとなるが、この組成物も重合体と言う。 The polymer of the present invention can be produced by polymerizing the compound (1) or a composition containing them. When only one of the compounds (1) is polymerized, a homopolymer is obtained. When a composition containing a plurality of polymerizable compounds is polymerized, a copolymer is obtained. When a composition obtained by adding the compound (1) to a non-polymerizable liquid crystal composition is polymerized, a homopolymer of the compound (1) is contained in the non-polymerizable liquid crystal composition. This composition is also called a polymer.
 重合はエネルギー(電磁波)を照射することで実施できる。かかる電磁波は、紫外線、赤外線、可視光線、X線、γ線などである。また、イオンやエレクトロンといった高エネルギー粒子を照射してもよい。 Polymerization can be carried out by irradiating energy (electromagnetic waves). Such electromagnetic waves are ultraviolet rays, infrared rays, visible rays, X-rays, γ rays, and the like. Alternatively, high energy particles such as ions and electrons may be irradiated.
 化合物(1)またはこの組成物の配向は電磁波の照射で固定できる。電磁波の波長の範囲は150nmから500nmが好ましい。さらに好ましい範囲は250nmから450nmであり、特に好ましい範囲は300nmから400nmである。照射時の温度は、化合物(1)またはこの組成物が液晶状態である温度であるが、熱重合を防ぐために、100℃以下が好ましい。 The orientation of compound (1) or this composition can be fixed by irradiation with electromagnetic waves. The wavelength range of the electromagnetic wave is preferably 150 nm to 500 nm. A more preferable range is 250 nm to 450 nm, and a particularly preferable range is 300 nm to 400 nm. The temperature at the time of irradiation is a temperature at which the compound (1) or this composition is in a liquid crystal state, but is preferably 100 ° C. or lower in order to prevent thermal polymerization.
 化合物(1)は、液晶表示素子の基板間の液晶組成物中に於いて重合させることにより重合または架橋される。電圧または磁場を印加した状態で重合させてもよい。好ましい重合方法は例えば熱、または光重合であり、好ましくは光重合である。必要であればここに重合開始剤を加えることもできる。重合条件および重合開始剤の適当な種類は当業者に公知であり、文献に記載されている。 Compound (1) is polymerized or crosslinked by polymerizing in the liquid crystal composition between the substrates of the liquid crystal display element. Polymerization may be performed in a state where a voltage or a magnetic field is applied. A preferred polymerization method is, for example, heat or photopolymerization, preferably photopolymerization. If necessary, a polymerization initiator can be added here. Polymerization conditions and suitable types of polymerization initiators are known to those skilled in the art and are described in the literature.
 化合物(1)は、特に重合開始剤を用いることなく、速やかに反応する点で優れている。これによって未反応の光ラジカル重合開始剤またはその分解生成物に起因する表示不良を低減することおよび製品寿命の長期化を達成できる。本発明の重合性化合物は単独で用いても、その他の重合性化合物と混合して用いてもよい。併せて用いることのできる重合性化合物としては市販または公知のモノマー、例えば特開2004-123829に記載の液晶表示素子に好適である既存の単官能または多官能の液晶性モノマーが挙げられる。 Compound (1) is excellent in that it reacts quickly without using a polymerization initiator. As a result, it is possible to reduce display defects due to unreacted radical photopolymerization initiator or its decomposition products and to prolong the product life. The polymerizable compound of the present invention may be used alone or in combination with other polymerizable compounds. Examples of the polymerizable compound that can be used in combination include commercially available or known monomers, for example, existing monofunctional or polyfunctional liquid crystalline monomers suitable for liquid crystal display elements described in JP-A No. 2004-123829.
 本発明の液晶表示素子は、例えば透明電極と液晶分子を配向させる配向制御膜とを備えた二枚の基板を有する。これらの基板の間に重合性化合物を含む液晶組成物を配置する。これらの基板の中の重合性化合物を重合することによって、素子は製造される。重合は電圧を印加しながら行われることもある。 The liquid crystal display element of the present invention has, for example, two substrates provided with a transparent electrode and an alignment control film for aligning liquid crystal molecules. A liquid crystal composition containing a polymerizable compound is disposed between these substrates. A device is manufactured by polymerizing the polymerizable compound in these substrates. The polymerization may be performed while applying a voltage.
 化合物(1)および組成物に含まれる成分化合物の合成法を説明する。このような化合物は、有機合成化学の手法を組み合わせることにより合成できる。出発物質に目的の末端基、環および結合基を導入する方法は、フーベン-ヴァイル(Houben-Wyle, Methoden der Organische Chemie, Georg-Thieme Verlag, Stuttgart)、オーガニック シンセシス(Organic Syntheses, John Wily & Sons, Inc.)、オーガニック リアクションズ(Organic Reactions, John Wily & Sons Inc.)、コンプリヘンシブ オーガニック シンセシス(Comprehensive Organic Synthesis, Pergamon Press)、新実験化学講座(丸善)などの成書に記載されている。 The method for synthesizing the compound (1) and the component compounds contained in the composition will be described. Such compounds can be synthesized by combining organic synthetic chemistry techniques. Methods for introducing the desired end groups, rings and linking groups into the starting materials are as follows: Houben-Wyle (Methoden der Organische Chemie, Georg-Thieme Verlag, Stuttgart), Organic Synthesis (Organic Syntheses, John Wily & Sons, Inc.), Organic Reactions (Johnson Wily & Sons Inc.), Comprehensive Organic Synthesis (Pergenmon Press), and New Experimental Chemistry Course (Maruzen).
 結合基Zから結合基Zの生成について、項(I)から項(IX)で説明する。このスキームにおいて、MSG(またはMSG)は少なくとも1つの環を有する一価の有機基である。複数のMSG(またはMSG)が表わす一価の有機基は、同一であってもよいし、または異なってもよい。化合物(1A)から化合物(1L)は、化合物(1)に相当する。 The generation of the linking group Z 1 to the linking group Z 3 will be described in the terms (I) to (IX). In this scheme, MSG 1 (or MSG 2 ) is a monovalent organic group having at least one ring. The monovalent organic groups represented by a plurality of MSG 1 (or MSG 2 ) may be the same or different. From compound (1A) to compound (1L) corresponds to compound (1).
(I) 単結合の生成
Figure JPOXMLDOC01-appb-I000042
(I) Generation of a single bond
Figure JPOXMLDOC01-appb-I000042
 アリールホウ酸(Q1)と公知の方法で合成される化合物(Q2)とを、炭酸塩水溶液中、テトラキス(トリフェニルホスフィン)パラジウムのような触媒の存在下で反応させて化合物(1A)を合成する。この化合物(1A)は、公知の方法で合成される化合物(Q3)にn-ブチルリチウムを、次いで塩化亜鉛を反応させ、ジクロロビス(トリフェニルホスフィン)パラジウムのような触媒の存在下で化合物(Q2)を反応させることによっても合成される。 Compound (1A) is synthesized by reacting arylboric acid (Q1) with compound (Q2) synthesized by a known method in an aqueous carbonate solution in the presence of a catalyst such as tetrakis (triphenylphosphine) palladium. . This compound (1A) is obtained by reacting compound (Q3) synthesized by a known method with n-butyllithium and then with zinc chloride, and in the presence of a catalyst such as dichlorobis (triphenylphosphine) palladium. ) Is also reacted.
(II) -CH=CH-の生成
Figure JPOXMLDOC01-appb-I000043
(II) Formation of —CH═CH—
Figure JPOXMLDOC01-appb-I000043
 公知の方法で合成されるホスホニウム塩(Q5)にカリウムt-ブトキシドのような塩基を作用して発生させたリンイリドを、アルデヒド(Q4)に反応させて化合物(1B)を合成する。 Compound (1B) is synthesized by reacting a phosphonium salt (Q5) synthesized by a known method with a base such as potassium t-butoxide and a phosphorus ylide generated with aldehyde (Q4).
(III) -(CH22-の生成
Figure JPOXMLDOC01-appb-I000044
(III) Formation of — (CH 2 ) 2
Figure JPOXMLDOC01-appb-I000044
 化合物(1B)をパラジウム炭素のような触媒の存在下で水素化することにより、化合物(1C)を合成する。 Compound (1C) is synthesized by hydrogenating compound (1B) in the presence of a catalyst such as palladium carbon.
(IV) -(CH24-の生成
Figure JPOXMLDOC01-appb-I000045
(IV) Formation of — (CH 2 ) 4
Figure JPOXMLDOC01-appb-I000045
 ホスホニウム塩(Q5)の代わりにホスホニウム塩(Q7)を用い、項(II)の方法に従って-(CH22-CH=CH-を有する化合物を得る。これを接触水素化して化合物(1E)を合成する。 Using phosphonium salt (Q7) instead of phosphonium salt (Q5), a compound having — (CH 2 ) 2 —CH═CH— is obtained according to the method of item (II). This is catalytically hydrogenated to synthesize compound (1E).
(V) -CHO-または-OCH-の生成
Figure JPOXMLDOC01-appb-I000046
(V) Formation of —CH 2 O— or —OCH 2
Figure JPOXMLDOC01-appb-I000046
 化合物(Q4)を水素化ホウ素ナトリウムなどの還元剤で還元して化合物(Q8)を得る。これを臭化水素酸などで臭素化して化合物(Q9)を得る。炭酸カリウムなどの存在下で、化合物(Q9)を化合物(Q10)と反応させて化合物(1F)を合成する。この方法によって-CH2O-を有する化合物も合成できる。 Compound (Q4) is reduced with a reducing agent such as sodium borohydride to obtain compound (Q8). This is brominated with hydrobromic acid or the like to obtain compound (Q9). Compound (1F) is synthesized by reacting compound (Q9) with compound (Q10) in the presence of potassium carbonate or the like. A compound having —CH 2 O— can also be synthesized by this method.
(VI) -COO-と-OCO-の生成
Figure JPOXMLDOC01-appb-I000047
(VI) Formation of —COO— and —OCO—
Figure JPOXMLDOC01-appb-I000047
 化合物(Q3)にn-ブチルリチウムを、続いて二酸化炭素を反応させてカルボン酸(Q11)を得る。化合物(Q11)とフェノール(Q16)とを、DCC(1,3-ジシクロヘキシルカルボジイミド)とDMAP(4-ジメチルアミノピリジン)との存在下で、脱水させて-COO-を有する化合物(1G)を合成する。この方法によって-OCO-を有する化合物も合成できる。 Compound (Q3) is reacted with n-butyllithium and subsequently with carbon dioxide to obtain carboxylic acid (Q11). Compound (1G) having —COO— is synthesized by dehydrating compound (Q11) and phenol (Q16) in the presence of DCC (1,3-dicyclohexylcarbodiimide) and DMAP (4-dimethylaminopyridine). To do. A compound having —OCO— can also be synthesized by this method.
(VII) -C≡C-の生成
Figure JPOXMLDOC01-appb-I000048
(VII) Formation of —C≡C—
Figure JPOXMLDOC01-appb-I000048
 ジクロロパラジウムとハロゲン化銅との触媒存在下、化合物(Q13)を化合物(Q2)と反応させて、化合物(1J)を合成する。 Compound (1J) is synthesized by reacting compound (Q13) with compound (Q2) in the presence of a catalyst of dichloropalladium and copper halide.
(VIII) -C≡C-COO-の生成
Figure JPOXMLDOC01-appb-I000049
(VIII) Formation of —C≡C—COO—
Figure JPOXMLDOC01-appb-I000049
 化合物(Q13)をn-ブチルリチウムでリチオ化した後、二酸化炭素を作用しカルボン酸(Q14)を得る。カルボン酸(Q14)とフェノール(Q16)とをDCCとDMAPの存在下で脱水させて-C≡C-COO-を有する化合物(1K)を合成する。この方法によって-OCO-C≡C-を有する化合物も合成できる。 After lithiation of compound (Q13) with n-butyllithium, carboxylic acid (Q14) is obtained by the action of carbon dioxide. Carboxylic acid (Q14) and phenol (Q16) are dehydrated in the presence of DCC and DMAP to synthesize compound (1K) having —C≡C—COO—. A compound having —OCO—C≡C— can also be synthesized by this method.
(IX) -C≡C-CH=CH-と-CH=CH-C≡C-の生成
Figure JPOXMLDOC01-appb-I000050
(IX) Formation of —C≡C—CH═CH— and —CH═CH—C≡C—
Figure JPOXMLDOC01-appb-I000050
 化合物(Q13)とビニルブロミド(Q15)とのクロスカップリング反応により、-C≡C-CH=CH-を有する化合物(1L)を合成できる。シス体の化合物(Q15)を使用すれば、シス体の(1L)が生成する。 Compound (1L) having —C≡C—CH═CH— can be synthesized by cross-coupling reaction of compound (Q13) and vinyl bromide (Q15). When the cis-form compound (Q15) is used, a cis-form (1L) is produced.
 重合性の基(P-1)または基(P-2)は、水酸基を持つ有機基にアクリル酸またはメタクリル酸の酸塩化物(または酸無水物)を作用させることにより導入できる。重合性の基(P-3)はハロゲンを有する有機基とビニルブロミドとのGrignard反応により導入できる。組成物は、このようにして得た化合物から公知の方法によって調製される。例えば、成分化合物を混合し、そして加熱によって互いに溶解させる。 The polymerizable group (P-1) or group (P-2) can be introduced by allowing an acid chloride (or acid anhydride) of acrylic acid or methacrylic acid to act on an organic group having a hydroxyl group. The polymerizable group (P-3) can be introduced by a Grignard reaction between a halogen-containing organic group and vinyl bromide. The composition is prepared from the compound thus obtained by known methods. For example, the component compounds are mixed and dissolved in each other by heating.
 以上の方法により、化合物(a-1)から化合物(a-292)を合成する。 The compound (a-292) is synthesized from the compound (a-1) by the above method.
Figure JPOXMLDOC01-appb-I000051
Figure JPOXMLDOC01-appb-I000051
Figure JPOXMLDOC01-appb-I000052
Figure JPOXMLDOC01-appb-I000052
Figure JPOXMLDOC01-appb-I000053
Figure JPOXMLDOC01-appb-I000053
Figure JPOXMLDOC01-appb-I000054
Figure JPOXMLDOC01-appb-I000054
Figure JPOXMLDOC01-appb-I000055
Figure JPOXMLDOC01-appb-I000055
Figure JPOXMLDOC01-appb-I000056
Figure JPOXMLDOC01-appb-I000056
Figure JPOXMLDOC01-appb-I000057
Figure JPOXMLDOC01-appb-I000057
Figure JPOXMLDOC01-appb-I000058
Figure JPOXMLDOC01-appb-I000058
Figure JPOXMLDOC01-appb-I000059
Figure JPOXMLDOC01-appb-I000059
Figure JPOXMLDOC01-appb-I000060
Figure JPOXMLDOC01-appb-I000060
Figure JPOXMLDOC01-appb-I000061
Figure JPOXMLDOC01-appb-I000061
Figure JPOXMLDOC01-appb-I000062
Figure JPOXMLDOC01-appb-I000062
Figure JPOXMLDOC01-appb-I000063
Figure JPOXMLDOC01-appb-I000063
Figure JPOXMLDOC01-appb-I000064
Figure JPOXMLDOC01-appb-I000064
Figure JPOXMLDOC01-appb-I000065
Figure JPOXMLDOC01-appb-I000065
Figure JPOXMLDOC01-appb-I000066
Figure JPOXMLDOC01-appb-I000066
Figure JPOXMLDOC01-appb-I000067
Figure JPOXMLDOC01-appb-I000067
Figure JPOXMLDOC01-appb-I000068
Figure JPOXMLDOC01-appb-I000068
Figure JPOXMLDOC01-appb-I000069
Figure JPOXMLDOC01-appb-I000069
Figure JPOXMLDOC01-appb-I000070
Figure JPOXMLDOC01-appb-I000070
Figure JPOXMLDOC01-appb-I000071
Figure JPOXMLDOC01-appb-I000071
Figure JPOXMLDOC01-appb-I000072
Figure JPOXMLDOC01-appb-I000072
Figure JPOXMLDOC01-appb-I000073
Figure JPOXMLDOC01-appb-I000073
Figure JPOXMLDOC01-appb-I000074
Figure JPOXMLDOC01-appb-I000074
Figure JPOXMLDOC01-appb-I000075
Figure JPOXMLDOC01-appb-I000075
Figure JPOXMLDOC01-appb-I000076
Figure JPOXMLDOC01-appb-I000076
Figure JPOXMLDOC01-appb-I000077
Figure JPOXMLDOC01-appb-I000077
Figure JPOXMLDOC01-appb-I000078
Figure JPOXMLDOC01-appb-I000078
Figure JPOXMLDOC01-appb-I000079
Figure JPOXMLDOC01-appb-I000079
Figure JPOXMLDOC01-appb-I000080
Figure JPOXMLDOC01-appb-I000080
Figure JPOXMLDOC01-appb-I000081
Figure JPOXMLDOC01-appb-I000081
 以下、実施例により本発明をさらに詳しく説明するが、本発明はこれら実施例によっては制限されない。なお特に断りのない限り、「%」は「重量%」を意味する。 Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples. Unless otherwise specified, “%” means “% by weight”.
1.化合物の実施例
 合成した化合物は、プロトン核磁気共鳴分光法(H-NMR)などにより同定した。化合物の融点は、示差走査熱量測定(DSC)により決定した。まず、各分析方法について説明をする。
1. Example of Compound The synthesized compound was identified by proton nuclear magnetic resonance spectroscopy ( 1 H-NMR) and the like. The melting point of the compound was determined by differential scanning calorimetry (DSC). First, each analysis method will be described.
 H-NMR分析:測定装置は、DRX-500(ブルカーバイオスピン製)を用いた。測定は、実施例などで製造したサンプルを、CDClなどのサンプルが可溶な重水素化溶媒に溶解し、室温で、500MHz、積算回数24回などの条件で行った。核磁気共鳴スペクトルの説明において、sはシングレット、dはダブレット、tはトリプレット、qはカルテット、mはマルチプレットであることを意味する。また、化学シフトδ値のゼロ点の基準物質としてはテトラメチルシラン(TMS)を用いた。 1 H-NMR analysis: DRX-500 (manufactured by Bruker BioSpin) was used as a measuring apparatus. The measurement was carried out by dissolving the sample produced in Examples and the like in a deuterated solvent in which a sample such as CDCl 3 is soluble and at room temperature under conditions of 500 MHz and 24 times of integration. In the description of the nuclear magnetic resonance spectrum, s means a singlet, d is a doublet, t is a triplet, q is a quartet, and m is a multiplet. Tetramethylsilane (TMS) was used as a reference material for the zero point of the chemical shift δ value.
 HPLC分析:測定装置は、島津製作所製のProminence(LC-20AD;SPD-20A)を用いた。カラムはワイエムシー製のYMC-Pack ODS-A(長さ150mm、内径4.6mm、粒子径5μm)を用いた。溶出液はアセトニトリルと純水を適宜混合して用いた。検出器としてはUV検出器、RI検出器、CORONA検出器などを適宜用いた。UV検出器を用いた場合、検出波長は254nmとした。 HPLC analysis: Prominence (LC-20AD; SPD-20A) manufactured by Shimadzu Corporation was used as the measurement apparatus. As the column, YMC-Pack ODS-A (length 150 mm, inner diameter 4.6 mm, particle diameter 5 μm) manufactured by YMC was used. As an eluent, acetonitrile and pure water were appropriately mixed and used. As a detector, a UV detector, an RI detector, a CORONA detector, or the like was appropriately used. When a UV detector was used, the detection wavelength was 254 nm.
 試料はアセトニトリルに溶解して、0.1重量%の溶液となるように調製し、この溶液1μLを試料室に導入した。記録計としては島津製作所製のC-R7Aplusを用いた。得られたクロマトグラムには、成分化合物に対応するピークの保持時間およびピークの面積値が示されている。 The sample was dissolved in acetonitrile to prepare a 0.1 wt% solution, and 1 μL of this solution was introduced into the sample chamber. As a recorder, a C-R7Aplus manufactured by Shimadzu Corporation was used. The obtained chromatogram shows the peak retention time and peak area values corresponding to the component compounds.
 HPLCより得られたクロマトグラムにおけるピークの面積比は成分化合物の割合に相当する。一般には、分析サンプルの成分化合物の重量%は、分析サンプルの各ピークの面積%と完全に同一ではないが、本発明において上述したカラムを用いる場合には、実質的に補正係数は1であるので、分析サンプル中の成分化合物の重量%は、分析サンプル中の各ピークの面積%とほぼ対応している。成分の液晶性化合物における補正係数に大きな差異がないからである。 The peak area ratio in the chromatogram obtained from HPLC corresponds to the ratio of the component compounds. In general, the weight% of the component compound of the analysis sample is not completely the same as the area% of each peak of the analysis sample. However, when the above-described column is used in the present invention, the correction factor is substantially 1. Therefore, the weight% of the component compound in the analysis sample substantially corresponds to the area% of each peak in the analysis sample. This is because there is no significant difference in the correction coefficients of the component liquid crystal compounds.
 DSC測定:パーキンエルマー社製走査熱量計DSC-7システム、またはDiamond DSCシステムを用いて、3℃/分速度で昇降温し、試料の相変化に伴う吸熱ピーク、または発熱ピークの開始点を外挿により求め、融点を決定した。 DSC measurement: Using a scanning calorimeter DSC-7 system manufactured by PerkinElmer or a Diamond DSC system, the temperature is raised and lowered at a rate of 3 ° C / min. The melting point was determined by insertion.
[測定試料]
 相構造および転移温度を測定するときには、液晶性化合物そのものを試料として用いた。ネマチック相の上限温度、粘度、光学的異方性、誘電率異方性などの物性を測定するときには、化合物を母液晶に混合して調製した組成物を試料として用いた。
[Measurement sample]
When measuring the phase structure and transition temperature, the liquid crystalline compound itself was used as a sample. When measuring physical properties such as the upper limit temperature, viscosity, optical anisotropy and dielectric anisotropy of the nematic phase, a composition prepared by mixing a compound with a mother liquid crystal was used as a sample.
 化合物を母液晶と混合した試料を用いる場合には、次の方法で測定を行った。化合物15重量%と母液晶85重量%とを混合して試料を調製した。この試料の測定値から、次の式で表わされる外挿法にしたがって、外挿値を計算し、この値を記載した。〈外挿値〉=(100×〈試料の測定値〉-〈母液晶の重量%〉×〈母液晶の測定値〉)/〈化合物の重量%〉 When a sample in which a compound was mixed with mother liquid crystals was used, measurement was performed by the following method. A sample was prepared by mixing 15% by weight of the compound and 85% by weight of the mother liquid crystals. An extrapolated value was calculated from the measured value of this sample according to the extrapolation method represented by the following formula, and this value was described. <Extrapolated value> = (100 × <Measured value of sample> − <Weight% of mother liquid crystal> × <Measured value of mother liquid crystal>) / <Weight% of compound>
[測定方法]
 物性の測定は下記の方法で行った。これらの多くは、日本電子機械工業会規格(Standard of Electronic Industries Association of Japan)、EIAJ・ED-2521Aに記載された方法、またはこれを修飾した方法であった。測定に用いたTN素子には、TFTを取り付けなかった。
[Measuring method]
The physical properties were measured by the following methods. Many of these were the methods described in the Standard of Electronic Industries Association of Japan, EIAJ • ED-2521A, or a modified method thereof. No TFT was attached to the TN device used for measurement.
(1)相構造
 偏光顕微鏡を備えた融点測定装置のホットプレート(メトラー社FP-52型ホットステージ)に試料(化合物)を置き、3℃/分の速度で加熱しながら相状態とその変化を偏光顕微鏡で観察し、相の種類を特定した。
(1) Phase structure A sample (compound) is placed on a hot plate (Mettler FP-52 type hot stage) of a melting point measurement apparatus equipped with a polarizing microscope, and the phase state and its change are heated while heating at a rate of 3 ° C / min. Observation with a polarizing microscope identified the type of phase.
(2)転移温度(℃)
 パーキンエルマー社製走査熱量計DSC-7システム、またはDiamond DSCシステムを用いて、3℃/分速度で昇降温し、試料(化合物)の相変化に伴う吸熱ピーク、または発熱ピークの開始点を外挿により求め、転移温度を決定した。化合物が固体からスメクチック相、ネマチック相などの液晶相に転移する温度を「液晶相の下限温度」と略すことがある。化合物が液晶相から液体に転移する温度を「透明点」と略すことがある。
(2) Transition temperature (° C)
Using a scanning calorimeter DSC-7 system or a Diamond DSC system manufactured by PerkinElmer Inc., the temperature is raised and lowered at a rate of 3 ° C / min. The transition temperature was determined by insertion. The temperature at which a compound transitions from a solid to a liquid crystal phase such as a smectic phase or a nematic phase may be abbreviated as “lower limit temperature of liquid crystal phase”. The temperature at which the compound transitions from the liquid crystal phase to the liquid may be abbreviated as “clearing point”.
 結晶はCと表した。結晶の種類の区別がつく場合は、それぞれCまたはCと表した。スメクチック相はS、ネマチック相はNと表した。スメクチック相の中で、スメクチックA相、スメクチックB相、スメクチックC相、またはスメクチックF相の区別がつく場合は、それぞれS、S、S、またはSと表した。液体(アイソトロピック)はIと表した。転移温度は、例えば、「C 50.0 N 100.0 I」のように表記した。これは、結晶からネマチック相への転移温度(CN)が50.0℃であり、ネマチック相から液体への転移温度(透明点)が100.0℃であることを示す。 The crystal was represented as C. When the types of crystals can be distinguished, they are expressed as C 1 or C 2 , respectively. The smectic phase is represented as S and the nematic phase is represented as N. In the smectic phase, when a smectic A phase, a smectic B phase, a smectic C phase, or a smectic F phase can be distinguished, they are represented as S A , S B , S C , or S F , respectively. The liquid (isotropic) was designated as I. The transition temperature is expressed as “C 50.0 N 100.0 I”, for example. This indicates that the transition temperature (CN) from the crystal to the nematic phase is 50.0 ° C., and the transition temperature (clearing point) from the nematic phase to the liquid is 100.0 ° C.
(3)低温相溶性
 化合物の割合が、20重量%、15重量%、10重量%、5重量%、3重量%、および1重量%となるように母液晶と化合物とを混合した試料を調製し、試料をガラス瓶に入れた。このガラス瓶を、-10℃または-20℃のフリーザー中に一定期間保管したあと、結晶またはスメクチック相が析出しているかどうか観察をした。
(3) Low temperature compatibility Samples prepared by mixing the mother liquid crystal and the compound so that the ratio of the compound is 20% by weight, 15% by weight, 10% by weight, 5% by weight, 3% by weight, and 1% by weight are prepared. The sample was placed in a glass bottle. The glass bottle was stored in a freezer at −10 ° C. or −20 ° C. for a certain period, and then it was observed whether a crystal or smectic phase was precipitated.
(4)ネマチック相の上限温度(TNIまたはNI;℃)
 偏光顕微鏡を備えた融点測定装置のホットプレートに試料を置き、1℃/分の速度で加熱した。試料の一部がネマチック相から等方性液体に変化したときの温度を測定した。ネマチック相の上限温度を「上限温度」と略すことがある。
(4) Maximum temperature of nematic phase (T NI or NI; ° C.)
A sample was placed on a hot plate of a melting point measurement apparatus equipped with a polarizing microscope and heated at a rate of 1 ° C./min. The temperature was measured when a part of the sample changed from a nematic phase to an isotropic liquid. The upper limit temperature of the nematic phase may be abbreviated as “upper limit temperature”.
(5)ネマチック相の下限温度(T;℃)
 ネマチック相を有する試料を0℃、-10℃、-20℃、-30℃、および-40℃のフリーザー中に10日間保管したあと、液晶相を観察した。例えば、試料が-20℃ではネマチック相のままであり、-30℃では結晶またはスメクチック相に変化したとき、Tを≦-20℃と記載した。ネマチック相の下限温度を「下限温度」と略すことがある。
(5) Minimum Temperature of a Nematic Phase (T C; ° C.)
A sample having a nematic phase was stored in a freezer at 0 ° C., −10 ° C., −20 ° C., −30 ° C., and −40 ° C. for 10 days, and then the liquid crystal phase was observed. For example, when the sample remained in a nematic phase at −20 ° C. and changed to a crystal or smectic phase at −30 ° C., TC was described as ≦ −20 ° C. The lower limit temperature of the nematic phase may be abbreviated as “lower limit temperature”.
(6)粘度(バルク粘度;η;20℃で測定;mPa・s)
 E型回転粘度計を用いて測定した。
(6) Viscosity (bulk viscosity; η; measured at 20 ° C .; mPa · s)
It measured using the E-type rotational viscometer.
(7)粘度(回転粘度;γ1;25℃で測定;mPa・s)
 測定はM. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, 37 (1995) に記載された方法に従った。ツイスト角が0°であり、そして2枚のガラス基板の間隔(セルギャップ)が5μmであるTN素子に試料を入れた。この素子に16Vから19.5Vの範囲で0.5V毎に段階的に印加した。0.2秒の無印加のあと、ただ1つの矩形波(矩形パルス;0.2秒)と無印加(2秒)の条件で印加を繰り返した。この印加によって発生した過渡電流(transient current)のピーク電流(peak current)とピーク時間(peak time)を測定した。これらの測定値とM. Imaiらの論文、40頁の計算式(8)とから回転粘度の値を得た。この計算で必要な誘電率異方性の値は、この回転粘度を測定した素子を用い、下に記載した方法で求めた。
(7) Viscosity (Rotational viscosity; γ1; measured at 25 ° C .; mPa · s)
The measurement followed the method described in M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, 37 (1995). A sample was put in a TN device having a twist angle of 0 ° and a distance (cell gap) between two glass substrates of 5 μm. A voltage was applied to this device in steps of 0.5 V in the range of 16 V to 19.5 V. After no application for 0.2 seconds, the application was repeated under the condition of only one rectangular wave (rectangular pulse; 0.2 seconds) and no application (2 seconds). The peak current and peak time of the transient current generated by this application were measured. The value of rotational viscosity was obtained from these measured values and the paper by M. Imai et al., Formula (8) on page 40. The value of dielectric anisotropy necessary for this calculation was determined by the method described below using the element whose rotational viscosity was measured.
(8)光学的異方性(屈折率異方性;25℃で測定;Δn)
 測定は、波長589nmの光を用い、接眼鏡に偏光板を取り付けたアッベ屈折計により行なった。主プリズムの表面を一方向にラビングしたあと、試料を主プリズムに滴下した。屈折率(n∥)は偏光の方向がラビングの方向と平行であるときに測定した。屈折率(n⊥)は偏光の方向がラビングの方向と垂直であるときに測定した。光学的異方性(Δn)の値は、Δn=n∥-n⊥、の式から計算した。
(8) Optical anisotropy (refractive index anisotropy; measured at 25 ° C .; Δn)
The measurement was performed with an Abbe refractometer using light having a wavelength of 589 nm and a polarizing plate attached to the eyepiece. After rubbing the surface of the main prism in one direction, the sample was dropped on the main prism. The refractive index (n∥) was measured when the direction of polarized light was parallel to the direction of rubbing. The refractive index (n⊥) was measured when the direction of polarized light was perpendicular to the direction of rubbing. The value of optical anisotropy (Δn) was calculated from the equation: Δn = n∥−n⊥.
(9)誘電率異方性(Δε;25℃で測定)
 2枚のガラス基板の間隔(セルギャップ)が9μmであり、そしてツイスト角が80度であるTN素子に試料を入れた。この素子にサイン波(10V、1kHz)を印加し、2秒後に液晶分子の長軸方向における誘電率(ε∥)を測定した。この素子にサイン波(0.5V、1kHz)を印加し、2秒後に液晶分子の短軸方向における誘電率(ε⊥)を測定した。誘電率異方性の値は、Δε=ε∥-ε⊥、の式から計算した。
(9) Dielectric anisotropy (Δε; measured at 25 ° C.)
A sample was put in a TN device in which the distance between two glass substrates (cell gap) was 9 μm and the twist angle was 80 degrees. Sine waves (10 V, 1 kHz) were applied to the device, and after 2 seconds, the dielectric constant (ε∥) in the major axis direction of the liquid crystal molecules was measured. Sine waves (0.5 V, 1 kHz) were applied to the device, and after 2 seconds, the dielectric constant (ε⊥) in the minor axis direction of the liquid crystal molecules was measured. The value of dielectric anisotropy was calculated from the equation: Δε = ε∥−ε⊥.
(10)弾性定数(K;25℃で測定;pN)
 測定には横河・ヒューレットパッカード株式会社製のHP4284A型LCRメータを用いた。2枚のガラス基板の間隔(セルギャップ)が20μmである水平配向素子に試料を入れた。このセルに0ボルトから20ボルト電荷を印加し、静電容量および印加電圧を測定した。測定した静電容量(C)と印加電圧(V)の値を「液晶デバイスハンドブックク」(日刊工業新聞社)、75頁にある式(2.98)、式(2.101)を用いてフィッティングし、式(2.99)からK11およびK33の値を得た。次に171頁にある式(3.18)に、先ほど求めたK11およびK33の値を用いてK22を算出した。弾性定数は、このようにして求めたK11、K22、およびK33の平均値である。
(10) Elastic constant (K; measured at 25 ° C .; pN)
For measurement, an HP4284A LCR meter manufactured by Yokogawa Hewlett-Packard Co., Ltd. was used. A sample was put in a horizontal alignment element in which the distance between two glass substrates (cell gap) was 20 μm. A charge of 0 to 20 volts was applied to the cell, and the capacitance and applied voltage were measured. Using the formula (2.98) and formula (2.101) on page 75 of “Liquid Crystal Device Handbook” (Nikkan Kogyo Shimbun), the values of the measured capacitance (C) and applied voltage (V) are calculated. Fitting was performed, and values of K 11 and K 33 were obtained from the equation (2.99). Then the equation (3.18) on page 171, to calculate the K 22 using the values of K 11 and K 33 was determined previously. The elastic constant is an average value of K 11 , K 22 , and K 33 thus obtained.
(11)しきい値電圧(Vth;25℃で測定;V)
 測定には大塚電子株式会社製のLCD5100型輝度計を用いた。光源はハロゲンランプである。2枚のガラス基板の間隔(セルギャップ)が約0.45/Δn(μm)であり、ツイスト角が80度であるノーマリーホワイトモード(normally white mode)のTN素子に試料を入れた。この素子に印加する電圧(32Hz、矩形波)は0Vから10Vまで0.02Vずつ段階的に増加させた。この際に、素子に垂直方向から光を照射し、素子を透過した光量を測定した。この光量が最大になったときが透過率100%であり、この光量が最小であったときが透過率0%である電圧-透過率曲線を作成した。しきい値電圧は透過率が90%になったときの電圧である。
(11) Threshold voltage (Vth; measured at 25 ° C .; V)
An LCD5100 luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source is a halogen lamp. A sample was put in a normally white mode TN device in which the distance between two glass substrates (cell gap) was about 0.45 / Δn (μm) and the twist angle was 80 degrees. The voltage (32 Hz, rectangular wave) applied to this element was increased stepwise from 0V to 10V by 0.02V. At this time, the device was irradiated with light from the vertical direction, and the amount of light transmitted through the device was measured. A voltage-transmittance curve was created in which the transmittance was 100% when the light amount reached the maximum and the transmittance was 0% when the light amount was the minimum. The threshold voltage is a voltage when the transmittance reaches 90%.
[実施例1]
化合物(a-4)の合成
Figure JPOXMLDOC01-appb-I000082
[Example 1]
Synthesis of compound (a-4)
Figure JPOXMLDOC01-appb-I000082
第1工程:化合物(S-3)の合成
 窒素雰囲気下、化合物(S-1)(50.0g,0.269mol)、トリエチルアミン(20.4g,0.202mol)、2,6-ジ-tert-ブチル-p-クレゾール(BHT)(5.000mg、0.0220mmol)、ジクロロメタン(500mL)の混合物に氷冷下で化合物(S-2)(17.5g,0.167mol)のジクロロメタン(40mL)溶液を滴下し、その後徐々に室温まで昇温した。室温で16時間撹拌した後、反応溶液を水に注ぎ、有機層を1M塩酸、次いで飽和食塩水で洗浄した。有機層を無水硫酸マグネシウムで乾燥した後、有機溶媒を減圧下留去した。残渣をシリカゲルカラムクロマトグラフィー(展開溶媒 ヘプタン:酢酸エチル=5:5(容積比))で精製し、化合物(S-3)を無色結晶(18.6g)として得た。
First Step: Synthesis of Compound (S-3) In a nitrogen atmosphere, compound (S-1) (50.0 g, 0.269 mol), triethylamine (20.4 g, 0.202 mol), 2,6-di-tert Compound (S-2) (17.5 g, 0.167 mol) in dichloromethane (40 mL) was added to a mixture of butyl-p-cresol (BHT) (5.000 mg, 0.0220 mmol) and dichloromethane (500 mL) under ice-cooling. The solution was added dropwise, and then the temperature was gradually raised to room temperature. After stirring at room temperature for 16 hours, the reaction solution was poured into water, and the organic layer was washed with 1M hydrochloric acid and then with saturated brine. After drying the organic layer with anhydrous magnesium sulfate, the organic solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent heptane: ethyl acetate = 5: 5 (volume ratio)) to obtain compound (S-3) as colorless crystals (18.6 g).
第2工程:化合物(a-4)の合成
 窒素雰囲気下、化合物(S-3)(16.0g,0.0629mol)、トリエチルアミン(3.82g,0.0377mol)、BHT(5.000mg、0.0220mmol)、ジクロロメタン(200mL)の混合物に氷冷下で化合物(S-4)(4.17g,0.0346mol)のジクロロメタン(10mL)溶液を滴下し、その後徐々に室温まで昇温した。室温で16時間撹拌した後、反応溶液を水に注ぎ、有機層を1M塩酸、飽和食塩水、1M水酸化ナトリウム水溶液で順次洗浄した。有機層を無水硫酸マグネシウムで乾燥した後、有機溶媒を減圧下留去した。残渣をシリカゲルカラムクロマトグラフィー(展開溶媒 トルエン:酢酸エチル=9:1(容積比))で精製し、エタノールとジクロロメタンの混合溶媒より再結晶を行い、化合物(a-4)を無色結晶(17.1g)として得た。
 融点:67.0℃.
 H-NMR(DMSO-d;δ ppm):7.57(dd,4H),7.26(dd,2H),7.20(dd,2H),6.38(s,1H),6.06-5.98(m,1H),5.78(t,1H),5.47-5.43(m,1H),5.35(dd,1H),4.77-4.76(m,2H),2.08(s,3H).
Second Step: Synthesis of Compound (a-4) In a nitrogen atmosphere, compound (S-3) (16.0 g, 0.0629 mol), triethylamine (3.82 g, 0.0377 mol), BHT (5.000 mg, 0 0.020 mmol) and dichloromethane (200 mL) were added dropwise a solution of compound (S-4) (4.17 g, 0.0346 mol) in dichloromethane (10 mL) under ice cooling, and then the temperature was gradually raised to room temperature. After stirring at room temperature for 16 hours, the reaction solution was poured into water, and the organic layer was washed successively with 1M hydrochloric acid, saturated brine, and 1M aqueous sodium hydroxide. After drying the organic layer with anhydrous magnesium sulfate, the organic solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent toluene: ethyl acetate = 9: 1 (volume ratio)) and recrystallized from a mixed solvent of ethanol and dichloromethane to give compound (a-4) as colorless crystals (17. Obtained as 1 g).
Melting point: 67.0 ° C.
1 H-NMR (DMSO-d; δ ppm): 7.57 (dd, 4H), 7.26 (dd, 2H), 7.20 (dd, 2H), 6.38 (s, 1H), 6 .06-5.98 (m, 1H), 5.78 (t, 1H), 5.47-5.43 (m, 1H), 5.35 (dd, 1H), 4.77-4.76 (M, 2H), 2.08 (s, 3H).
[実施例2]
化合物(a-14)の合成
Figure JPOXMLDOC01-appb-I000083
[Example 2]
Synthesis of compound (a-14)
Figure JPOXMLDOC01-appb-I000083
第1工程:化合物(S-7)の合成
 窒素雰囲気下、化合物(S-5)(20.0g,0.0803mol)、テトラキス(トリフェニルホスフィン)パラジウム(3.71g,3.21mmol)、ヨウ化銅(1.84g,9.64mmol)、N,N-ジイソプロピルエチルアミン(20mL)、N,N-ジメチルホルムアミド(DMF)(100mL)の混合物に、氷冷下、化合物(S-6)(5.40g,0.0964mol)を滴下し1時間撹拌した。次に反応液を50℃に加熱し、4時間撹拌した。反応液を水に注ぎ、2M塩酸を加えて酸性にした。水層をジエチルエーテルで抽出し、無水硫酸マグネシウムで乾燥した後、有機溶媒を減圧下留去し、化合物(S-7)(15.8g)を得た。
First Step: Synthesis of Compound (S-7) Compound (S-5) (20.0 g, 0.0803 mol), tetrakis (triphenylphosphine) palladium (3.71 g, 3.21 mmol), iodine under nitrogen atmosphere To a mixture of copper chloride (1.84 g, 9.64 mmol), N, N-diisopropylethylamine (20 mL), N, N-dimethylformamide (DMF) (100 mL) was added compound (S-6) (5 .40 g, 0.0964 mol) was added dropwise and stirred for 1 hour. Next, the reaction solution was heated to 50 ° C. and stirred for 4 hours. The reaction mixture was poured into water and acidified with 2M hydrochloric acid. The aqueous layer was extracted with diethyl ether and dried over anhydrous magnesium sulfate, and then the organic solvent was evaporated under reduced pressure to obtain compound (S-7) (15.8 g).
第2工程:化合物(S-8)の合成
 窒素雰囲気下、水素化ビス(2-メトキシエトキシ)アルミニウムナトリウム(3.6mol/Lトルエン溶液)(24.0mL,0.0864mol)のジエチルエーテル(50mL)溶液に、氷冷下、化合物(S-7)(12.0g,0.0535mol)のジエチルエーテル(60mL)溶液を滴下した。滴下終了後、反応溶液を室温に戻し、1時間撹拌した。反応溶液に1M硫酸(70mL)を滴下した後、有機層を水、次いで飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥した。有機溶媒を減圧下留去し、化合物(S-8)(9.53g)を得た。
Second Step: Synthesis of Compound (S-8) Diethyl ether (50 mL) of sodium bis (2-methoxyethoxy) aluminum hydride (3.6 mol / L toluene solution) (24.0 mL, 0.0864 mol) under nitrogen atmosphere ) A solution of compound (S-7) (12.0 g, 0.0535 mol) in diethyl ether (60 mL) was added dropwise to the solution under ice cooling. After completion of the dropwise addition, the reaction solution was returned to room temperature and stirred for 1 hour. 1M sulfuric acid (70 mL) was added dropwise to the reaction solution, and then the organic layer was washed with water and then with saturated brine, and dried over anhydrous magnesium sulfate. The organic solvent was distilled off under reduced pressure to obtain Compound (S-8) (9.53 g).
第3工程:化合物(a-14)の合成
 窒素雰囲気下、化合物(S-8)(6.00g,0.0265mol)、トリエチルアミン(5.90g,0.0583mol)、BHT(5.000mg、0.0220mmol)、ジクロロメタン(100mL)の混合物に氷冷下で化合物(S-2)(6.09g,0.0583mol)のジクロロメタン(5mL)溶液を滴下し、その後徐々に室温まで昇温した。室温で16時間撹拌した後、反応溶液を水に注ぎ、有機層を1M塩酸、飽和食塩水、1M水酸化ナトリウム水溶液で順次洗浄した。有機層を無水硫酸マグネシウムで乾燥した後、有機溶媒を減圧下留去した。残渣をシリカゲルカラムクロマトグラフィー(展開溶媒 トルエン:酢酸エチル=9:1(容積比))で精製し、エタノールとジクロロメタンの混合溶媒より再結晶を行い、化合物(a-14)を無色結晶(6.77g)として得た。
 融点:72.0℃.
 H-NMR(DMSO-d;δ ppm):7.61(d,2H),7.55(d,2H),7.47(d,2H),7.20(d,2H),6.71(d,2H),6.40-6.35(m,1H),6.38(s,1H),6.17(s,1H),5.78(t,1H),5.61(t,1H),4.84(dd,2H),2.09(s,3H),1.99(s,3H).
Third Step: Synthesis of Compound (a-14) Compound (S-8) (6.00 g, 0.0265 mol), triethylamine (5.90 g, 0.0583 mol), BHT (5.000 mg, 0) under nitrogen atmosphere 0.020 mmol) and dichloromethane (100 mL) were added dropwise a solution of compound (S-2) (6.09 g, 0.0583 mol) in dichloromethane (5 mL) under ice cooling, and then the temperature was gradually raised to room temperature. After stirring at room temperature for 16 hours, the reaction solution was poured into water, and the organic layer was washed successively with 1M hydrochloric acid, saturated brine, and 1M aqueous sodium hydroxide. After drying the organic layer with anhydrous magnesium sulfate, the organic solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent toluene: ethyl acetate = 9: 1 (volume ratio)) and recrystallized from a mixed solvent of ethanol and dichloromethane to give compound (a-14) as colorless crystals (6. 77 g).
Melting point: 72.0 ° C.
1 H-NMR (DMSO-d; δ ppm): 7.61 (d, 2H), 7.55 (d, 2H), 7.47 (d, 2H), 7.20 (d, 2H), 6 .71 (d, 2H), 6.40-6.35 (m, 1H), 6.38 (s, 1H), 6.17 (s, 1H), 5.78 (t, 1H), 5. 61 (t, 1H), 4.84 (dd, 2H), 2.09 (s, 3H), 1.99 (s, 3H).
[実施例3]
化合物(a-17)の合成
Figure JPOXMLDOC01-appb-I000084
[Example 3]
Synthesis of compound (a-17)
Figure JPOXMLDOC01-appb-I000084
第1工程:化合物(S-10)の合成
 窒素雰囲気下、化合物(S-1)(100g,0.537mol)とDMF(500mL)の混合物を40℃に加温した。ここに60%水素化ナトリウム(22.6g,0.565mol)を加え、70℃で1時間撹拌した。次に、化合物(S-9)(52.9g,0.269mol)を30分間で反応溶液に滴下し、さらに95℃で2時間撹拌した。反応溶液を60℃に冷却し、0.6M水酸化ナトリウム水溶液(1L)に注ぎ、メチルtert-ブチルエーテル(MTBE):ヘキサン=1:1(容積比)の混合溶媒で抽出した後、有機層を0.6M水酸化ナトリウム水溶液で洗浄した。有機溶媒を減圧下留去し、化合物(S-10)を黄色液体(47.1g)として得た。
First Step: Synthesis of Compound (S-10) A mixture of compound (S-1) (100 g, 0.537 mol) and DMF (500 mL) was heated to 40 ° C. under a nitrogen atmosphere. 60% sodium hydride (22.6 g, 0.565 mol) was added thereto, and the mixture was stirred at 70 ° C. for 1 hour. Next, compound (S-9) (52.9 g, 0.269 mol) was added dropwise to the reaction solution over 30 minutes, and the mixture was further stirred at 95 ° C. for 2 hours. The reaction solution was cooled to 60 ° C., poured into 0.6 M aqueous sodium hydroxide solution (1 L), extracted with a mixed solvent of methyl tert-butyl ether (MTBE): hexane = 1: 1 (volume ratio), Washed with 0.6M aqueous sodium hydroxide. The organic solvent was distilled off under reduced pressure to obtain compound (S-10) as a yellow liquid (47.1 g).
第2工程:化合物(S-12)の合成
 窒素雰囲気下、化合物(S-10)(47.1g,0.156mol)、化合物(S-11)(13.4g,0.156mol)、4-ジメチルアミノピリジン(DMAP)(1.91g,0.0156mol)とジクロロメタン(800mL)の混合物中、N,N’-ジシクロヘキシルカルボジイミド(DCC)(33.7g,0.163mol)のジクロロメタン(100mL)溶液を25℃で滴下し、15時間撹拌した。反応溶液中の析出物をろ過後、有機層を水洗し、無水硫酸マグネシウムで乾燥した。有機溶媒を減圧下留去後、残渣をシリカゲルカラムクロマトグラフィー(展開溶媒 ジクロロメタン:ヘキサン=1:1(容積比))で精製し、化合物(S-12)を無色結晶(46.2g)として得た。
Second Step: Synthesis of Compound (S-12) In a nitrogen atmosphere, Compound (S-10) (47.1 g, 0.156 mol), Compound (S-11) (13.4 g, 0.156 mol), 4- A mixture of N, N′-dicyclohexylcarbodiimide (DCC) (33.7 g, 0.163 mol) in dichloromethane (100 mL) in a mixture of dimethylaminopyridine (DMAP) (1.91 g, 0.0156 mol) and dichloromethane (800 mL). The solution was added dropwise at 25 ° C. and stirred for 15 hours. After filtering the precipitate in the reaction solution, the organic layer was washed with water and dried over anhydrous magnesium sulfate. After evaporating the organic solvent under reduced pressure, the residue was purified by silica gel column chromatography (developing solvent: dichloromethane: hexane = 1: 1 (volume ratio)) to obtain compound (S-12) as colorless crystals (46.2 g). It was.
第3工程:化合物(S-13)の合成
 窒素雰囲気下、化合物(S-12)(46.2g,0.125mol)をアセトン(300mL)とTHF(600mL)の混合溶媒に溶解し、5℃で2M塩酸を滴下し、室温で15時間撹拌した。反応溶液を減圧下200mL程度溶媒を留去し、濃縮した反応溶液中の析出物をろ取した。得られた固形物を50℃で2時間乾燥し、化合物(S-13)を無色結晶(31.9g)として得た。
Third Step: Synthesis of Compound (S-13) Under a nitrogen atmosphere, compound (S-12) (46.2 g, 0.125 mol) was dissolved in a mixed solvent of acetone (300 mL) and THF (600 mL), and 5 ° C. 2M hydrochloric acid was added dropwise and stirred at room temperature for 15 hours. About 200 mL of the solvent was distilled off from the reaction solution under reduced pressure, and the precipitate in the concentrated reaction solution was collected by filtration. The obtained solid was dried at 50 ° C. for 2 hours to obtain compound (S-13) as colorless crystals (31.9 g).
第4工程:化合物(a-17)の合成
 窒素雰囲気下、化合物(S-13)(31.9g,0.101mol)とトルエン(900mL)の混合物に、炭酸カリウム(83.8g,0.606mol)次いで化合物(S-14)(155g,1.01mol)を加え、40時間加熱還流した。反応溶液を室温まで放冷し、析出物をろ別した。ろ液の溶媒を減圧下留去し、残渣をシリカゲルクロマトグラフィー(展開溶媒 1,2-ジクロロエタン:ヘキサン=3:7(容積比))で精製した。得られた結晶をヘキサン(100mL)中で1時間加熱還流し、冷却後析出物をろ取し、化合物(a-17)を無色結晶(8.31g)として得た。
 融点:111.0℃.
 H-NMR(DMSO-d;δ ppm):7.74-7.67(m,4H),7.28-7.20(m,4H),6.89(d,1H),6.62(d,1H),6.30(s,1H),6.17(s,1H),5.91(s,1H),5.84(s,1H),2.02(s,3H),1.94(s,3H).
Fourth Step: Synthesis of Compound (a-17) Under a nitrogen atmosphere, potassium carbonate (83.8 g, 0.606 mol) was added to a mixture of compound (S-13) (31.9 g, 0.101 mol) and toluene (900 mL). Then, compound (S-14) (155 g, 1.01 mol) was added, and the mixture was heated to reflux for 40 hours. The reaction solution was allowed to cool to room temperature, and the precipitate was filtered off. The solvent of the filtrate was distilled off under reduced pressure, and the residue was purified by silica gel chromatography (developing solvent 1,2-dichloroethane: hexane = 3: 7 (volume ratio)). The obtained crystals were heated to reflux in hexane (100 mL) for 1 hour. After cooling, the precipitate was collected by filtration to obtain compound (a-17) as colorless crystals (8.31 g).
Melting point: 111.0 ° C.
1 H-NMR (DMSO-d; δ ppm): 7.74-7.67 (m, 4H), 7.28-7.20 (m, 4H), 6.89 (d, 1H), 6. 62 (d, 1H), 6.30 (s, 1H), 6.17 (s, 1H), 5.91 (s, 1H), 5.84 (s, 1H), 2.02 (s, 3H) ), 1.94 (s, 3H).
 実施例1~3に示した合成方法により、下記の化合物を対応する出発原料から合成した。 The following compounds were synthesized from the corresponding starting materials by the synthesis methods shown in Examples 1 to 3.
[実施例4]
化合物(a-33)
Figure JPOXMLDOC01-appb-I000085
[Example 4]
Compound (a-33)
Figure JPOXMLDOC01-appb-I000085
 融点:89.4℃.
 H-NMR(CDCl;δ ppm):7.55(dd,4H),7.20(d,2H),7.13(d,2H),6.98(d,1H),6.65-6.56(m,2H),6.38-6.20(m,3H),6.04(dd,1H),5.97(dd,1H).
Melting point: 89.4 ° C.
1 H-NMR (CDCl 3 ; δ ppm): 7.55 (dd, 4H), 7.20 (d, 2H), 7.13 (d, 2H), 6.98 (d, 1H), 6. 65-6.56 (m, 2H), 6.38-6.20 (m, 3H), 6.04 (dd, 1H), 5.97 (dd, 1H).
[実施例5]
化合物(a-16)
Figure JPOXMLDOC01-appb-I000086
[Example 5]
Compound (a-16)
Figure JPOXMLDOC01-appb-I000086
 融点:80.0℃.
 H-NMR(CDCl;δ ppm):7.55(dd,4H),7.19(d,2H),7.13(d,2H),6.96(d,1H),6.63(dd,1H),6.37-6.29(m,2H),6.18(d,1H),6.04(d,1H),5.71(t,1H),2.01(s,3H).
Melting point: 80.0 ° C.
1 H-NMR (CDCl 3 ; δ ppm): 7.55 (dd, 4H), 7.19 (d, 2H), 7.13 (d, 2H), 6.96 (d, 1H), 6. 63 (dd, 1H), 6.37-6.29 (m, 2H), 6.18 (d, 1H), 6.04 (d, 1H), 5.71 (t, 1H), 2.01 (S, 3H).
[実施例6]
化合物(a-68)
Figure JPOXMLDOC01-appb-I000087
[Example 6]
Compound (a-68)
Figure JPOXMLDOC01-appb-I000087
 融点:105.9℃.
 H-NMR(CDCl;δ ppm):7.55(t,4H),7.18(d,2H),7.13(d,2H),6.98(d,1H),6.58(dd,1H),6.37(s,1H),6.26(dd,1H),6.20(d,1H),5.97(dd,1H),5.78(t,1H),2.08(s,3H).
Melting point: 105.9 ° C.
1 H-NMR (CDCl 3 ; δ ppm): 7.55 (t, 4H), 7.18 (d, 2H), 7.13 (d, 2H), 6.98 (d, 1H), 6. 58 (dd, 1H), 6.37 (s, 1H), 6.26 (dd, 1H), 6.20 (d, 1H), 5.97 (dd, 1H), 5.78 (t, 1H) ), 2.08 (s, 3H).
[実施例7]
化合物(a-31)
Figure JPOXMLDOC01-appb-I000088
[Example 7]
Compound (a-31)
Figure JPOXMLDOC01-appb-I000088
 融点:58.0℃.
 H-NMR(CDCl;δ ppm):7.52(d,2H),7.37-7.32(m,2H),7.22(t,1H),7.13(d,2H),6.96(d,1H),6.41(s,1H),6.29(s,1H),6.18(d,1H),5.82(s,1H),5.71(s,1H),2.09(s,3H),2.01(s,3H).
Melting point: 58.0 ° C.
1 H-NMR (CDCl 3 ; δ ppm): 7.52 (d, 2H), 7.37-7.32 (m, 2H), 7.22 (t, 1H), 7.13 (d, 2H) ), 6.96 (d, 1H), 6.41 (s, 1H), 6.29 (s, 1H), 6.18 (d, 1H), 5.82 (s, 1H), 5.71 (S, 1H), 2.09 (s, 3H), 2.01 (s, 3H).
[実施例8]
化合物(a-25)

Figure JPOXMLDOC01-appb-I000089
[Example 8]
Compound (a-25)

Figure JPOXMLDOC01-appb-I000089
 融点:64.7℃.
 H-NMR(CDCl;δ ppm):7.82(d,1H),7.74(dd,1H),7.54(d,2H),7.36(d,1H),7.16(d,2H),6.96(d,1H),6.42(s,1H),6.29(s,1H),6.19(d,1H),5.83(s,1H),5.71(s,1H),2.09(s,3H),2.00(s,3H).
Melting point: 64.7 ° C.
1 H-NMR (CDCl 3 ; δ ppm): 7.82 (d, 1H), 7.74 (dd, 1H), 7.54 (d, 2H), 7.36 (d, 1H), 7. 16 (d, 2H), 6.96 (d, 1H), 6.42 (s, 1H), 6.29 (s, 1H), 6.19 (d, 1H), 5.83 (s, 1H) ), 5.71 (s, 1H), 2.09 (s, 3H), 2.00 (s, 3H).
[実施例9]
化合物(a-261)
Figure JPOXMLDOC01-appb-I000090
[Example 9]
Compound (a-261)
Figure JPOXMLDOC01-appb-I000090
 融点:156.7℃.
 H-NMR(CDCl;δ ppm):7.66-7.59(m,6H),7.42(dd,1H),7.37(dd,1H),7.23-7.18(m,4H),6.99(d,1H),6.38(s,1H),6.29(s,1H),6.17(d,1H),5.79(t,1H),5.72(t,1H),2.09(s,3H),2.01(s,3H).
Melting point: 156.7 ° C.
1 H-NMR (CDCl 3 ; δ ppm): 7.66-7.59 (m, 6H), 7.42 (dd, 1H), 7.37 (dd, 1H), 7.23-7.18 (M, 4H), 6.99 (d, 1H), 6.38 (s, 1H), 6.29 (s, 1H), 6.17 (d, 1H), 5.79 (t, 1H) , 5.72 (t, 1H), 2.09 (s, 3H), 2.01 (s, 3H).
[実施例10]
化合物(a-262)
Figure JPOXMLDOC01-appb-I000091
[Example 10]
Compound (a-262)
Figure JPOXMLDOC01-appb-I000091
 融点:91.3℃.
 H-NMR(CDCl;δ ppm):7.64(d,2H),7.57(dd,2H),7.48(t,1H),7.42(dd,1H),7.37(dd,1H),7.22(dd,2H),7.15(dd,2H),6.97(d,1H),6.38(s,1H),6.29(s,1H),6.21(d,1H),5.78(t,1H),5.71(t,1H),2.08(s,3H),2.01(s,3H).
Melting point: 91.3 ° C.
1 H-NMR (CDCl 3 ; δ ppm): 7.64 (d, 2H), 7.57 (dd, 2H), 7.48 (t, 1H), 7.42 (dd, 1H), 7. 37 (dd, 1H), 7.22 (dd, 2H), 7.15 (dd, 2H), 6.97 (d, 1H), 6.38 (s, 1H), 6.29 (s, 1H ), 6.21 (d, 1H), 5.78 (t, 1H), 5.71 (t, 1H), 2.08 (s, 3H), 2.01 (s, 3H).
[実施例11]
化合物(a-199)
Figure JPOXMLDOC01-appb-I000092
[Example 11]
Compound (a-199)
Figure JPOXMLDOC01-appb-I000092
 融点:107.1℃.
 H-NMR(CDCl;δ ppm):7.65(d,2H),7.58(dd,2H),7.48(t,1H),7.40(dd,1H),7.37(dd,1H),7.22(dd,2H),7.15(dd,2H),6.98(d,1H),6.65-6.57(m,2H),6.38-6.21(m,3H),6.02(dd,1H),5.98(dd,1H).
Melting point: 107.1 ° C.
1 H-NMR (CDCl 3 ; δ ppm): 7.65 (d, 2H), 7.58 (dd, 2H), 7.48 (t, 1H), 7.40 (dd, 1H), 7. 37 (dd, 1H), 7.22 (dd, 2H), 7.15 (dd, 2H), 6.98 (d, 1H), 6.65-6.57 (m, 2H), 6.38 -6.21 (m, 3H), 6.02 (dd, 1H), 5.98 (dd, 1H).
[実施例12]
化合物(a-241)
Figure JPOXMLDOC01-appb-I000093
[Example 12]
Compound (a-241)
Figure JPOXMLDOC01-appb-I000093
 融点:113.5℃.
 H-NMR(CDCl;δ ppm):7.63(d,2H),7.57(dd,2H),7.49(t,1H),7.42(dd,1H),7.37(dd,1H),7.22(dd,2H),7.16(dd,2H),6.99(d,1H),6.58(dd,1H),6.38(s,1H),6.26(dd,1H),6.22(d,1H),5.98(dd,1H),5.79(t,1H),2.09(s,3H).
Melting point: 113.5 ° C.
1 H-NMR (CDCl 3 ; δ ppm): 7.63 (d, 2H), 7.57 (dd, 2H), 7.49 (t, 1H), 7.42 (dd, 1H), 7. 37 (dd, 1H), 7.22 (dd, 2H), 7.16 (dd, 2H), 6.99 (d, 1H), 6.58 (dd, 1H), 6.38 (s, 1H ), 6.26 (dd, 1H), 6.22 (d, 1H), 5.98 (dd, 1H), 5.79 (t, 1H), 2.09 (s, 3H).
2.組成物の実施例
 実施例により本発明の液晶組成物を詳細に説明する。本発明は下記の実施例によって限定されない。実施例における化合物は、下記の表1の定義に基づいて記号により表した。表1において、1,4-シクロヘキシレンに関する立体配置はトランスである。液晶性化合物の割合(百分率)は、液晶組成物の全重量に基づいた重量百分率(重量%)である。最後に、組成物の物性値をまとめた。物性は、先に記載した方法にしたがって測定し、測定値を外挿することなくそのまま記載した。
2. Example of Composition The liquid crystal composition of the present invention will be described in detail by way of examples. The present invention is not limited by the following examples. The compounds in Examples were represented by symbols based on the definitions in Table 1 below. In Table 1, the configuration regarding 1,4-cyclohexylene is trans. The ratio (percentage) of the liquid crystal compound is a weight percentage (% by weight) based on the total weight of the liquid crystal composition. Finally, the physical properties of the composition are summarized. The physical properties were measured according to the method described above, and the measured values were described as they were without extrapolation.
Figure JPOXMLDOC01-appb-I000094
Figure JPOXMLDOC01-appb-I000094
[実施例13](使用例1)
2-HH-3                      15%
3-HH-4                       5%
3-HB-O2                      5%
3-HHB-1                      8%
3-HHB-3                      2%
3-HBB-F                     20%
2-HHB(F,F)-F                14%
3-HHB(F,F)-F                 4%
3-HBB(F,F)-F                 2%
5-HBB(F,F)-F                 6%
2-HHBB(F,F)-F                8%
3-HHBB(F,F)-F                5%
4-HHBB(F,F)-F                6%
 上記組成物100重量部に下記化合物を0.3重量部添加した。
Figure JPOXMLDOC01-appb-I000095
[Example 13] (Use Example 1)
2-HH-3 15%
3-HH-4 5%
3-HB-O2 5%
3-HHB-1 8%
3-HHB-3 2%
3-HBB-F 20%
2-HHB (F, F) -F 14%
3-HHB (F, F) -F 4%
3-HBB (F, F) -F 2%
5-HBB (F, F) -F 6%
2-HHBB (F, F) -F 8%
3-HHBB (F, F) -F 5%
4-HHBB (F, F) -F 6%
0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
Figure JPOXMLDOC01-appb-I000095
[実施例14](使用例2)
5-HB-CL                     16%
3-HH-4                      12%
3-HH-5                       4%
3-HHB-F                      4%
3-HHB-CL                     3%
4-HHB-CL                     4%
3-HHB(F)-F                  10%
4-HHB(F)-F                   9%
5-HHB(F)-F                   9%
7-HHB(F)-F                   8%
5-HBB(F)-F                   4%
1O1-HBBH-5                   3%
3-HHBB(F,F)-F                2%
4-HHBB(F,F)-F                3%
5-HHBB(F,F)-F                3%
3-HH2BB(F,F)-F               3%
4-HH2BB(F,F)-F               3%
 上記組成物100重量部に下記化合物を0.3重量部添加した。
Figure JPOXMLDOC01-appb-I000096

 NI=113.9℃;Δn=0.090;Δε=3.8;η=19.2mPa・s.
[Example 14] (Use Example 2)
5-HB-CL 16%
3-HH-4 12%
3-HH-5 4%
3-HHB-F 4%
3-HHB-CL 3%
4-HHB-CL 4%
3-HHB (F) -F 10%
4-HHB (F) -F 9%
5-HHB (F) -F 9%
7-HHB (F) -F 8%
5-HBB (F) -F 4%
1O1-HBBH-5 3%
3-HHBB (F, F) -F 2%
4-HHBB (F, F) -F 3%
5-HHBB (F, F) -F 3%
3-HH2BB (F, F) -F 3%
4-HH2BB (F, F) -F 3%
0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
Figure JPOXMLDOC01-appb-I000096

NI = 113.9 ° C .; Δn = 0.090; Δε = 3.8; η = 19.2 mPa · s.
[実施例15](使用例3)
3-HHB(F,F)-F                 9%
3-H2HB(F,F)-F                8%
4-H2HB(F,F)-F                8%
5-H2HB(F,F)-F                8%
3-HBB(F,F)-F                21%
5-HBB(F,F)-F                20%
3-H2BB(F,F)-F               10%
5-HHBB(F,F)-F                3%
5-HHEBB-F                    2%
3-HH2BB(F,F)-F               3%
1O1-HBBH-4                   4%
1O1-HBBH-5                   4%
 上記組成物100重量部に下記化合物を0.3重量部添加した。
Figure JPOXMLDOC01-appb-I000097

 NI=98.8℃;Δn=0.117;Δε=9.1;η=35.3mPa・s.
[Example 15] (Use Example 3)
3-HHB (F, F) -F 9%
3-H2HB (F, F) -F 8%
4-H2HB (F, F) -F 8%
5-H2HB (F, F) -F 8%
3-HBB (F, F) -F 21%
5-HBB (F, F) -F 20%
3-H2BB (F, F) -F 10%
5-HHBB (F, F) -F 3%
5-HHEBB-F 2%
3-HH2BB (F, F) -F 3%
1O1-HBBH-4 4%
1O1-HBBH-5 4%
0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
Figure JPOXMLDOC01-appb-I000097

NI = 98.8 ° C .; Δn = 0.117; Δε = 9.1; η = 35.3 mPa · s.
[実施例16](使用例4)
5-HB-F                      12%
6-HB-F                       9%
7-HB-F                       7%
2-HHB-OCF3                   7%
3-HHB-OCF3                   7%
4-HHB-OCF3                   7%
5-HHB-OCF3                   5%
3-HH2B-OCF3                  4%
5-HH2B-OCF3                  4%
3-HHB(F,F)-OCF2H             4%
3-HHB(F,F)-OCF3              5%
3-HH2B(F)-F                  3%
3-HBB(F)-F                  10%
5-HBB(F)-F                  10%
5-HBBH-3                     3%
3-HB(F)BH-3                  3%
 上記組成物100重量部に下記化合物を0.3重量部添加した。
Figure JPOXMLDOC01-appb-I000098
[Example 16] (Use Example 4)
5-HB-F 12%
6-HB-F 9%
7-HB-F 7%
2-HHB-OCF3 7%
3-HHB-OCF3 7%
4-HHB-OCF3 7%
5-HHB-OCF3 5%
3-HH2B-OCF3 4%
5-HH2B-OCF3 4%
3-HHB (F, F) -OCF2H 4%
3-HHB (F, F) -OCF3 5%
3-HH2B (F) -F 3%
3-HBB (F) -F 10%
5-HBB (F) -F 10%
5-HBBH-3 3%
3-HB (F) BH-3 3%
0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
Figure JPOXMLDOC01-appb-I000098
[実施例17](使用例5)
5-HB-CL                     11%
3-HH-4                       8%
3-HHB-1                      5%
3-HHB(F,F)-F                 8%
3-HBB(F,F)-F                20%
5-HBB(F,F)-F                15%
3-HHEB(F,F)-F               10%
4-HHEB(F,F)-F                3%
5-HHEB(F,F)-F                3%
2-HBEB(F,F)-F                3%
3-HBEB(F,F)-F                5%
5-HBEB(F,F)-F                3%
3-HHBB(F,F)-F                6%
 上記組成物100重量部に下記化合物を0.3重量部添加した。
Figure JPOXMLDOC01-appb-I000099
[Example 17] (Use Example 5)
5-HB-CL 11%
3-HH-4 8%
3-HHB-1 5%
3-HHB (F, F) -F 8%
3-HBB (F, F) -F 20%
5-HBB (F, F) -F 15%
3-HHEB (F, F) -F 10%
4-HHEB (F, F) -F 3%
5-HHEB (F, F) -F 3%
2-HBEB (F, F) -F 3%
3-HBEB (F, F) -F 5%
5-HBEB (F, F) -F 3%
3-HHBB (F, F) -F 6%
0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
Figure JPOXMLDOC01-appb-I000099
[実施例18](使用例6)
3-HB-CL                      6%
5-HB-CL                      4%
3-HHB-OCF3                   5%
3-H2HB-OCF3                  5%
5-H4HB-OCF3                 15%
V-HHB(F)-F                   5%
3-HHB(F)-F                   5%
5-HHB(F)-F                   5%
3-H4HB(F,F)-CF3              8%
5-H4HB(F,F)-CF3             10%
5-H2HB(F,F)-F                5%
5-H4HB(F,F)-F                7%
2-H2BB(F)-F                  5%
3-H2BB(F)-F                 10%
3-HBEB(F,F)-F                5%
 上記組成物100重量部に下記化合物を0.3重量部添加した。
Figure JPOXMLDOC01-appb-I000100

NI=70.4℃;Δn=0.098;Δε=8.4;η=25.6mPa・s.
[Example 18] (Use Example 6)
3-HB-CL 6%
5-HB-CL 4%
3-HHB-OCF3 5%
3-H2HB-OCF3 5%
5-H4HB-OCF3 15%
V-HHB (F) -F 5%
3-HHB (F) -F 5%
5-HHB (F) -F 5%
3-H4HB (F, F) -CF3 8%
5-H4HB (F, F) -CF3 10%
5-H2HB (F, F) -F 5%
5-H4HB (F, F) -F 7%
2-H2BB (F) -F 5%
3-H2BB (F) -F 10%
3-HBEB (F, F) -F 5%
0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
Figure JPOXMLDOC01-appb-I000100

NI = 70.4 ° C .; Δn = 0.098; Δε = 8.4; η = 25.6 mPa · s.
[実施例19](使用例7)
5-HB-CL                     17%
7-HB(F,F)-F                  3%
3-HH-4                      10%
3-HH-5                       5%
3-HB-O2                     15%
3-HHB-1                      8%
3-HHB-O1                     5%
2-HHB(F)-F                   7%
3-HHB(F)-F                   7%
5-HHB(F)-F                   7%
3-HHB(F,F)-F                 6%
3-H2HB(F,F)-F                5%
4-H2HB(F,F)-F                5%
 上記組成物100重量部に下記化合物を0.3重量部添加した。
Figure JPOXMLDOC01-appb-I000101
 NI=71.7℃;Δn=0.074;Δε=2.9.
[Example 19] (Use Example 7)
5-HB-CL 17%
7-HB (F, F) -F 3%
3-HH-4 10%
3-HH-5 5%
3-HB-O2 15%
3-HHB-1 8%
3-HHB-O1 5%
2-HHB (F) -F 7%
3-HHB (F) -F 7%
5-HHB (F) -F 7%
3-HHB (F, F) -F 6%
3-H2HB (F, F) -F 5%
4-H2HB (F, F) -F 5%
0.3 parts by weight of the following compound was added to 100 parts by weight of the composition.
Figure JPOXMLDOC01-appb-I000101
NI = 71.7 ° C .; Δn = 0.074; Δε = 2.9.
[実施例20](使用例8)
5-HB-CL                      3%
7-HB(F)-F                    7%
3-HH-4                       9%
3-HH-EMe                    23%
3-HHEB-F                     8%
5-HHEB-F                     8%
3-HHEB(F,F)-F               10%
4-HHEB(F,F)-F                5%
4-HGB(F,F)-F                 5%
5-HGB(F,F)-F                 6%
2-H2GB(F,F)-F                4%
3-H2GB(F,F)-F                5%
5-GHB(F,F)-F                 7%
 上記組成物100重量部に下記化合物を0.15重量部添加し、
Figure JPOXMLDOC01-appb-I000102

さらに下記化合物を0.15重量部添加した。
Figure JPOXMLDOC01-appb-I000103

NI=80.1℃;Δn=0.065;Δε=5.8;η=20.1mPa・s.
[Example 20] (Use Example 8)
5-HB-CL 3%
7-HB (F) -F 7%
3-HH-4 9%
3-HH-EMe 23%
3-HHEB-F 8%
5-HHEB-F 8%
3-HHEB (F, F) -F 10%
4-HHEB (F, F) -F 5%
4-HGB (F, F) -F 5%
5-HGB (F, F) -F 6%
2-H2GB (F, F) -F 4%
3-H2GB (F, F) -F 5%
5-GHB (F, F) -F 7%
0.15 parts by weight of the following compound is added to 100 parts by weight of the composition,
Figure JPOXMLDOC01-appb-I000102

Further, 0.15 parts by weight of the following compound was added.
Figure JPOXMLDOC01-appb-I000103

NI = 80.1 ° C .; Δn = 0.065; Δε = 5.8; η = 20.1 mPa · s.
[比較例1]
化合物(R-1)の合成
Figure JPOXMLDOC01-appb-I000104
[Comparative Example 1]
Synthesis of compound (R-1)
Figure JPOXMLDOC01-appb-I000104
第1工程
 化合物(S-8)を化合物(S-1)に変更した以外は、[実施例2]の第3工程と同様に合成を行い、化合物(R-1)の無色結晶を得た。
融点:150.0℃
 H-NMR(DMSO-d;δ ppm):7.24(d,4H),6.96(d,4H),6.41(d,2H),6.26(d,2H),1.98(s,6H).
Step 1 Synthesis was performed in the same manner as in Step 3 of [Example 2] except that the compound (S-8) was changed to the compound (S-1), and colorless crystals of the compound (R-1) were obtained. .
Melting point: 150.0 ° C
1 H-NMR (DMSO-d; δ ppm): 7.24 (d, 4H), 6.96 (d, 4H), 6.41 (d, 2H), 6.26 (d, 2H), 1 .98 (s, 6H).
[比較例2]
化合物(R-2)の合成
Figure JPOXMLDOC01-appb-I000105
[Comparative Example 2]
Synthesis of compound (R-2)
Figure JPOXMLDOC01-appb-I000105
第1工程
 窒素雰囲気下、化合物(S-15)(100g,0.768mol)、トルエン(300mL)、ピリジン(100mL)の混合物中に、氷冷下、化合物(S-16)(161g,0.845mol)を滴下し、室温で18時間撹拌した。純水を加え、40℃で4時間撹拌した後、反応溶液をトルエンで抽出し、有機層を水洗し、無水硫酸マグネシウムで乾燥した。有機溶媒を減圧下留去し、化合物(S-17)を無色液体(207g)として得た。
First Step Under a nitrogen atmosphere, compound (S-16) (161 g, 0...) In a mixture of compound (S-15) (100 g, 0.768 mol), toluene (300 mL) and pyridine (100 mL) under ice-cooling. 845 mol) was added dropwise and stirred at room temperature for 18 hours. After adding pure water and stirring at 40 ° C. for 4 hours, the reaction solution was extracted with toluene, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. The organic solvent was distilled off under reduced pressure to obtain compound (S-17) as a colorless liquid (207 g).
第2工程
 窒素雰囲気下、化合物(S-1)(30.0g,0.161mol)、DMF(200mL)の混合物に、水素化ナトリウム(55%)(16.8g,0.386mol)を加え、80℃で1時間撹拌した。反応溶液にBHT(5.000mg、0.0220mmol)とDMF(600mL)を加えた後、化合物(S-17)(110g,0.387mol)を加え、60℃で4時間撹拌した。反応溶液に純水を注ぎ、トルエンで抽出し、有機層を水洗し、無水硫酸マグネシウムで乾燥後、有機溶媒を減圧下留去した。残渣をシリカゲルカラムクロマトグラフィー(展開溶媒 トルエン:酢酸エチル=9:1(容積比))で精製後、エタノールより再結晶し、化合物(R-2)を無色結晶(22.3g)として得た。
 融点:89.0℃
 H-NMR(DMSO-d;δ ppm):7.47(d,4H),6.98(d,4H),6.15(s,2H),5.60(t,2H),4.52(t,4H),4.26(t,4H),1.96(s,6H).
Second Step Under a nitrogen atmosphere, sodium hydride (55%) (16.8 g, 0.386 mol) was added to a mixture of compound (S-1) (30.0 g, 0.161 mol) and DMF (200 mL), Stir at 80 ° C. for 1 hour. BHT (5.000 mg, 0.0220 mmol) and DMF (600 mL) were added to the reaction solution, compound (S-17) (110 g, 0.387 mol) was added, and the mixture was stirred at 60 ° C. for 4 hr. Pure water was poured into the reaction solution, extracted with toluene, the organic layer was washed with water and dried over anhydrous magnesium sulfate, and then the organic solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent toluene: ethyl acetate = 9: 1 (volume ratio)) and recrystallized from ethanol to obtain Compound (R-2) as colorless crystals (22.3 g).
Melting point: 89.0 ° C
1 H-NMR (DMSO-d; δ ppm): 7.47 (d, 4H), 6.98 (d, 4H), 6.15 (s, 2H), 5.60 (t, 2H), 4 .52 (t, 4H), 4.26 (t, 4H), 1.96 (s, 6H).
[比較例3]
(液晶組成物への溶解性の比較)
 液晶組成物Aに化合物(a-17)を0.3重量%加え、50℃で30分間加熱した。溶解した液晶組成物を室温で2日間放置した。その後、目視により結晶の析出の有無を確認した。化合物(a-262)についても同様に測定した。一方、[比較例1]の化合物(R-1)および[比較例2]の化合物(R-2)についても同様に測定した。表2に結果を示す。表2中の記号において“○”は結晶が認められないもの、“×”は結晶が認められたものを示す。
 液晶組成物Aの成分とその割合は以下のとおりである。
[Comparative Example 3]
(Comparison of solubility in liquid crystal composition)
0.3% by weight of the compound (a-17) was added to the liquid crystal composition A and heated at 50 ° C. for 30 minutes. The dissolved liquid crystal composition was left at room temperature for 2 days. Thereafter, the presence or absence of crystal precipitation was visually confirmed. The same measurement was performed for compound (a-262). On the other hand, the same measurement was performed for the compound (R-1) of [Comparative Example 1] and the compound (R-2) of [Comparative Example 2]. Table 2 shows the results. In the symbols in Table 2, “◯” indicates that no crystal was observed, and “x” indicates that a crystal was observed.
The components of the liquid crystal composition A and the ratios thereof are as follows.
Figure JPOXMLDOC01-appb-I000106
Figure JPOXMLDOC01-appb-I000106
 表2.液晶組成物への溶解性の比較
Figure JPOXMLDOC01-appb-I000107
Table 2. Comparison of solubility in liquid crystal compositions
Figure JPOXMLDOC01-appb-I000107
 表2から、本発明の重合性化合物は、液晶組成物Aへの溶解性が良好であることが分かった。 From Table 2, it was found that the polymerizable compound of the present invention has good solubility in the liquid crystal composition A.
[比較例4]
(残留モノマー濃度の比較)
 液晶組成物Aに重合性化合物(a-17)を0.3重量%加え溶解し、11mW/cmの紫外線(HOYA CANDEO OPTRONICS株式会社製EXECURE4000-D;水銀キセノンランプ)を273秒間照射した。その後、HPLCにより残存モノマー濃度を測定した。一方、[比較例1]の化合物(R-1)および[比較例2]の化合物(R-2)についても同様に測定した。表3に結果を示す。この比較により本発明の化合物は残留モノマー濃度が低いことがわかった。
[Comparative Example 4]
(Comparison of residual monomer concentration)
The liquid crystal composition A was dissolved by adding 0.3% by weight of the polymerizable compound (a-17) and irradiated with 11 mW / cm 2 ultraviolet rays (EXECURE 4000-D manufactured by HOYA CANDEO OPTRONICS Co., Ltd .; mercury xenon lamp) for 273 seconds. Thereafter, the residual monomer concentration was measured by HPLC. On the other hand, the same measurement was performed for the compound (R-1) of [Comparative Example 1] and the compound (R-2) of [Comparative Example 2]. Table 3 shows the results. From this comparison, it was found that the compound of the present invention had a low residual monomer concentration.
表3.重合反応性の比較
Figure JPOXMLDOC01-appb-I000108
Table 3. Comparison of polymerization reactivity
Figure JPOXMLDOC01-appb-I000108

Claims (23)

  1.  式(1)で表わされる化合物。
    Figure JPOXMLDOC01-appb-I000001

    式(1)において、
     Aは独立して単結合、1,4-シクロへキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリミジン-2,5-ジイル、またはピリジン-2,5-ジイルであり、これらにおいて、少なくとも1つの水素は、ハロゲン、炭素数1から12のアルキル、または少なくとも1つの水素がハロゲンで置き換えられた炭素数1から12のアルキルで、置き換えられてもよく;
     Aは1,4-フェニレンまたはナフタレン-2,6-ジイルであり、これらにおいて、少なくとも1つの水素は、ハロゲン、炭素数1から12のアルキル、または少なくとも1つの水素がハロゲンで置き換えられた炭素数1から12のアルキルで、置き換えられてもよく;
     Zは炭素数1から12のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよく;
     Zは独立して、単結合または炭素数1から12のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよく;
     全てのAおよびAが、1つの水素も置き換えられていない基の場合、ZおよびZの少なくとも1つが不飽和結合を有しており;
     Xは、水素、フッ素、メチル、またはトリフルオロメチルであり;
     Pは重合可能な基であり;
     aは0から3の整数である。
    A compound represented by formula (1).
    Figure JPOXMLDOC01-appb-I000001

    In equation (1),
    A 1 is independently a single bond, 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1, 3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, or pyridine-2,5-diyl, in which at least one hydrogen is halogen, alkyl having 1 to 12 carbons, or at least One hydrogen may be replaced by alkyl having 1 to 12 carbons replaced by halogen;
    A 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is halogen, alkyl having 1 to 12 carbons, or carbon in which at least one hydrogen is replaced by halogen. May be substituted with an alkyl of the number 1 to 12;
    Z 1 is alkylene having 1 to 12 carbons, in which at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH═CH—, or — May be replaced by C≡C-;
    Z 2 is independently a single bond or alkylene having 1 to 12 carbon atoms, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, — May be replaced by CH═CH—, or —C≡C—;
    When all A 1 and A 2 are groups in which no hydrogen is replaced, at least one of Z 1 and Z 2 has an unsaturated bond;
    X 1 is hydrogen, fluorine, methyl, or trifluoromethyl;
    P 1 is a polymerizable group;
    a is an integer of 0 to 3.
  2.  請求項1に記載の式(1)において、
     Aが1,4-シクロへキシレン、1,4-フェニレン、またはナフタレン-2,6-ジイルであり、これらにおいて、少なくとも1つの水素は、フッ素、塩素、炭素数1から4のアルキル、または少なくとも1つの水素がハロゲンで置き換えられた炭素数1から4のアルキルで、置き換えられてもよく;
     Aが1,4-フェニレンまたはナフタレン-2,6-ジイルであり、これらにおいて、少なくとも1つの水素は、フッ素、塩素、炭素数1から4のアルキル、または少なくとも1つの水素がハロゲンで置き換えられた炭素数1から4のアルキルで、置き換えられてもよく;
     Zが炭素数1から12のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよく;
     Zが単結合または炭素数1から12のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられてもよく;
     ZおよびZの少なくとも1つは、少なくとも1つの-CH-が、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられた炭素数1から12のアルキレンであり;
     Xが水素またはメチルであり;
     Pが、式(P-1)から式(P-3)で表わされる基から選択された基であり;
    Figure JPOXMLDOC01-appb-I000002

     aが1である請求項1に記載の化合物。
    In formula (1) according to claim 1,
    A 1 is 1,4-cyclohexylene, 1,4-phenylene, or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl having 1 to 4 carbons, or At least one hydrogen may be replaced by alkyl of 1 to 4 carbons replaced by halogen;
    A 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl of 1 to 4 carbons, or at least one hydrogen is replaced by halogen Optionally substituted with 1 to 4 carbon alkyls;
    Z 1 is alkylene having 1 to 12 carbons, in which at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH═CH—, or — May be replaced by C≡C-;
    Z 2 is a single bond or alkylene having 1 to 12 carbons, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH═CH—. Or may be replaced by -C≡C-;
    At least one of Z 1 and Z 2 is a carbon number in which at least one —CH 2 — is replaced by —COO—, —OCO—, —OCOO—, —CH═CH—, or —C≡C—. 1 to 12 alkylene;
    X 1 is hydrogen or methyl;
    P 1 is a group selected from the groups represented by formula (P-1) to formula (P-3);
    Figure JPOXMLDOC01-appb-I000002

    The compound according to claim 1, wherein a is 1.
  3.  請求項1に記載の式(1)において、
     Aが、1,4-シクロへキシレン、1,4-フェニレン、またはナフタレン-2,6-ジイルであり、これらにおいて、少なくとも1つの水素は、フッ素、塩素、炭素数1から4のアルキル、または少なくとも1つの水素がフッ素で置き換えられた炭素数1から4のアルキルで、置き換えられてもよく;
     Aが1,4-フェニレンまたはナフタレン-2,6-ジイルであり、これらにおいて、少なくとも1つの水素は、フッ素、塩素、炭素数1から4のアルキル、または少なくとも1つの水素がフッ素で置き換えられた炭素数1から4のアルキルで、置き換えられてもよく;
     Zが炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-または-CH=CH-で置き換えられてもよく;
     Zが単結合または炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-または-CH=CH-で置き換えられてもよく;
     ZおよびZの少なくとも1つは、少なくとも1つの-CH-が-CH=CH-で置き換えられた炭素数1から7のアルキレンであり;
     Xが水素またはメチルであり;
     Pが式(P-1)から式(P-3)で表わされる基から選択された基であり;
    Figure JPOXMLDOC01-appb-I000003

     aが1である、請求項1に記載の化合物。
    In formula (1) according to claim 1,
    A 1 is 1,4-cyclohexylene, 1,4-phenylene, or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl having 1 to 4 carbons, Or at least one hydrogen may be replaced by alkyl having 1 to 4 carbon atoms replaced by fluorine;
    A 2 is 1,4-phenylene or naphthalene-2,6-diyl, in which at least one hydrogen is fluorine, chlorine, alkyl of 1 to 4 carbons, or at least one hydrogen is replaced by fluorine Optionally substituted with 1 to 4 carbon alkyls;
    Z 1 is alkylene having 1 to 7 carbons, in which at least one —CH 2 — may be replaced by —O— or —CH═CH—;
    Z 2 is a single bond or alkylene having 1 to 7 carbon atoms, in which at least one —CH 2 — may be replaced by —O— or —CH═CH—;
    At least one of Z 1 and Z 2 is an alkylene of 1 to 7 carbons in which at least one —CH 2 — is replaced by —CH═CH—;
    X 1 is hydrogen or methyl;
    P 1 is a group selected from the groups represented by formula (P-1) to formula (P-3);
    Figure JPOXMLDOC01-appb-I000003

    The compound according to claim 1, wherein a is 1.
  4.  式(1-1)で表される請求項1に記載の化合物。
    Figure JPOXMLDOC01-appb-I000004

    式(1-1)において、
     Zは炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-または-C≡C-で置き換えられてもよく;
     YからY8は独立して、水素、フッ素、メチル、またはトリフルオロメチルであり;
     YからY8がすべて水素の場合、Zが、少なくとも1つの-CH-が、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられた炭素数1から7のアルキレンであり;
     Xは、水素、フッ素、メチル、またはトリフルオロメチルであり;
     Pは重合可能な基である。
    The compound according to claim 1 represented by formula (1-1).
    Figure JPOXMLDOC01-appb-I000004

    In formula (1-1),
    Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH═CH— or —C May be replaced by ≡C-;
    Y 1 to Y 8 are independently hydrogen, fluorine, methyl, or trifluoromethyl;
    When Y 1 to Y 8 are all hydrogen, Z 3 is replaced with at least one —CH 2 — with —COO—, —OCO—, —OCOO—, —CH═CH—, or —C≡C—. 1 to 7 carbon atoms produced;
    X 1 is hydrogen, fluorine, methyl, or trifluoromethyl;
    P 1 is a polymerizable group.
  5.  請求項4に記載の式(1-1)において、Zが炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-が、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられており、そして少なくとも1つの-CH-が、-O-で置き換えられてもよく;YからYが独立して、水素、フッ素、メチル、またはトリフルオロメチルである請求項4に記載の化合物。 In the formula (1-1) according to claim 4, Z 3 is alkylene having 1 to 7 carbon atoms, and in the alkylene, at least one —CH 2 — is —COO—, —OCO—, —OCOO. —, —CH═CH—, or —C≡C—, and at least one —CH 2 — may be replaced with —O—; Y 1 to Y 8 are independently 5. A compound according to claim 4 which is hydrogen, fluorine, methyl or trifluoromethyl.
  6.  請求項4に記載の式(1-1)において、Zが炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-で置き換えられてもよく;YからYが独立して、水素、フッ素、メチル、またはトリフルオロメチルであり、YからYのうち少なくとも1つが、フッ素、メチル、またはトリフルオロメチルである請求項4に記載の化合物。 In formula (1-1) according to claim 4, Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — may be replaced by —O—; 5. The method according to claim 4, wherein Y 1 to Y 8 are independently hydrogen, fluorine, methyl or trifluoromethyl, and at least one of Y 1 to Y 8 is fluorine, methyl or trifluoromethyl. Compound.
  7.  請求項4に記載の式(1-1)において、Xが水素またはメチルであり;YからYがすべて水素である請求項5に記載の化合物。 6. The compound according to claim 5, wherein in formula (1-1) according to claim 4, X 1 is hydrogen or methyl; and Y 1 to Y 8 are all hydrogen.
  8.  請求項4に記載の式(1-1)において、Pが請求項3に記載の式(P-1)および式(P-2)で表わされる基から選択された基である、請求項5に記載の化合物。 The formula (1-1) according to claim 4, wherein P 1 is a group selected from the groups represented by formula (P-1) and formula (P-2) according to claim 3. 5. The compound according to 5.
  9.  請求項4に記載の式(1-1)において、Pが請求項3に記載の式(P-3)で表わされる基である請求項5に記載の化合物。 The compound according to claim 5, wherein P 1 is a group represented by the formula (P-3) according to claim 3 in the formula (1-1) according to claim 4.
  10.  式(1-2)で表される請求項1に記載の化合物。
    Figure JPOXMLDOC01-appb-I000005

    式(1-2)において、
     Zは炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-、-COO-、-OCO-、-OCOO-、-CH=CH-または-C≡C-で置き換えられてもよく;
     LからL12は独立して、水素、フッ素、メチル、またはトリフルオロメチルであり
     LからL12がすべて水素の場合、Zが、少なくとも1つの-CH-が、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられた炭素数1から7のアルキレンであり;
     Xは、水素、フッ素、メチル、またはトリフルオロメチルであり;
     Pは重合可能な基である。
    The compound according to claim 1, which is represented by formula (1-2).
    Figure JPOXMLDOC01-appb-I000005

    In formula (1-2),
    Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — is —O—, —COO—, —OCO—, —OCOO—, —CH═CH— or —C May be replaced by ≡C-;
    L 1 to L 12 are independently hydrogen, fluorine, methyl, or trifluoromethyl, and when L 1 to L 12 are all hydrogen, Z 3 is at least one —CH 2 — is —COO—, Alkylene having 1 to 7 carbon atoms replaced by —OCO—, —OCOO—, —CH═CH—, or —C≡C—;
    X 1 is hydrogen, fluorine, methyl, or trifluoromethyl;
    P 1 is a polymerizable group.
  11.  請求項10に記載の式(1-2)において、Zが炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-が、-COO-、-OCO-、-OCOO-、-CH=CH-、または-C≡C-で置き換えられており、そして少なくとも1つの-CH-が、-O-で置き換えられてもよく;LからL12が独立して、水素、フッ素、メチル、またはトリフルオロメチルである請求項10に記載の化合物。 In the formula (1-2) according to claim 10, Z 3 is alkylene having 1 to 7 carbon atoms, and in the alkylene, at least one —CH 2 — is —COO—, —OCO—, —OCOO. —, —CH═CH—, or —C≡C—, and at least one —CH 2 — may be replaced with —O—; L 1 to L 12 are independently 11. A compound according to claim 10 which is hydrogen, fluorine, methyl or trifluoromethyl.
  12.  請求項10に記載の式(1-2)において、Zが炭素数1から7のアルキレンであり、このアルキレンにおいて、少なくとも1つの-CH-は、-O-で置き換えられてもよく;LからL12が独立して、水素、フッ素、メチル、またはトリフルオロメチルであり;LからL12のうち少なくとも1つが、フッ素、メチル、またはトリフルオロメチルである請求項10に記載の化合物。 In formula (1-2) according to claim 10, Z 3 is alkylene having 1 to 7 carbons, and in this alkylene, at least one —CH 2 — may be replaced by —O—; L 12 from L 1 are independently hydrogen, fluorine, methyl or trifluoromethyl; but from L 1 at least one of L 12, fluorine, according to claim 10 which is methyl or trifluoromethyl, Compound.
  13.  請求項10に記載の式(1-2)において、Xが水素またはメチルであり;LからL12がすべて水素である請求項11に記載の化合物。 The compound according to claim 11, wherein in the formula (1-2) according to claim 10, X 1 is hydrogen or methyl; and L 1 to L 12 are all hydrogen.
  14.  請求項10に記載の式(1-2)において、Pが請求項3に記載の式(P-1)および式(P-2)で表わされる基から選択された基である、請求項11に記載の化合物。 The formula (1-2) according to claim 10, wherein P 1 is a group selected from the groups represented by formula (P-1) and formula (P-2) according to claim 3. 11. The compound according to 11.
  15.  請求項10に記載の式(1-2)において、Pが請求項3に記載の式(P-3)で表わされる基である請求項11に記載の化合物。 The compound according to claim 11, wherein P 1 is a group represented by the formula (P-3) according to claim 3 in the formula (1-2) according to claim 10.
  16.  請求項1から15のいずれか1項に記載の化合物を含む組成物。 A composition comprising the compound according to any one of claims 1 to 15.
  17.  請求項1から15のいずれか1項に記載の化合物を、非重合性の液晶組成物に添加してなる請求項16に記載の組成物。 The composition according to claim 16, wherein the compound according to any one of claims 1 to 15 is added to a non-polymerizable liquid crystal composition.
  18.  式(2)から式(4)で表わされる化合物の群から選択される少なくとも1つの化合物をさらに含有する請求項16または17に記載の組成物。
    Figure JPOXMLDOC01-appb-I000006

    式(2)から式(4)において、
     R11は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの水素はフッ素で置き換えられてもよく、少なくとも1つの-CH-は-O-で置き換えられてもよく;
     環B11、環B12、および環B13は独立して、1,4-シクロヘキシレン、1,3-ジオキサン-2,5-ジイル、テトラヒドロピラン-2,5-ジイル、または少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレンであり;
     Z11およびZ12は独立して、-(CH-、-(CH-、-COO-、-CFO-、-OCF-、-CH=CH-、-C≡C-、-CHO-、または単結合であり;
     Y11は独立して、フッ素、塩素、-OCF、-OCHF、-CF、-CHF、-CHF、-OCFCHF、または-OCFCHFCFであり;
     Y12およびY13は独立して水素またはフッ素である。
    The composition according to claim 16 or 17, further comprising at least one compound selected from the group of compounds represented by formula (2) to formula (4).
    Figure JPOXMLDOC01-appb-I000006

    In Formula (2) to Formula (4),
    R 11 is independently alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, in which at least one hydrogen may be replaced by fluorine, and at least one —CH 2 -May be replaced by -O-;
    Ring B 11 , Ring B 12 , and Ring B 13 are independently 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, tetrahydropyran-2,5-diyl, or at least one hydrogen Is 1,4-phenylene which may be replaced by fluorine;
    Z 11 and Z 12 are independently — (CH 2 ) 2 —, — (CH 2 ) 4 —, —COO—, —CF 2 O—, —OCF 2 —, —CH═CH—, —C≡. C—, —CH 2 O—, or a single bond;
    Y 11 is independently fluorine, chlorine, —OCF 3 , —OCHF 2 , —CF 3 , —CHF 2 , —CH 2 F, —OCF 2 CHF 2 , or —OCF 2 CHFCF 3 ;
    Y 12 and Y 13 are independently hydrogen or fluorine.
  19.  式(5)から式(7)で表わされる化合物の群から選択される少なくとも1つの化合物をさらに含有する請求項16、17または18に記載の組成物。
    Figure JPOXMLDOC01-appb-I000007

    式(5)から式(7)において、
     R12およびR13は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの水素はフッ素で置き換えられてもよく、少なくとも1つの-CH-は-O-で置き換えられてもよく;
     環C11、環C12、および環C13は独立して、1,4-シクロヘキシレン、1,4-フェニレン、2-フルオロ-1,4-フェニレン、または2,5-ジフルオロ-1,4-フェニレンであり;
     Z13およびZ14は独立して、-(CH-、-COO-、-CH=CH-、-C≡C-、または単結合である。
    The composition according to claim 16, 17 or 18, further comprising at least one compound selected from the group of compounds represented by formula (5) to formula (7).
    Figure JPOXMLDOC01-appb-I000007

    In the equations (5) to (7),
    R 12 and R 13 are independently alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, in which at least one hydrogen may be replaced by fluorine, and at least one —CH 2 — may be replaced by —O—;
    Ring C 11 , Ring C 12 , and Ring C 13 are independently 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, or 2,5-difluoro-1,4 -Phenylene;
    Z 13 and Z 14 are independently — (CH 2 ) 2 —, —COO—, —CH═CH—, —C≡C—, or a single bond.
  20.  請求項1から15のいずれか1項に記載の化合物を重合させて得られる重合体。 A polymer obtained by polymerizing the compound according to any one of claims 1 to 15.
  21.  請求項16から19のいずれか1項に記載の組成物を重合させて得られる重合体。 A polymer obtained by polymerizing the composition according to any one of claims 16 to 19.
  22.  請求項1から15のいずれか1項に記載の化合物、請求項16から19のいずれか1項に記載の組成物、および請求項20または21に記載の重合体の群から選択される少なくとも1つを含む液晶表示素子。 21. At least one selected from the group of compounds according to any one of claims 1 to 15, a composition according to any one of claims 16 to 19, and a polymer according to claim 20 or 21. Liquid crystal display element including two.
  23.  請求項1から15のいずれか1項に記載の化合物、請求項16から19のいずれか1項に記載の組成物、および請求項20または21に記載の重合体の群から選択される少なくとも1つの液晶表示素子における使用。 21. At least one selected from the group of compounds according to any one of claims 1 to 15, a composition according to any one of claims 16 to 19, and a polymer according to claim 20 or 21. Use in two liquid crystal display elements.
PCT/JP2012/080130 2011-11-24 2012-11-21 Polymerizable compound WO2013077343A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013545941A JP6136932B2 (en) 2011-11-24 2012-11-21 Polymerizable compound

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2011-256266 2011-11-24
JP2011256266 2011-11-24
JP2012164426 2012-07-25
JP2012-164426 2012-07-25

Publications (1)

Publication Number Publication Date
WO2013077343A1 true WO2013077343A1 (en) 2013-05-30

Family

ID=48469785

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2012/080130 WO2013077343A1 (en) 2011-11-24 2012-11-21 Polymerizable compound

Country Status (2)

Country Link
JP (1) JP6136932B2 (en)
WO (1) WO2013077343A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104927876A (en) * 2014-03-21 2015-09-23 默克专利股份有限公司 Polymerisable Compounds And The Use Thereof In Liquid-Crystal Displays
JP2016040368A (en) * 2014-08-11 2016-03-24 Jnc株式会社 Polymerizable compound and liquid crystal display element
JP2016108558A (en) * 2014-12-01 2016-06-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Liquid crystal medium
JP2016108310A (en) * 2014-11-27 2016-06-20 Jnc株式会社 Compound with poly(difluoromethylene) chain, liquid crystal composition and liquid crystal display element
JP2017141424A (en) * 2016-02-05 2017-08-17 Jnc株式会社 Liquid crystal composition and liquid crystal display element
JP2017523289A (en) * 2014-07-28 2017-08-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Liquid crystal medium having homeotropic alignment
WO2017199778A1 (en) 2016-05-19 2017-11-23 Jnc株式会社 Polymerizable compound and composition, liquid crystal composite, optically anisotropic body, liquid crystal display element, and use therefor
WO2018117213A1 (en) * 2016-12-22 2018-06-28 Dic株式会社 Liquid crystal display element

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06507987A (en) * 1992-04-27 1994-09-08 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング electro-optical liquid crystal system
JPH08231562A (en) * 1994-11-10 1996-09-10 Consortium Elektrochem Ind Gmbh Production of liquid crystal polyorganosiloxane having methacryloxy group and/or acryloxy group and film made from said polyorgano-siloxane
WO2009104468A1 (en) * 2008-02-22 2009-08-27 株式会社Adeka Liquid crystal composition containing polymerizable compound, and liquid crystal display element comprising the liquid crystal composition
JP2010159324A (en) * 2009-01-06 2010-07-22 Adeka Corp Polymerizable liquid crystal composition containing polymerizable liquid crystalline compound, and optically anisotropic film containing polymer of the polymerizable liquid crystalline composition
JP2010537256A (en) * 2007-08-30 2010-12-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング LCD display
WO2011035842A1 (en) * 2009-09-28 2011-03-31 Merck Patent Gmbh Polymerizable compounds and their use in liquid-crystal displays
WO2011050893A1 (en) * 2009-10-28 2011-05-05 Merck Patent Gmbh Polymerizable compounds and use thereof in liquid crystal displays
JP2011162571A (en) * 2010-02-04 2011-08-25 Dic Corp Liquid crystal composition containing polymerizable compound and liquid crystal display element using the same
JP2011184417A (en) * 2010-03-11 2011-09-22 Dic Corp Polymerizable acetylene compound
JP2011202168A (en) * 2009-04-14 2011-10-13 Dic Corp Liquid crystal composition containing polymerizable compound and liquid crystal display element using the same
JP2011225665A (en) * 2010-04-16 2011-11-10 Dic Corp Liquid-crystal composition containing polymerizable compound and liquid-crystal display element using the same
JP2011227187A (en) * 2010-04-16 2011-11-10 Dic Corp Liquid crystal composition containing polymerizable compound and liquid crystal display element using the liquid crystal composition
WO2011160765A1 (en) * 2010-06-25 2011-12-29 Merck Patent Gmbh Polymerizible compounds and use thereof in liquid crystal displays
JP2012077200A (en) * 2010-10-01 2012-04-19 Dic Corp Liquid crystal composition containing polymerizable compound and liquid crystal display element using the same
JP2012082349A (en) * 2010-10-13 2012-04-26 Dic Corp Polymerizable compound containing liquid crystal composition, and liquid crystal display element using the same
JP2012082350A (en) * 2010-10-13 2012-04-26 Dic Corp Polymerizable compound containing liquid crystal composition, and liquid crystal display element using the same
JP2012241124A (en) * 2011-05-20 2012-12-10 Dic Corp Polymerizable compound-containing liquid crystal composition and liquid crystal display element using the same

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06507987A (en) * 1992-04-27 1994-09-08 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング electro-optical liquid crystal system
JPH08231562A (en) * 1994-11-10 1996-09-10 Consortium Elektrochem Ind Gmbh Production of liquid crystal polyorganosiloxane having methacryloxy group and/or acryloxy group and film made from said polyorgano-siloxane
JP2010537256A (en) * 2007-08-30 2010-12-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング LCD display
WO2009104468A1 (en) * 2008-02-22 2009-08-27 株式会社Adeka Liquid crystal composition containing polymerizable compound, and liquid crystal display element comprising the liquid crystal composition
JP2010159324A (en) * 2009-01-06 2010-07-22 Adeka Corp Polymerizable liquid crystal composition containing polymerizable liquid crystalline compound, and optically anisotropic film containing polymer of the polymerizable liquid crystalline composition
JP2011202168A (en) * 2009-04-14 2011-10-13 Dic Corp Liquid crystal composition containing polymerizable compound and liquid crystal display element using the same
WO2011035842A1 (en) * 2009-09-28 2011-03-31 Merck Patent Gmbh Polymerizable compounds and their use in liquid-crystal displays
WO2011050893A1 (en) * 2009-10-28 2011-05-05 Merck Patent Gmbh Polymerizable compounds and use thereof in liquid crystal displays
JP2011162571A (en) * 2010-02-04 2011-08-25 Dic Corp Liquid crystal composition containing polymerizable compound and liquid crystal display element using the same
JP2011184417A (en) * 2010-03-11 2011-09-22 Dic Corp Polymerizable acetylene compound
JP2011225665A (en) * 2010-04-16 2011-11-10 Dic Corp Liquid-crystal composition containing polymerizable compound and liquid-crystal display element using the same
JP2011227187A (en) * 2010-04-16 2011-11-10 Dic Corp Liquid crystal composition containing polymerizable compound and liquid crystal display element using the liquid crystal composition
WO2011160765A1 (en) * 2010-06-25 2011-12-29 Merck Patent Gmbh Polymerizible compounds and use thereof in liquid crystal displays
JP2012077200A (en) * 2010-10-01 2012-04-19 Dic Corp Liquid crystal composition containing polymerizable compound and liquid crystal display element using the same
JP2012082349A (en) * 2010-10-13 2012-04-26 Dic Corp Polymerizable compound containing liquid crystal composition, and liquid crystal display element using the same
JP2012082350A (en) * 2010-10-13 2012-04-26 Dic Corp Polymerizable compound containing liquid crystal composition, and liquid crystal display element using the same
JP2012241124A (en) * 2011-05-20 2012-12-10 Dic Corp Polymerizable compound-containing liquid crystal composition and liquid crystal display element using the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BARDOSOVA,M. ET AL.: "Thin films of liquid crystal fumarates and a related acrylate", THIN SOLID FILMS, vol. 300, 1997, pages 234 - 239, XP005256897, DOI: doi:10.1016/S0040-6090(96)09550-8 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2921545A3 (en) * 2014-03-21 2015-12-30 Merck Patent GmbH Polymerisable compounds and the use thereof in liquid-crystal displays
CN104927876A (en) * 2014-03-21 2015-09-23 默克专利股份有限公司 Polymerisable Compounds And The Use Thereof In Liquid-Crystal Displays
JP2017523289A (en) * 2014-07-28 2017-08-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Liquid crystal medium having homeotropic alignment
JP2016040368A (en) * 2014-08-11 2016-03-24 Jnc株式会社 Polymerizable compound and liquid crystal display element
US9637578B2 (en) 2014-08-11 2017-05-02 Jnc Corporation Polymerizable compound, polymerizable composition and liquid crystal display device
JP2016108310A (en) * 2014-11-27 2016-06-20 Jnc株式会社 Compound with poly(difluoromethylene) chain, liquid crystal composition and liquid crystal display element
JP2016108558A (en) * 2014-12-01 2016-06-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Liquid crystal medium
JP2017141424A (en) * 2016-02-05 2017-08-17 Jnc株式会社 Liquid crystal composition and liquid crystal display element
WO2017199778A1 (en) 2016-05-19 2017-11-23 Jnc株式会社 Polymerizable compound and composition, liquid crystal composite, optically anisotropic body, liquid crystal display element, and use therefor
JPWO2017199778A1 (en) * 2016-05-19 2019-02-14 Jnc株式会社 Polymerizable compound and composition, liquid crystal composite, optical anisotropic body, liquid crystal display element and use thereof
JP2020011987A (en) * 2016-05-19 2020-01-23 Jnc株式会社 Polymerizable compound and composition, liquid crystal composite, optical anisotropic body, liquid crystal display element and use thereof
JP2020011988A (en) * 2016-05-19 2020-01-23 Jnc株式会社 Polymerizable compound and composition, liquid crystal composite, optical anisotropic body, liquid crystal display element and use thereof
US11193066B2 (en) 2016-05-19 2021-12-07 Jnc Corporation Polymerizable compound and composition, liquid crystal composite, optical anisotropic body, liquid crystal display device and use thereof
WO2018117213A1 (en) * 2016-12-22 2018-06-28 Dic株式会社 Liquid crystal display element

Also Published As

Publication number Publication date
JPWO2013077343A1 (en) 2015-04-27
JP6136932B2 (en) 2017-05-31

Similar Documents

Publication Publication Date Title
JP6146412B2 (en) Polymerizable compound, liquid crystal composition, and liquid crystal display device
JP6379735B2 (en) Polymerizable compound having triple bond, liquid crystal composition, and liquid crystal display device
JP5850023B2 (en) Liquid crystal compound, liquid crystal composition and liquid crystal display element having CF2OCF3 at terminal
JP6136932B2 (en) Polymerizable compound
JP6566031B2 (en) Liquid crystalline compound having benzothiophene, liquid crystal composition, and liquid crystal display device
JP2015078282A (en) Polymerizable compound, polymerizable composition and liquid crystal display element
WO2015004947A1 (en) Polymerizable compound, polymerizable composition, and liquid crystal display element
JP2016011346A (en) Polymerizable compound, polymerizable composition, and liquid crystal display element
JP6850410B2 (en) Liquid crystal compounds, liquid crystal compositions and liquid crystal display devices with benzothiophene
JP6311531B2 (en) Compound having 3,3-difluoro-1-propenyloxy, liquid crystal composition and liquid crystal display device
JP6524699B2 (en) Liquid crystalline compound having vinylene group, liquid crystal composition and liquid crystal display device
WO2015076077A1 (en) Piperidine derivative, liquid crystal composition, and liquid crystal display element
JP2020011987A (en) Polymerizable compound and composition, liquid crystal composite, optical anisotropic body, liquid crystal display element and use thereof
JP6451549B2 (en) Polymerizable compound and liquid crystal display device
WO2015129540A1 (en) Liquid crystal compound having 1,1,3,3-tetrafluoroallyloxy group, liquid crystal composition, and liquid crystal display element
JP6578690B2 (en) Liquid crystal compound having halogenated alkyl, liquid crystal composition, and liquid crystal display device
WO2017014013A1 (en) Polymerizable polar compound, liquid crystal composition and liquid crystal display element
JP2015030668A (en) Polymerizable compound having oxygen-containing five-membered ring, liquid crystal composition and liquid crystal display device
JP6787478B2 (en) Polymerizable compounds and liquid crystal display devices
JP6638814B2 (en) Polymerizable polar compound, liquid crystal composition and liquid crystal display device
JP6555144B2 (en) Liquid crystal compound, liquid crystal composition, and liquid crystal display device
WO2020080120A1 (en) Compound, liquid crystal composition, and liquid crystal display element
JP2018070584A (en) Liquid crystalline compound having fluorene and cf2o, liquid crystal composition and liquid crystal display element
TWI753222B (en) Compound, liquid crystal composition and liquid crystal display element
JP2019199461A (en) Compound, liquid crystal composition, and liquid crystal display element

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12852175

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2013545941

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12852175

Country of ref document: EP

Kind code of ref document: A1